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Abstract 
Objective: The overarching purpose of this dissertation was to provide an evidence-based 
portrayal of i) incidence, ii) predictors and iii) causes of death in athletes from Major League 
Baseball, the National Basketball Association and American Basketball Association, the 
National Football League and the National Hockey League. More specifically, this investigation 
highlighted i) mortality outcome differences of athletes between and within professional sport(s), 
ii) potential statistical artifacts that may be empowering biases of risk of certain lifespan 
predictors and iii) the challenges of contextualizing historical data to answer questions with 
relevance in the present where socio-contextual factors may be different. 
Methods: Data on player lifespan and biological and occupational variables were collected from 
publically available sources. A majority of the data were collected from wikipedia.org and 
sports-reference.com, which is a recognized sports archive of aggregated athlete records, and 
were cross-verified through rigorous web-based and sport encyclopedia archival searches. 
Several methodological approaches were used across seven studies, including descriptive and 
Kaplan-Meier and Cox regression survival analyses.   
Results: The key findings of this dissertation suggest that elite athletes generally have 
favourable lifespan outcomes, although numerous characteristics need to be taken into 
consideration, such as occupational (e.g., required energy system needed for participation) and 
biological (e.g., height) differences. As well, the leading causes of death in players from the four 
major sports in North America are similar to the leading causes of death in the age- and sex-
matched controls from the Canadian and United States general population.  
Conclusions: Statistical limitations and biased reporting may skew public perception of the 
relationship between participation in high performance sport and lifespan. As such, there is 
inherent value in scientists critically examining the health outcomes of athletes and to make these 
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data known to a broader audience, particularly as preconceived notions of health risks from sport 
participation vocalized through media often distort reality and can adversely affect sport 
participation rates. In summary, a comprehensive understanding of the implications of 
involvement in elite sport informs our broader understanding of general athlete health and helps 
to form evidence-based models of athlete development and care.  
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CHAPTER ONE: GENERAL INTRODUCTION 
 
Background and Rationale 
 
 One of the most linear relationships in behavioural science was described by Oeppen and 
Vaupel in 2002, where a four-decade increase in life expectancy across 16 decades was found for 
both women (r
2 
= 0.992) and men (r
2 
= 0.980). They noted that this linear-regression trend “may 
be the most remarkable regularity of mass endeavor ever observed” (Oeppen & Vaupel, 2002; p. 
1029). Certainly, the notion of life expectancy continuing to steadily increase evokes feelings of 
optimism, yet it is deceptively simple. The mercurial nature of lifespan is the result of numerous 
natural and unnatural confounders impacting an individuals’ age of death. From a population 
health perspective, Parrish (2010) illustrated a causal web that depicted the complexity of health 
outcomes in populations, which included interactions among cultural, environmental, political, 
social, economic, behavioural and genetic factors. The health outcomes were shown to be 
affected by ‘intermediate’ influences such as proximal factors (e.g., diet, exercise) leading to 
physiological changes (e.g., blood pressure, cholesterol) and changing prevalence of diseases and 
injury (e.g., diabetes, falls). Adding to the complexity, ‘reverse causality’ can exist where health 
outcomes such as morbidity can change a risk factor (e.g., a congenital disability negatively 
affecting participation in physical activity; Kindig, 2014). Importantly, Kindig (2014) implied 
that each of these determinants does not contribute equally to health outcomes, and that 
differences exist depending on the population studied. For example, while Oeppen and Vaupel’s 
(2002) findings implicitly suggest that we as a species are engaging in healthier practices, 
Carrera-Bastos, Fontes-Villalba, O’Keefe, Lindeberg and Cordain (2011) reported that today’s 
greater life expectancy is not due to a healthier diet and lifestyle; but to improved sanitation, 
vaccinations, antibiotics, better medical care and lower physical trauma. Further, Samaras (2012) 
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suggested that these improvements in modern medicine have sharply reduced infant, childhood 
and maternal mortality and increased our ability to keep older people alive; however, we should 
have a much higher life expectancy as these trends do not indicate that people are living 
healthier. As such, although the upper limit of human life expectancy has incrementally 
increased, determining the exact impact of each health determinant on lifespan remains a major 
challenge in health research.  
Historical Changes 
 
The World Health Organization has not amended their definition of health since 1948, 
which states that “health is a state of complete physical, mental and social well-being and not 
merely the absence of disease of infirmity” (World Health Organization, 1948). As a variety of 
socioeconomic, demographic, and epidemiologic factors shape population change (Omran, 
2005), so do the magnitude and causal risk factors of health that affect life expectancy. Historical 
shifts in patterns of health and disease are generally considered the fundamental elements of 
population change, and have been illuminated through evolving theories and contemporary 
branches of science that capture the changing population health patterns over the past century. 
For example, Vaupel’s research in biodemography, an emerging sub-field within human 
demography that examines biological and demographic determinants of health (Carey & Vaupel, 
2005), has used the biodemographic framework to investigate causal factors affecting increased 
longevities (e.g., Vaupel et al., 1998) and human aging through ‘postponement of mortality’ (i.e., 
delaying the process of aging; e.g., Vaupel, 2010). In addition, the epidemiologic transition 
theory (originally posited by Omran in 1971) describes the changes in health of a country 
undergoing modernization through population growth resulting from medical advancements 
(Omran, 2005). More specifically, the leading causes of death in the developed world have 
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changed from predominantly infectious diseases (e.g., tuberculosis) earlier in the twentieth 
century to non-communicable diseases (i.e., chronic and degenerative diseases such as 
cardiovascular disease) after 1950 (Omran, 2005).  
While studying population health necessitates and facilitates integration of knowledge 
across the breadth of factors that influence health, it has also been criticized for its broad 
perspective, which limits its practicality in guiding specific research or policy (Kindig, 2014). 
Parrish (2010) suggested that understanding that death (or loss of function) can occur as the 
result of any of the aforementioned determinants of health (e.g., negative lifestyle choices such 
as smoking) may impact those determinants through either behaviour change or have 
implications on policy changes. Mortality and life expectancy are widely considered as the two 
basic measures of population health (e.g., Parrish, 2010), and Vaupel proposed in his 2010 
Nature article that “mortality is by far the most readily and reliably measured index of health” (p. 
537). As such, adopting a more focused thanatological (i.e., scientific study of death) approach 
can be useful for understanding and reducing longevity outcome disparities between the 
heterogeneous sub-groups of the population.   
Athlete Health 
 
Critical and comprehensive investigations of elite athletes’ lifespans can provide fruitful 
avenues to explore issues of human health through engagement in sport and assist in decoding 
risk factors of premature mortality (i.e., dying earlier than life expectancy at birth). While elite 
athletes represent a relatively homogeneous occupational population, North American 
professional sport leagues dating back at least half a century permit interesting opportunities to 
explore mortality outcomes of athletes from sports where the demographics of the athlete 
population have considerably evolved. More specifically, increased anthropometric and racial 
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heterogeneity in the four major professional team sport leagues in North America, Major League 
Baseball (MLB), the National Basketball Association (NBA), the National Football League 
(NFL) and the National Hockey League (NHL), reflect and overlap with i) the epidemiologic 
transition theory by virtue of the population boom and thus having larger pools of athletes to 
select from, and ii) the Civil Rights Movement in the United States (US) during the 1950s and 
1960s with its goal to end racial segregation and discrimination, thus giving African-Americans a 
greater opportunity to participate in professional sport. As a result, from the social determinants 
of health perspective, major paradigm shifts in society over time have underpinned socio-cultural 
divisions, where exceptional high achievers such as professional athletes generally benefit from 
relatively higher income, social status and working conditions. Therefore, examining mortality 
outcomes of athletes from these four leagues given their historical nature and diverse cultural 
make-up can unveil incidences, predictors and causes of death that help form a more complete 
understanding of the relationship between participation in elite sport (i.e., participation in 
national, professional, and international competition such as the Olympics) and health. 
While this research can inform our broader understanding of population health through 
more sophisticated knowledge of what makes and keeps athletes living longer, there is value in 
examining health of elite athletes from a lifespan perspective as well. For example, Wylleman 
and Reints’ (2010) “whole career/whole person” conceptualization of career transitions of elite 
athletes addresses transitional challenges that athletes may go through, which can ultimately 
have important implications on health behaviours later in life, such as long-term involvement in 
vigorous physical activity.  
Availability Heuristic 
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In Polednak’s 1979 book The Longevity of Athletes, he prefaced his summary of studies 
by acknowledging that the data presented aimed to dispel common misconceptions regarding the 
longevity and health of former athletes. Fast forward to today, this trend of reductive 
generalizations still persists. It is difficult to ignore the rise in mass media (i.e., news media such 
as print media, broadcast news and the Internet) coverage of visible tragedies in sport, such as a 
premature cardiac-related death or suicide of a high-profile athlete. In particular, as social media 
represents a ubiquitous form of ‘direct-to-consumer’ communication, there is growing 
importance and necessity for evidence-based research that dispels social bias of 
misrepresentative health risks. Parrish (2010) suggested that measuring the function and well-
being of a population or society itself (rather than individual members) is the most appropriate 
approach to measuring population health outcomes since “it focuses on how well the population 
produces societal-level conditions that optimally sustain the health of all people” (p. 2). 
Unfortunately, the predominantly public nature of social media can propagate a narrative that 
suggests athletes are at an increased risk of premature death, skewing public perception of the 
relationship between sport and health. This concept was indirectly supported in Link and Estes’ 
(2012) study on sudden cardiac death in athletes, where they drew attention to the tendency of 
athletes’ deaths to be nationally noted compared to much less media coverage for non-athletes.   
An aggregation of similar causes of death in an alike demographic group in a short period 
of time, combined with inequalities between reporting deaths in higher profile and lesser known 
athletes, can produce a psychological phenomenon known as the availability heuristic. Tversky 
and Kahneman (1973), who posited the term, defined it as a cognitive predisposition to rely upon 
readily available knowledge and the ease with which an event can be brought to mind rather than 
examining other alternatives. This ideology also has a serial position effect (i.e., primacy-
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recency) undertone, a cognitive bias where we recall the most recent information (along with 
primary/first information) better than information received in the middle (Ebbinghaus, 1902). 
These cognitive biases are corroborated through frequent exposure to trending topics and news 
stories, creating a susceptibility to overreact to news of a young athlete death. For example, 
implementing electrocardiograms as part of the pre-participation physical examination for 
athletes, such as runners prior to a marathon as a result of a previous sudden cardiac death during 
a race, may not be feasible and has been debated by sports federations and governing bodies 
(e.g., Harmon, Drezner, O’Connor, Asplund, & Finnoff, 2016).  
Popular media that normalizes an overly simplistic view regarding risks of death of 
athletes can be particularly harmful at the youth levels of sport. Larson and Verma (1999) found 
that among post-industrial populations, sport was one of the most common leisure-time activities 
youth participated and spent time in. As such, there is inherent value in scientists critically 
examining the health outcomes of athletes and to make these data known to a broader audience, 
particularly as preconceived notions of health risks from sport participation vocalized through 
media often distort reality and can adversely affect sport participation rates.  
Purpose and Objectives  
 
 Much attention has been given to the question of whether participation in sport is a 
healthy pursuit (e.g., see Baker, Safai, & Fraser-Thomas, 2014). This dissertation focuses on a 
branch of this question by critically examining the ultimate health outcome: mortality. While 
mass media can play a positive role in raising awareness to issues (e.g., long-term cognitive 
impact of concussions), it also provided the initial impetus for this research on mortality 
outcomes of high performance athletes. Thus, the overarching purpose of this research was to 
provide an evidence-based portrayal of i) incidence, ii) predictors and iii) causes of death in 
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athletes from MLB, the NBA (and American Basketball Association; ABA), the NFL and the 
NHL. More specifically, this investigation highlighted i) mortality outcome differences of 
athletes between and within professional sport(s), ii) potential statistical artifacts that may be 
empowering biases of risk of certain lifespan predictors and iii) the challenges of contextualizing 
historical data to answer questions with relevance in the present where socio-contextual factors 
may be different. The objectives of each study/chapter were as follows:  
 Chapter Two includes a systematic literature review of mortality and longevity in elite 
athletes which identified several risk factors within and between sports that may have powerful 
effects on mortality outcomes (Lemez & Baker, 2015). Chapter Three examines the occupational 
risk factor of career precocity in depth through a more critical methodological lens by providing 
a historical review of the precocity-longevity hypothesis, along with two studies that examined 
this relationship in Canadian-born NHL players (Lemez, Wattie, Ardern, & Baker, 2014) and 
NBA/ABA players. Chapter Four directly addresses the notion of growing premature deaths in 
professional athletes by examining the trends and causes of death in players from MLB, the 
NBA, the NFL and the NHL who died during their playing careers (Lemez, Wattie, & Baker, 
2015). Chapters Five and Six re-visit the framework of cognitive biases manifested through 
media portrayals by investigating i) a biological mechanism in height and its role on lifespan and 
ii) the causes and early predictors of death in former NBA/ABA players. In addition, Chapter Six 
illuminates the statistical limitations and artifacts of using historical data for likelihood estimates 
with relevance in the present. Chapter Seven includes the final study of this dissertation which 
comprehensively examined the lifespans and mortality trends of athletes from MLB, the 
NBA/ABA, the NFL and the NHL. The key findings and practical implications of these studies 
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are discussed in Chapter Eight, along with future directions and a general conclusion to this 
dissertation.  
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CHAPTER TWO: SYSTEMATIC LITERATURE REVIEW 
 
 
 
 
 
Do elite athletes live longer? A systematic review of mortality and longevity in elite athletes 
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Chapter Two Overview 
Background: Understanding of an athlete’s lifespan is limited with a much more sophisticated 
knowledge of their competitive careers and little knowledge of post-career outcomes. In this 
review we consider the relationship between participation at elite levels of sport and early 
mortality risk relative to other athletes and age- and sex-matched controls from the general 
population. Our objective was to identify, collate and disseminate a comprehensive list of risk 
factors associated with longevity and trends and causes of mortality among elite athletes.  
Methods: English language articles were searched using the Web of Science database. Key 
words athletes, death, elite, “high performance” life expect*, longevity, mortality, players, 
professional, and sport were used to locate research articles. Seventeen additional articles were 
retrieved from reference lists found in these papers and a general web search. The inclusion 
criteria were the following: (1) publication year 1980 or later; (2) the study examined elite-level 
athletes; and (3) outcome data measured mortality/longevity trends and/or causes.  
Results: Fifty-four peer-reviewed publications and three articles from online sources met the 
criteria for inclusion. Baseball, football, soccer, basketball, and cycling had the most reported 
data on elite athletes’ lifespans. A variety of characteristics have attempted to explain risk of 
early mortality (e.g., handedness, playing position, achievement, etc.). Considerable support was 
found for superior longevity outcomes for elite athletes, particularly those in endurance and 
mixed-sports. 
Conclusions: Participation in elite sport is generally favourable to longevity. Future research 
into the mechanisms and occupation-specific risk factors that may adversely affect health is 
important for a better understanding of life expectancies in both eminent and non-eminent 
populations. 
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Key Points: 
 
• A majority of studies included in this review reported superior lifespan outcomes for elite 
athletes compared to age- and sex-matched controls from the general population and 
other athletes. 
• Several characteristics within and between sports may have powerful effects on the 
overall lifespans of players (e.g., type of sport, playing position, race, and energy 
system). 
• Future research on mortality in elite athletes would benefit from more comprehensive 
statistical measures and reliable databases to determine potential mechanisms and risk 
factors that may influence mortality trends and causes in both athlete and non-athlete 
samples.  
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Do elite athletes live longer? A systematic review of mortality and longevity in elite athletes 
 
Background 
Rationale 
Researchers have given considerable attention to the athlete development process (e.g., 
positive youth development through sport; see Holt, 2008). Interestingly, insight into post-career 
outcomes is significantly limited. For instance, our knowledge of how participation in elite sport 
affects lifespan is particularly incomplete. This lack of information about later phases of athletes’ 
lifespans may be attributable to several factors, such as the greater access to athletes during their 
competitive careers as well as the preponderance of participation- and performance-based 
theories focusing on elements related to understanding the antecedents of sporting success (e.g., 
Baker & Horton, 2004). Attaining a complete understanding of an athlete’s lifespan requires 
knowledge of the inherent complexity of relationships that link hereditary and environmental 
characteristics to developmental outcomes. In this study, we focus on mortality of previously-
elite athletes.  
An important challenge to mortality research in sport is the lack of data on the health 
behaviours of athletes post-retirement. Much of our current understanding of trends and causes in 
elite athlete mortality derives from what appear to be ‘one-off’ studies by small teams of 
researchers. Past work examining this issue in depth appears to be limited, although the Finnish 
studies that examined lifespans of former elite endurance, team, and power athletes who 
represented Finland between the years 1920 to 1965 are exceptions (e.g., Kettunen et al., 2014; 
Kujala et al., 2001; Sarna, Kaprio, Kujala, & Koskenvuo, 1997; Sarna, Sahi, Koskenvuo, & 
Kaprio, 1993). In addition, views on elite athlete mortality are largely shaped by popular media 
sources, which may downplay tenets of the lifespan and create false perceptions of early 
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mortality in athletes (e.g., MLB’s Tony Gwynn at 54 years [cancer], the NFL’s Junior Seau at 43 
years [suicide], boxing’s Tommy Morrison at 44 years [AIDS], sailing’s Andrew Simpson at 36 
years [drowning] and skiing’s Sarah Burke at 29 years [training fall]). 
A recent meta-analysis completed by Garatachea et al. (2014) indicated that elite athletes 
live longer than the general population, with an all-cause pooled standard mortality ratio (SMR) 
of 0.67 (95% confidence interval [CI] 0.55–0.81; P < .001). Further, they found a lower risk of 
cardiovascular disease (CVD) and cancer in those who participated in high performance sport, 
which emphasized the health benefits of exercise (Garatachea et al., 2014). While their study 
makes an important contribution to our knowledge of longevity outcomes in elite sport, the 
restrictive sampling frame necessary for a meta-analysis excluded numerous studies that could 
inform our broader understanding of elite athlete health. For example, Garatachea et al. (2014) 
included 10 studies of elite athlete longevity in their meta-analyses, but their inclusion criteria 
excluded studies that did not use SMR as a statistical measure of mortality (38 studies were 
excluded for this reason). As a result, studies with important information regarding longevity in 
elite athletes were excluded, such as greater longevity in Norwegian professional divers (hazard 
ratio [HR] = 0.79, 95% CI 0.63–0.997; Irgens, Troland, Thorsen & Grønning, 2013), and 
important risk factors that may influence longevity, such as sex, as indicated by Olympic medal-
winning females having greater longevity relative to Olympic medal-winning male athletes (HR 
= 0.61, 95% CI 0.51–0.72; Coate & Sun, 2013), and race, as indicated by African-American 
professional basketball players having a 77% greater risk of death compared with white players 
(HR = 1.77, 95% CI 1.35–2.32; Lawler, Lawler, Gibson, & Murray, 2012). Further, several 
studies which reported SMRs were not included in the meta-analysis (e.g., Farahmand, Broman, 
de Faire, Vågerö, & Ahlbom, 2009; Lehman, Hein, Baron, & Gersic, 2012; Morcet, Perrin, 
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Trégaro, Carré, & Deugnier, 2012; Poznańska & Gajewski, 2001; Reynolds & Day, 2012). As 
such, there is an opportunity to grow our current limited understanding of longevity outcomes of 
elite athletes by examining a wider range of studies and sports through a systematic review.  
Similarly, Teramoto and Bungum (2010) completed a narrative review of mortality and 
longevity of elite athletes; however, a relatively small sample of 14 epidemiological studies was 
included. Their primary method of literature retrieval was through the PubMed (1950–) and 
Scopus (1960–) databases, using key words mortality, longevity, life expectancy, death and 
(elite/professional) athletes and players. While this literature search strategy was appropriate, a 
large number of studies on elite athlete mortality and longevity were published during or after 
their publication year of 2010 (e.g., Abel & Kruger, 2010; Baird et al., 2010; Baron, Hein, 
Lehman, & Gersic, 2012; Clarke et al., 2012; Coate & Schwenkenberg, 2012; Coate & Sun, 
2013; Grimsmo, Maehlum, Moelstad, & Arnesen, 2011; Irgens et al., 2013; Kettunen et al., 
2014; Koning & Amelink, 2012; Kuss, Kluttig, & Greiser, 2011; Lawler & Lawler, 2011; Lawler 
et al., 2012; Lehman et al., 2012; Lindqvist et al., 2014; Marijon et al., 2013; Morcet et al., 2012; 
Reynolds & Day, 2012; Sanchis-Gomar, Olaso-Gonzalez, Corella, Gomez-Cabrera, & Vina, 
2011; Smith, 2011a, 2011b; Zwiers et al., 2012). As a result, risk factors such as race have since 
been validated as more consistent indicators of early mortality (e.g., Baron et al., 2012; Lawler et 
al., 2012). Currently, it may be premature to make conclusions about the long-term value of 
being a professional athlete considering the new evidence that has emerged from literature.  
Although it appears that there are many unanswered questions concerning athletes’ 
lifespans, Teramoto and Bungum (2010) presented enough empirical evidence to determine some 
cross-sport and energy systems trends. Teramoto and Bungum (2010) found a trend towards 
endurance (e.g., long-distance runners) and mixed-sport (e.g., soccer) athletes having more 
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favourable survival outcomes relative to power sport (e.g., weightlifters) athletes and the general 
population. Similarly, a meta-analysis performed by Löllgen, Böckenhoff and Knapp (2009) 
examined 38 studies that measured physical activity and all-cause mortality in samples of 
physically active individuals (non-elite athletes) and reported an overall significant relationship 
between physical activity participation and lower all-cause mortality. Light and moderate 
intensity levels of activity were generally associated with a reduction in early mortality, whereas 
training at high intensities was not required for the main prevention against all-cause mortality 
(Löllgen et al., 2009). While Löllgen and colleagues (2009) provided evidence of physical 
activity positively influencing lifespan independent of age and sex, the relationship between 
participation in elite sport and longevity can enhance our understanding of the benefits of 
physical activity at the highest levels of competition in unique athletic cohorts. 
Teramoto and Bungum’s (2010) review suggested that the type and dose of elite sport 
participation may ultimately determine mortality risk. In addition, Teramoto and Bungum (2010) 
highlighted the importance of considering elite athletes as a heterogeneous group with respect to 
mortality trends; differences between and within sports exist. In particular, the differences in 
health-related behaviours between and within sports may also create modifiable factors that are 
associated with longevity and mortality. As a result, overall mortality risk is explained by several 
modifiable factors, such as obesity and physical inactivity, and non-modifiable (unchangeable) 
factors, such as age and race, that are unique to athletes. For instance, Baron et al. (2012) found 
an overall decrease in mortality rates in National Football Players (NFL) who were active 
between 1959 and 1988; however, defensive linemen had increased mortality rates from CVD 
and cardiomyopathy. Moreover, those with a playing time body mass index (BMI) of >30 kg/m² 
had a significantly higher risk of CVD, which was also influenced by race/ethnicity (Baron et al., 
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2012). Although the effects of playing position on lifespan may be more pronounced in contact 
sports such as football, we cannot overlook the differences and nuances in health-related 
behaviours between and within sports that may influence lifespans.    
Objectives 
A subject such as death rates in professional athletes may be more susceptible to 
sensationalism when trends begin to emerge; therefore, it is essential that the data being 
disseminated are transparent and accurate. In this review, we consider the relationship between 
participation at elite levels of sport and mortality risk relative to other athletes and age- and sex-
matched controls from the general population. Our objective was to extend the narrative review 
of Teramoto and Bungum (2010) with a more comprehensive and up-to-date list of studies on 
mortality and longevity in previously elite athletes. More specifically, our aim was to advance 
knowledge in this area by collating athlete mortality/longevity literature that may help refine 
future analytic methods, form evidence-based models of athlete longevity, and determine 
whether elite-level participation in high performance sport produces a lifespan advantage. 
Similar to Teramoto and Bungum’s (2010) research questions, we asked the following: (1) do 
elite athletes have superior longevity outcomes relative to the general population, and (2) which 
mechanisms and risk factors are associated with longevity and are potential precursors to early 
mortality? 
Methods 
Literature Search 
Following the PRISMA statement (Moher, Liberati, Tetzlaff, & Altman, 2009), a 
systematic review of literature was performed using the Web of Science database (1 January 
1980–30 September 2014; see Tables 1.1 and 1.2). Web of Science was chosen as our primary 
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citation index as it contained over 90 million records through its 7 online databases, which would 
have made searches into smaller citation indexes largely redundant (e.g., EMBASE contains over 
28 million records). Further, given this review’s objective, Web of Science’s databases appeared 
to be the most relevant to our study (e.g., Science Citation Index Expanded). Key words, 
including athletes, death, elite, “high performance” life expect*, longevity, mortality, players, 
professional, and sport, were used to locate research articles. While a full electronic search 
strategy for at least one database is recommended (Moher et al., 2009), we further located 
research articles by searching the references of records that were identified through our database 
search, in addition to performing a general web search through the Google Scholar search 
engine. 
Inclusion Criteria 
The inclusion criteria were the following: (1) publication year 1980 or later; (2) the study 
examined elite-level athletes; and (3) outcome data measured mortality/longevity trends and/or 
causes. We excluded studies with no full-text availability (abstracts, conference proceedings, 
commentaries, and editorials), no English-text availability (a small proportion of international 
articles were unavailable for translation to English), other literature reviews with different 
inclusion criteria (e.g., non-elite samples), duplicates, case reports, studies on morbidity (i.e., 
CVD risk factors, etc.), psychosocial measures, collegiate athletes, and studies on the 
effectiveness of pre-screening strategies and prevention. For consistency, we use “elite” 
synonymously with any form of high performance participation in sport (i.e., national, 
professional, and international competition such as the Olympics).  
Data Extraction 
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We identified 1,001 records through database searching using the aforementioned key 
words. After review of title and abstract, we excluded 961 of those records (identical papers, n = 
31; inclusion criteria not fulfilled, n = 930; most commonly due to studies not examining elite 
athletes and/or mortality/longevity trends), which left 40 eligible full-text articles from the Web 
of Science database search. Seventeen additional articles were retrieved from reference lists 
found in these papers and a general web search. In total, 57 studies filled the criteria for inclusion 
(Tables 1.1 and 1.2): 54 peer-reviewed publications (see Table 1.1), in addition to three articles 
from online sources included to investigate findings of mortality risk in elite athletes that may be 
disseminated to a different cohort of the population (e.g., social media users; see Table 1.2). 
Specifically, these three additional articles were located through Google Scholar’s search engine 
using the same key words as used in the Web of Science database search (e.g., athletes, death, 
etc.). We assessed the quality of each of these records through the Newcastle-Ottawa Quality 
Assessment Scale for cohort studies (Wells et al., 2015). See Fig. 1.1 for the PRISMA statement 
(Moher et al., 2009).  
Measured Outcomes 
This review was comprised of elite athlete mortality/longevity studies from 13 different 
countries: Belgium, Finland, France, Germany, Italy, Japan, Netherlands, New Zealand, Norway, 
Poland, Sweden, UK and the USA. Measures of mortality included: hazard rate/ratio of death 
(HR), life expectancy (LE), mortality rate (MR), odds ratio for mortality (OR), relative 
conditional survival (RCS), relative survival ratio (RSR), SMR, and standardized proportionate 
mortality ratio (SPMR). All LE and MR data were compared to age-matched controls from the 
general population and all studies were on male participants, unless stated otherwise in the 
tables.  
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Results 
 
Literature Search 
 
From 1 January 1980 to 30 September 2014, we located 54 peer-reviewed studies (Abel 
& Kruger, 2004, 2005a, 2005b, 2006a, 2006b, 2007a, 2007b, 2010; Aggleton, Bland, Kentridge, 
& Neave, 1994; Aggleton, Kentridge, & Neave, 1993; Baird et al., 2010; Baron et al., 2012; 
Beaglehole & Stewart, 1983; Belli & Vanacore, 2005; Bianco et al., 2007; Boren & Erickson, 
1998; Clarke et al., 2012; Coate & Schwenkenberg, 2012; Coate & Sun, 2013; Fafian, 1997; 
Farahmand et al., 2009; Fudin, Renninger, Lembessis, & Hirshon, 1993; Gajewski & Poznańska, 
2008; Grimsmo et al., 2011; Halpern & Coren, 1988; Hicks, Johnson, Cuevas, DeHaro, & 
Bautista, 1994; Irgens et al., 2013; Kalist & Peng, 2007; Kanda et al., 2009; Kettunen et al., 
2014; Koning & Amelink, 2012; Kujala et al., 2001; Kuss et al., 2011; Lawler & Lawler, 2011; 
Lawler et al., 2012; Lehman et al., 2012; Lindqvist et al., 2014; Marijon et al., 2013; Menotti et 
al., 1990; Morcet et al., 2012; Pärssinen, Kujala, Vartiainen, Sarna, & Seppälä, 2000; Poznańska 
& Gajewski, 2001; Reynolds & Day, 2012; Saint Onge, Rogers, & Krueger, 2008; Samaras, 
Storms, & Elrick, 2002; Sanchis-Gomar et al., 2011; Sarna et al., 1993; Sarna et al., 1997; 
Selden, Helzberg, & Waeckerle, 2009; Smith, 2011a, 2011b; Taioli, 2007; Waterbor, Cloe, 
Delzell, & Andjelkovich, 1988; Zwiers et al., 2012) and three online articles (Barnwell, 2012; 
Baron & Rinsky, 1994; Hargrove, 2006) that examined mortality and longevity in elite athletes 
(N = 57). This is an addition of 43 peer-reviewed studies that were not included in Teramoto and 
Bungum’s (2010) review (11 peer-reviewed studies overlap). Three peer-reviewed studies from 
their review did not match our inclusion criteria (<1980).  
Summary of Life Expectancy in Elite Athletes from Literature 
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 This review included a total of 465,575 athletes: 450,295 from peer-reviewed literature 
(Table 1.1) and 15,280 from online articles (Table 1.2). Of those 465,575 examined, only 5,610 
(1.2%) were female athletes. Although it appears that females have been grossly 
underrepresented in mortality and longevity studies of elite athletes, the extremely low 
proportion of 1.2% is skewed by separate studies examining the same cohort of players (e.g., 
Baron et al., 2012 and Lehman et al., 2012, N = 3,439; Kettunen et al., 2014, Kujala et al., 2001, 
and Sarna et al., 1993, 1997, active Finnish athletes from 1920 to 1965), single studies that 
contained very large sample sizes of male athletes (e.g., Farahmand et al., 2009; N = 300,818), 
and instances where the breakdown of sex in the sample went unreported (e.g., Zwiers et al., 
2012). Nevertheless, only 6 peer-reviewed studies on elite athlete mortality and longevity that 
included females in their samples were identified (Clarke et al., 2012; Coate & Sun, 2013; 
Gajewski & Poznańska, 2008; Kuss et al., 2011; Menotti et al., 1990; Zwiers et al., 2012), and no 
studies that investigated females exclusively.  
From the 9-point Newcastle-Ottawa Quality Assessment Scale (Wells et al., 2015), one 
study had a quality score of 6, six studies had a quality score of 7, 32 studies had a quality score 
of 8, and 15 studies had a quality score of 9 (only peer-reviewed articles were assessed). 
Therefore, the majority of the studies included in this review were generally of high quality (e.g., 
representative sample sizes, age- and sex-matched control groups from the general population, 
etc.).    
Of the 54 peer-reviewed studies included, four were responses to the authors of different 
studies related to mortality and longevity of elite athletes (Fudin et al., 1993; Hicks et al., 1994; 
Smith, 2011a, 2011b). Aside from the studies or reviews that examined multiple sports, 
professional baseball players (n = 16), football players (4 peer-reviewed, 2 online), soccer 
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players (n = 4), basketball players (n = 3), and cyclists (n = 3) were identified through our 
literature search as having the most reported data on elite athletes’ mortality outcomes. In 
particular, MLB players (Abel & Kruger, 2005a, 2006a; Kalist & Peng, 2007; Reynolds & Day, 
2012; Saint Onge et al., 2008; Waterbor et al., 1988), NFL players (Abel & Kruger, 2006b; 
Baron & Rinsky, 1994; Baron et al., 2012; Lehman et al., 2012), cyclists (Marijon et al., 2013; 
Morcet et al., 2012; Sanchis-Gomar et al., 2011), NBA players (Fafian, 1997; Lawler et al., 
2012), and golfers (Coate & Schwenkenberg, 2012; Farahmand et al., 2009) had the most robust 
evidence of greater longevity. These LE benefits generally ranged from 4 to 8 years (e.g., Abel & 
Kruger, 2005a and Sanchis-Gomar et al., 2011, respectively).  
A majority of studies included in this review examined sport organizations that were 
primarily located in the USA, and used age- and sex-matched controls that were also American 
(MLB, NBA, and NFL). The general finding of these studies was a greater longevity for elite 
athletes relative to their American controls. Notably, the majority of mixed-sport studies 
included in this review also found support for greater longevity for athletes who competed at 
elite levels of competition (e.g., Olympics). Similarly, the ‘one-off’ studies from international 
researchers whose controls spanned 12 different countries also reflect a general trend towards 
increased survival rates for a diverse group of athletes relative to their country-specific controls 
from the general population. For example, elite cyclists, such as French, Italian, and Belgian 
Tour de France participants, had greater longevities when compared to the pooled general 
population from their respective countries for the appropriate age cohorts (Marijon et al., 2013; 
Morcet et al., 2012; Sanchis-Gomar et al., 2011). Further, Norwegian divers (Irgens et al., 2013) 
and skiers (Grimsmo et al., 2011), and Italian track and field athletes (Menotti et al., 1990), had 
greater longevities relative to controls from their respective countries as well. Alternatively, less 
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consistent results were found in soccer players, in which both superior survival rates in Dutch 
players (Koning & Amelink, 2012) and inferior survival rates in German players (Kuss et al., 
2011) were reported, alongside increases in amyotrophic lateral sclerosis (ALS) prevalence in 
Italian players (Belli & Vanacore, 2005; Taioli, 2007). In addition, elite Finnish powerlifters 
(Pärssinen et al., 2000) displayed lower lifespans compared to the Finnish general population.  
Risk Factors of Early Mortality and Primary Outcomes 
Considerable research attention has been given to identifying which mechanisms and risk 
factors may be precursors to early mortality, including handedness, precocity, names and initials 
of players/athletes, playing position and weight, education and race, achievement, and energy 
system classifications. First, the relationship between handedness and mortality in elite athletes 
has received increased attention within the last two decades. Nevertheless, differences in 
longevity related to handedness appear to be non-existent in MLB (Abel & Kruger, 2004; Fudin 
et al., 1993; Hicks et al., 1994) and NBA players (Lawler & Lawler, 2011). While a relationship 
between longevity and handedness was identified in elite cricketers (Aggleton et al., 1993), the 
inclusion of a larger sample size appears to have washed out previous significant findings 
(Aggleton et al., 1994). Second, the precocity-longevity hypothesis (see McCann, 2001), which 
investigates the relationship between precociousness (i.e., career debut) and early death, has been 
shown to affect MLB players’ longevities (Abel & Kruger, 2007a). Third, MLB players with 
positive initials in their names (e.g., A.C.E.) were found to live significantly longer than players 
with negative initials (e.g., D.E.D.; Abel & Kruger, 2007b) while baseball, hockey, football and 
basketball players with names beginning with D had shorter lifespans than those with names 
beginning with E to Z (Abel & Kruger, 2010). It is noteworthy that there has been some criticism 
regarding the methodologies used in these studies, such as using selective data and the 
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appropriateness of the statistical tests performed (Smith, 2011a, 2011b). Further, while it has 
been suggested that health is influenced by certain symbolic aspects of the environment 
(Christenfeld, Phillips, & Glynn, 1999), such as a decreased prevalence of death before birthdays 
(e.g., Phillips, Van Voorhees, & Ruth, 1992), the scientific rationale behind the initials of a name 
affecting longevity is limited. In turn, the emergence of a hypothetical name-longevity 
relationship in elite athletes emphasizes the need for greater replication in this area of research.  
Fourth, an athlete’s playing position is arguably the most obvious occupational 
characteristic that influences mortality risk, largely due to differences in exposures and perceived 
anthropometric differences that are determinants of health (e.g., weight). Longevity was found to 
be correlated with position in MLB (Waterbor et al., 1988) and NBA (Fafian, 1997) players. In 
particular, weight and position significantly influenced mortality risk in NFL players (Abel & 
Kruger, 2006b; Baron & Rinsky, 1994; Baron et al., 2012; Hargrove, 2006; Maher & Gill, 1997; 
Samaras et al., 2002; Selden et al., 2009). Further, weight also influenced the lifespans of 
baseball players (Samaras & Storms, 1992; Samaras et al., 2002), and played a role in the 
longevities of Japanese sumo wrestlers, although its influence appeared to be small (OR = 1.08, 
CI 1.01–1.15; Kanda et al., 2009). Fifth, athlete race has been shown to be associated with 
longevity in NBA (Lawler et al., 2012) and NFL players (Baron et al., 2012), even after 
controlling for covariates, as well as with education and longevity in MLB players (Kalist & 
Peng, 2007). Sixth, high achievement in sport emerged as a determinant of longevity, 
specifically through winning percentage in Japanese sumo wrestlers (Kanda et al., 2009), 
handicap in Swedish golfers (Farahmand et al., 2009), and Hall of Fame (HOF) induction in a 
diverse range of sports (Abel & Kruger, 2005b; Bianco et al., 2007). Although Abel and Kruger 
(2005b) reported differences in the life expectancies of MLB HOFs compared to non-inductees, 
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Smith (2011b) did not find a statistically significant difference using corrected data from the 
same sample.   
The last trend that developed from these studies, which served as a classification method 
for Teramoto and Bungum’s 2010 review, was the relationship between the type of sport and 
required energy systems for participation (i.e., aerobic/endurance, mixed, and anaerobic/power) 
and mortality. Similar to Teramoto and Bungum’s (2010) findings, the largest gains in lifespans 
were in endurance and mixed-sport athletes. The greatest LE advantages were found in European 
cyclists (Marijon et al., 2013; Morcet et al., 2012; Sanchis-Gomar et al., 2011), whereas the 
lowest LEs were found in Finnish power lifters (Pärssinen et al., 2000). Cross-sport analyses 
uniformly reported LE advantages in endurance and mixed-sport athletes compared to power-
sport athletes (Clarke et al., 2012; Kettunen et al., 2014; Kujala et al., 2001; Sarna et al., 1993, 
1997; Zwiers et al., 2012), who had some evidence of increased premature mortality from 
suicide suspected from prior anabolic steroid use (Lindqvist et al., 2014; Pärssinen et al., 2000). 
The inconsistent mortality outcomes in power sport athletes make it difficult to generalize across 
all sports. Nevertheless, there was considerable support in the existing literature for superior 
longevity outcomes for elite athletes compared to the age- and sex-matched controls from the 
general population.  
Discussion 
 
 The objective of our review was to advance knowledge on elite athlete mortality and 
longevity to ultimately determine whether elite-level participation in high performance sport 
produces a lifespan advantage. As a whole, the empirical evidence suggests several mechanisms 
and risk factors within and between sports have powerful effects on the overall lifespans of 
players. Our first research question considered whether elite athletes had superior longevity 
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outcomes relative to the general population. An overwhelming majority of studies included in 
this review reported favourable lifespans for athletes compared to their age- and sex-matched 
controls from the general population. In fact, only two studies reported lower lifespans in athletes 
relative to the controls: 812 male and female soccer players who participated in international 
matches for Germany between 1908 and 2006 (RSR = < 1) (Kuss et al., 2011), and 62 male 
Finnish powerlifters who placed first–fifth in their respective weight category in the Finnish 
championships between 1977 and 1982 (SMR = 4.6) (Pärssinen et al., 2000). Our second 
research question explored the risk factors associated with longevity and whether there were 
precursors to early mortality. Although our overall understanding of modifiable and non-
modifiable factors that contribute to mortality risk in elite athletes remains limited, in part due to 
methodological and data source inconsistencies (Smith, 2011a, 2011b), some trends emerged 
from our investigation. In particular, our review supports previous conclusions that aerobic and 
mixed-sport athletes have superior longevity outcomes relative to more anaerobic sport athletes. 
In addition, playing position and weight, as well as education and race appeared to be consistent 
indicators of mortality risk, whereas other risk factors and characteristics such as handedness, 
precocity, and names and initials appeared to be less consistent and/or examined.   
 In their review of the relationship between body size and lifespan, Samaras et al. (2002) 
drew attention to several confounders that may positively influence longevity outcomes, such as 
higher socioeconomic status, smaller body size, and positive environmental and health benefits. 
As highlighted in this review, weight is an important predictor of mortality risk. Likewise, 
significant empirical evidence suggests obesity is one of the major risk factors for premature 
death (e.g., Bahrami et al., 2008). While it is premature to undervalue the relationship between 
weight and mortality in athletes, particularly post-retirement, research has also highlighted the 
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importance of accounting for body composition. For example, it has been suggested that a 
measure of BMI is likely to overestimate adiposity in muscular athletes (e.g., Okorodudu et al., 
2010), particularly in NFL players (Baron et al., 2012). In addition, Koning and Amelink (2012) 
highlighted that self-selecting to participate in an occupation where health is important may 
predispose athletes to favourable survival outcomes relative to population comparisons. Factors 
such as these, in addition to a bevy of other confounders, such as access to high quality medical 
care (Koning & Amelink, 2012), are what make LE a difficult outcome to accurately predict.  
As a variety of confounders may impact longevity, the reasons for the differences in 
lifespans between elite athletes and the general population are likely to be multifactorial. 
Teramoto and Bungum (2010) provided possible explanations of increased survival in the elite 
athlete cohort; namely, participation in higher volumes of exercise training leading to higher 
physical fitness levels, the likelihood that elite athletes are comprised of the healthiest and fittest 
individuals, and the maintenance of active and healthy lifestyles later in life (although less is 
known about longitudinal lifestyle behaviours). The extents to which these confounders 
contribute to mortality risk are still largely unknown however, as survival statistics may 
undermine the interplay of complex socioeconomic factors (Omran, 2005). For example, medical 
care accessibility made available by higher income may improve the LE of athletes when 
compared to other groups. Further, plenty of corroborating evidence suggests health-care 
services alone do not result in improved health outcomes, but a variety of social factors such as 
education and employment produce these widespread biases in health (e.g., Kelly, Morgan, 
Bonnefoy, Butt, & Bergman, 2007). As a result, the historical investigations of elite athletes and 
longevity outcomes need to be cautiously interpreted and discussed in the contexts of a variety of 
possible influential factors of mortality.   
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 Abel and Kruger (2010) discussed two advantages to studying elite athletes with regard 
to longevity. First, they represent a relatively homogeneous occupational population, similar to 
Teramoto and Bungum’s (2010) classification of a distinct physically fit and healthy group, and, 
perhaps more importantly, many sports contain detailed statistical and historical databases that 
track a variety of variables that can influence longevity (e.g., anthropometrics, performance-
based indicators such as induction into the HOF, etc.). These advantages help contribute to the 
growing body of research on elite athlete mortality trends, which in turn can advance research by 
forming evidence-based models of athlete longevity through investigations into a variety of 
variables. In contrast, a caveat to this tendency of measuring the effects of sport-specific 
variables on mortality is that the amount of data available varies from sport to sport, and may be 
somewhat arbitrary. For example, handedness is unlikely to be measured in soccer players, and 
the influence of position in non-contact sports may be more relevant in life quality research 
rather than life longevity. In addition, each sport will have a different inaugural season, which 
limits the amount of deceased players in the relatively newer sports (e.g., Mixed Martial Arts). 
Therefore, each sport will have unique statistical variables that may make it more difficult for 
researchers to draw cross-sport comparisons.    
Limitations 
 
The main finding of this systematic review indicates favourable lifespan advantages for 
elite athletes relative to age- and sex-matched controls from the general population; however, 
limitations in reviewing literature on mortality and longevity in elite athletes exist. We will first 
examine the possible biases in epidemiological research in historical samples of athletes.  
Databases 
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The use of accurate and up-to-date databases is extremely important when analyzing a 
sample longitudinally; however, some statistical databases for past players have been found to be 
incomplete. For example, Smith (2011b) discovered a substantial portion of missing death date 
data (e.g., unknown death dates) in former MLB players in the Sean Lahman Baseball Archive 
(2010). Unfortunately, Smith’s (2011b) critique of Abel and Kruger’s (2005b) conclusion (cases 
without death date data were treated as living players) that HOF non-inductees had a five-year 
longevity advantage was not the only study on MLB player longevity that used the same 
database (e.g., Abel & Kruger, 2004, 2005a, 2006a, 2007a, 2007b, 2010; Kalist & Peng, 2007). 
Although it may be premature to conclude that other databases have similar fallibility (e.g., 
missing death date data), we must be cautious of the possible incongruency between reported and 
unreported/unknown death date data in other studies that bias lifespan results.  
Holistic Health 
As a variety of socioeconomic, demographic, and epidemiologic factors dynamically 
interact to shape population change (Omran, 2005), so do factors that influence holistic health. 
Arguably, the most objective measurement of elite athlete health is rate of mortality. Using 
mortality statistics of elite athletes who played in the earlier decades to make inferences 
regarding holistic health in present-day athletes may be deceptive. The information age has made 
information on elite athletes easy to access, whereas information on elite athletes from the earlier 
eras often fails to depict the mental and social well-being characteristics that encompass holistic 
health. Sorenson, Romano, Azen, Schroeder, and Salem’s (2014a) investigation of lifespan 
exercise among elite intercollegiate athletes is one of few studies that have presented empirical 
evidence of lifetime health and well-being in modern competitive athletes relative to age- and 
sex-matched controls. They found that current student athletes reported higher volumes of 
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weekly exercise, perceived exercise importance, and likelihood of compliance with American 
College of Sports Medicine (ACSM) exercise guidelines relative to non-athletes (Sorenson et al., 
2014a). Interestingly, Sorenson et al. (2014a) found no significant differences between alumni 
student athletes and non-athletes, suggesting that former athletes failed to maintain higher 
exercise levels later in life. Further, in their follow-up study on the same sample, Sorenson et al. 
(2014b) found that relatively older former student athletes (age 43+ years) had a greater risk for 
joint health concerns later in life compared to a non-athlete control group. These findings seem 
counterintuitive since physical activity is often associated with a substantial reduction of chronic 
disease risk and being important to overall health and well-being (e.g., Miles, 2007).  
To broaden our knowledge on holistic health outcomes and behaviour in former athletes, 
it is important to consider the totality of data that have been collected and analyzed to date, 
particularly as research pertaining to the “whole person” (e.g., physical and psychosocial 
measures) in modern competitive athletes gains momentum. It is equally important to make the 
distinction between “quality of life” and “longevity,” as physical health likely moderates 
psychosocial health. For example, evidence suggests that physical activity plays an important 
role in managing mental health diseases, such as anxiety and depression (e.g., Paluska & 
Schwenk, 2000). Thus, factors such as being physically capable to participate in physical activity 
are important to consider when determining an individual’s quality of life. As such, our current 
understanding of elite athletes’ quality of life during and after sport is limited relative to their 
mortality trends.  
Statistical Measures 
 Another criticism of the athlete-mortality literature is on methodological grounds; more 
specifically, cross-study discrepancies in the statistical tests and/or measures used. Although the 
 
 
33 
 
relative paucity of lifespan studies of elite athletes may serve as a temporary explanation for why 
different measures and control variables are used to analyze mortality, we cannot ignore the 
impact of possible statistical bias risk. Risk of bias can affect the cumulative evidence of a 
review of literature (Moher et al., 2009), such as selective reporting within studies, whereby 
researchers may under-report variables that were found to have less statistical impact on 
longevity outcomes in the course of reporting results that support the direction of their findings. 
As a result, the extent of our knowledge about the influence of certain variables on longevity 
may be restricted. Future work in this area of research would benefit from replication of control 
variables when analyzing the same or similar athletic populations to better establish important 
predictors of longevity. Further, meta-analyses on the longevity of elite athletes, such as the 
review completed by Garatachea and colleagues (2014), can provide more evidence-based data 
on the benefits of participating in physical activity. Moreover, it is notable that the sports 
examined have examined periods of different length. Ideally, comparisons would be best when 
comparing timespans of similar length; however, the timespans investigated have ranged from 
players being born from as early as 1840 (Aggleton et al., 1994) to being active as recently as 
2012 (Marijon et al., 2013). These differences could affect the proportion of those living or dead 
in a sample, which may affect measures such as SMR. The implication of these biases on the 
cumulative evidence of this review is unclear, and as a result, it is important to consider how 
publication bias can under- and over-estimate certain predictors of longevity.  
Longitudinal Lifestyle Factors 
Given that empirical evidence is necessary for coherent explanations of lifespan 
outcomes of elite athletes, do risk factors that typically influence longevity become ineffective 
and/or less powerful if maintenance of physical activity ceases? Although there has been some 
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evidence that former intercollegiate student athletes fail to maintain higher exercise levels later 
in life (Sorenson et al., 2014a), our understanding of the impact of different longitudinal lifestyle 
factors influencing lifespan remains incomplete. For example, former male Finnish world class 
athletes were found to be more active than their non-competitive controls (Fogelholm, Kaprio, & 
Sarna, 1994), and participation in physical activity at a young age predicted later life 
involvement, which reduced the prevalence of coronary heart disease (Kujala, Sarna, Kaprio, 
Tikkanen, & Koskenvuo, 2000). In addition, former athletes have been found to partake in fewer 
negative health habits, such as smoking and drinking alcohol (Fogelholm et al., 1994).  
Another issue that is emerging from more recent research relates to the possible 
detrimental effects of high levels of training. In particular, O’Keefe (e.g., Lavie, O’Keefe, Sallis, 
2015; O’Keefe et al., 2012) has advocated that ‘excessive’ aerobic training can result in 
cardiovascular damage (e.g., atrial fibrillation, coronary artery disease, and malignant ventricular 
arrhythmias). These effects may have particular relevance for studies of mortality in previously-
elite athletes. It is important for future research to determine which factors are more robust 
predictors of longevity and if they continue to be relevant in later life. In turn, these findings will 
have implications on the generalizability of factors found to predict early mortality and longevity 
in elite athletes that were measured at one point in time (i.e., active athletic career).  
Future Directions 
The relationship between sport and health has evolved considerably over the past 100 
years. The context in which the historical data are transferable is important to consider, 
particularly when discussing the social determinants of health (Kelly et al., 2007). Despite its 
limitations, historical analyses of sport and health shape our present understanding of its 
relationship and influence. 
Reliable Databases, Repetition, Causes of Mortality, and Follow-up Studies 
 
 
35 
 
Continued contributions to the growing body of research on longevity outcomes of elite 
athletes should utilize appropriate statistical testing with reliable and complete databases. 
Although there are a variety ways to statistically measure and report mortality, research must be 
substantiated through repetition. An important first step is locating or comprising a reliable and 
comprehensive database that embodies all accessible and applicable data. To this end, future 
research of athlete lifespan outcomes can arguably have the greatest impact by determining the 
causes of mortality. Current empirical evidence on the rates of mortality in athletes is far 
superior to our knowledge on the causes of mortality. Epidemiological studies with long-term 
follow-ups are also rare (Belli & Vanacore, 2005). For example, available evidence suggests a 
possible connection between dietary supplements and/or drug use and the high prevalence of 
amyotrophic lateral sclerosis (ALS) in former soccer players (Belli & Vanacore, 2005; Taioli, 
2007). This potential association emphasizes negative long-term neurological outcomes of 
performance demands that are not reflected in MR occurrence.      
Cross-sport Comparisons and Generalizability 
Several sports were noticeably absent from the elite athlete mortality literature (e.g., ice-
hockey, field hockey, handball, snowboarding, table tennis, volleyball, and motorsports). In 
addition, sex-related differences in lifespan remain largely unknown due to the paucity of studies 
on elite female athletes. This raises an important concern about the cross-sport generalizability 
disseminated in this review. Perhaps more importantly, the applicability of these results to the 
general population (i.e., non-elite-athletes) can likely be best explained by health risk factors that 
have not been extensively examined to date in the athlete cohort. Some examples include: 
smoking and diet/nutrition (as stated by Teramoto & Bungum, 2010), lifespan health 
(psychosocial and physical, such as the influence of morbidity on life quality, etc.), and the 
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interplay of nature (hereditary, such as superior genotypes for physical fitness) (e.g., 
Montgomery & Safari, 2007) and nurture (environmental influences). Presumably, elite athletes 
possess advantageous genetic traits. Research on the heritability of physical fitness (e.g., 
Garatachea & Lucia, 2013) suggests that we cannot discount the influence of advantageous 
genetic inheritance coupled with high levels of participation and competition in sport.    
Conclusion 
Risk factors such as type of sport, playing position, weight, education, and race can 
inform our understanding of lifespan, which places increased responsibility on future research to 
demystify and contextualize mortality risk in both eminent and non-eminent populations. In 
conclusion, while additional research studies are needed to address quality of life and wellness 
outcomes, this review highlights mortality trends among elite athletes and concludes that 
participation in elite sport is generally favourable to lifespan. 
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Figure 1.1: Flow of information through the different phases of a systematic review, as per the 
PRISMA statement (Moher et al., 2009).  
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identified through database searching and a general web search (i.e., Google Scholar) 
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Table 1.1: Peer-reviewed elite athlete mortality literature (> 1980; n = 54) 
 
Sport/Country   Authors                         N               Key finding                                                        LE vs. GP 
 
MLB¹    Abel & Kruger          6038   No significant differences in longevity related to handedness (F[2,6035] = 0.13);          -- 
  (2004)         (death < 2001)            
              
MLB¹    Abel & Kruger              2604   LE: ~4–5 years longer (f = 188.0, df = 1, 2,555, p < 0.001); (1900–1950 debut)              ↑                                                                   
   (2005a) 
 
MLB¹    Abel & Kruger                       3573     Median post-induction survival for HOFs was 5 years shorter than for                           -- 
  (2005b)          non-inducted players, 18 years (CI 15.0–21.0) vs. 23 years (CI 22.1–23.9) for 
   matched controls (OR = 1.37, CI 1.08–1.73); (death ≤ 2002) 
 
MLB¹    Abel & Kruger                       4492     LE: 4.8 years longer (SD = ± 15.0); career length increased longevity (F = 3.4,             ↑ 
  (2006a)          df = 3,4379; p < 0.02); (1900–1939 debut)                      
 
MLB¹    Abel & Kruger                       3760      Earlier career debut predicted earlier death (F[8,2898] = 7.78, p < 0.001);                    -- 
   (2007a)          (death < 2006; 1900–1935 debut)                    
 
MLB¹    Abel & Kruger                       3835      Players (n = 11) with positive initials (e.g., A.C.E.; 80.4 ± SE = 3.0) lived                    -- 
  (2007b)       significantly longer (F[2,904] = 3.7, p < 0.03, two-tailed) by 13 years than  
players (n = 30) with negative initials (e.g., D.E.D.; 67.0 ± SE = 3.1) or players  
(n = 864) with neutral initials (67.1 ± SE = 0.5); players with positive initials  
lived significantly longer than their matched controls and those with negative  
initials (p < 0.05); (died before 1950) 
 
MLB¹    Boren & Erickson                      28   The most common toxin that lead to death by poisoning was carbon                              -- 
   (1998)          monoxide; low overall risk (death 1889–1995)  
 
MLB¹    Fudin et al.                             1686     In response to Halpern and Coren’s (1988) study: Left-handers (n = 235) had a M       -- 
   (1993)      longevity of 64.46 years (SD = 15.34) compared to 64.56 years (SD = 15.02) for  
  right-handers (n = 1451), a difference of 38.57 days (t[1684] = 0.09, p > 0.05 for  
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  years lived; Halpern and Coren (1988) reported a difference of 244.72 days);  
  (considered longevity data through 1978) 
 
MLB¹    Halpern & Coren                   1708     M age at death for right-handers was 64.64 years (n = 1472; SD = 15.5) and 63.97        -- 
   (1988)          years for left-handers (n = 236; SD = 15.4), a significant difference (Z = 6.63,  
   P < 0.001) 
 
MLB¹    Hicks et al.                             5441     In response to Fudin et al.’s (1993) study: Reliable data were confirmed for 3501        -- 
   (1994)       right-handers (64.3%), 1199 mixed-handers (22.0%) and 741 left-handers (13.6%); 
         the differences in M days of life were not significant in each group 
               (F[2,5338] = .59, p = 0.55) and between just right- and left-handers 
   (t[4240] = -1.08, p = 0.28; M longevity less for right-handers) 
 
MLB¹    Kalist & Peng                         2641   Greater longevity overall (SMR = 0.31); positive relationship between education          ↑ 
   (2007)          and longevity (HR = 0.74, CI 0.56–0.977); black players had a HR 2.47 times  
   greater than white players (1963–1996 debut) 
 
MLB¹   Reynolds & Day                  14360     Greater longevity rates throughout the last century (1900–1999 debut);                          ↑     
   (2012)                             (SMR = 0.87, CI 0.85–0.89; 1930–1999) 
 
MLB¹   Saint Onge et al.                    6772     LE: ~5 years longer, compared to 20-year-old U.S. males; at 20 years, players               ↑ 
              (2008)        from the Modern Era can expect to live 65.5 years vs. 52.4 years and 58.3 years  
  from the Early and Golden Eras, respectively (1902–2004 debut)                  
 
MLB¹    Smith        --       In response to Abel and Kruger’s (2007b) study: No relationship between name            -- 
  (2011a)          initials and longevity (p > 0.05)                                                         
 
MLB¹    Smith       102     In response to Abel and Kruger’s (2005b) study: Corrected data shows that                   -- 
              (2011b)          there is no statistically significant difference in the LE of HOF players           
   (Z = 0.06, two-sided P = 0.952)                                                   
 
MLB¹  Waterbor et al.                          985     Greater longevity overall (SMR = 0.94); longevity was correlated with position             ↑ 
  (1988)          and in-game achievement (1911–1925 debut) 
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NBA¹    Fafian Jr.                                2810     Greater longevity overall, particularly in guards (active 1946–1994)                               ↑ 
   (1997) 
 
NBA¹    Lawler & Lawler                   3647     Handedness was not significantly related to LE (HR = 0.92, CI 0.54–1.60;                     -- 
  (2011)        P = 0.76); (active 1946–2009)                 
 
NBA¹    Lawler et al.                           3366     White players lived longer (~1.5 years) than black players (HR = 1.77,                           ↑ 
  (2012)        CI 1.35–2.32); LE: ~4 year longer overall (active 1946–2005) 
 
NFL¹     Abel & Kruger                       1512     LE: 6.1 years longer (SD = ± 11.9); career length (F = 4.7, df = 2,1504; p < 0.01)          ↑ 
  (2006b)         and BMI (R² = 0.01, p < 0.01) increased longevity (debut < 1940) 
 
NFL¹     Baron et al.                             3439     Greater longevity overall (SMR = 0.53, CI 0.48–0.59); BMI, race, and position           ↑ 
  (2012)          were associated with longevity (active 1959–1988) 
 
NFL¹     Lehman et al.                         3439      Greater longevity overall (SMR = 0.53, CI 0.48–0.59); increased overall risk of            ↑ 
  (2012)          neurodegenerative MR (SMR = 2.83–3.26, CI 1.36–5.21); elevated ALS 
   (SMR = 4.31, CI 1.73–8.87) and AD (SMR = 3.86, CI 1.55–7.95) subcategories  
   (active 1959–1988) 
 
NFL¹     *Selden et al.                            --        Review of recent data suggests ↑ CVD risk factors in players, particularly linemen       -- 
   (2009) 
 
Boxing   Baird et al.                              339      Decline in premature MR after 1983 (rounds reduced from 15 to 12);                            -- 
   (2010)         (death 1950–2007)     
 
Cricket¹³   Aggleton et al.                    3165     There was a significant lifespan difference (t[3163] = 2.77, P = 0.006, two-tailed)        -- 
     (1993)          between right-handers (n = 2580; 65.62 years) and left-handers (n = 585; 63.52  
   years); left-handers were more likely to die prematurely in accidents or in warfare 
   (players in the British Isles from 1864–1983) 
 
Cricket¹³   Aggleton et al.                    5960      No significant relation between mortality and handedness (P = 0.3); left-handers         -- 
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      (1994)          were more likely to die from unnatural causes (P = 0.03, log hazard 0.37,  
CI 0.04–0.70), particularly warfare (P = 0.009, log hazard 0.53, CI 0.13–0.92);  
(born between 1840–1960; players in the British Isles from 1864–1992) 
 
Cyclists²   Marijon et al.                        786     Greater longevity overall in Tour de France participants (SMR = 0.59, CI 0.51–0.68,    ↑ 
     (2013)        P < 0.0001); reduction in neoplasms (SMR = 0.56, CI 0.42–0.72, P < 0.0001) and  
  CVD (SMR = 0.67, CI 0.50–0.88, P = 0.004); (1947–2012 participants)                     
          
Cyclists²   Morcet et al.                         514      Greater longevity overall (SMR = 0.50, CI 0.34–0.71); although higher MR in              ↑ 
     (2012)         younger cyclists (active 1960–1990)                          
                
Cyclists²³⁴ Sanchis-Gomar et al.           834      LE: ~8 years longer for Tour de France participants (p < 0.05); (active 1930–1964)      ↑ 
       (2011) 
 
Diving⁵     Irgens et al.                        3130      Greater longevity overall (HR = 0.79, CI 0.63–0.997), although increased violent         ↑ 
      (2013)         deaths (born 1950–1999) 
    
Golf¹        Coate & Schwenkenberg,     313      LE: 5.4 years longer (won prize money 1980–2009)                                                        ↑ 
      (2012)    
 
Golf ⁶       Farahmand et al.             300818      Greater longevity overall (SMR = 0.60, CI 0.57–0.64); greatest longevity in most         ↑ 
         (2009)                   skilled players (SMR = 0.53, CI 0.41–0.67); (born > 1920, registered < 2001)        
            
PL⁷           Pärssinen et al.                       62      Increased premature MR (SMR = 4.6, CI 2.04–10.45; P = 0.0002), suspected from       ↓ 
      (2000)         prior anabolic steroid use (placed 1
st
-5
th
 in Finnish championships, 1977–1982) 
 
Rugby⁸     Beaglehole & Stewart          822      LE of All Blacks is the same as GP, although LE (73.0 years) for non-Māori All          = 
                  (1983)         Blacks was ~10 years longer (CI 71.8–74.5) relative to the Māori All Blacks  
   (1884–1981) 
   
Skiing⁵     Grimsmo et al.                      122     Total MR was 9% lower after a 30-year follow-up (P = 0.04); (study participants,         ↑ 
      (2011)          1976–1981)         
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Soccer³     Belli & Vanacore                  350     Similar observed and expected MR, although a ten-fold increase of ALS MR                = 
     (2005)          (SPMR = 1158, CI 672–1998) was present (active 1960–1996) 
 
Soccer⁹    Koning & Amelink               371      Greater longevity overall (P = 0.003); (active 1970–1973)                                              ↑ 
      (2012) 
 
Soccer¹⁰   Kuss et al.                             812      Cumulative observed survival was smaller than cumulative expected survival;              ↓ 
     (2011)          therefore, male and female players had reduced longevity (RSR = < 1);  
   (active 1908–2006)                                    
 
Soccer³     Taioli                                  5389     Greater longevity overall (SMR = 0.68, CI 0.52–0.86), although increased risk              ↑ 
     (2007)          for car accident (SMR = 2.23, CI 1.46–3.27) and ALS (SMR = 18.18, CI 
   5.00–46.55) death (active 1975–2003) 
 
SW¹¹        Kanda et al.                             73     Deceased wrestlers had higher BMIs (OR = 1.08, CI 1.01–1.15) and winning           -- 
      (2009)       percentages (OR = 1.29, CI 0.86–1.93); (active 1926–1989) 
 
T & F³     Menotti et al.                          983    Greater longevity in males (SMR = 0.73; n = 700) and females (SMR = 0.48;                ↑ 
    (1990)          n = 283); significant when analyzed together (P = 0.0296); (active > 1940) 
 
Mixed¹     Abel & Kruger                  10216     Decrease in longevity associated with names beginning with A to D; linear                   -- 
     (2010)        decrease for baseball and hockey players, but non-linear in football and basketball  
  players; for each sport, A names lived longer than E to Z names, and D names had         
  decreased longevities compared to E to Z names F(4,10,193) = 4.16, P = 0.002); 
  football players lived the longest (72.3 ± 12.7) and baseball players lived the least 
  years (70.8 ± 14.7); significant letter differences occurred between A and E-Z 
  (HR = 0.80, CI 0.71–0.91, p < 0.001) and D and E-Z (HR = 1.16, CI 1.04–1.30, 
   p < 0.01); (born 1875–1930) 
  
Mixed      Bianco et al.                          715     Baseball (LE: 76; n = 154), basketball (LE: 78; n = 58), boxing (LE: 73; n = 81),          ↑ 
     (2007)      football (LE: 77; n = 81), ice-hockey (LE: 74.5; n = 130), swimming (LE: 74;  
  n = 37), tennis (LE: 79; n = 83), track and field (LE: 75; n = 59), and wrestling  
                                                              (LE: 77; n = 32) HOFs had greater overall longevity (p < 0.05); (M = 76 years);  
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(born 1860–1930) 
 
Mixed      Clarke et al.                       15174     11,619 (76.6%) male and 3,555 (23.4%) female Olympic Game medalists’            ↑ 
                 (2012)       (1896–2010) LE was 2.8 years longer (RCS = 1.08, CI 1.07–1.10); endurance           
             (RCS = 1.13, CI 1.09–1.17) and mixed (RCS = 1.11, CI 1.09–1.13) sport athletes had 
   a more favourable survival advantage relative to power sport athletes (RCS = 1.05,  
   CI 1.01–1.08) 
 
Mixed¹     Coate & Sun                        2690     Females (n = 1348; HR = 0.61, CI 0.51–0.72) had a ~6 year LE advantage over            ↑ 
     (2013)       males (n = 1342), even though they competed in the same Olympic events (1900– 
2008) and tennis championships (HR = 0.65, CI 0.47–0.91; > 1880); Olympic  
medalists’ LE: 2-3 years longer if born < 1920, but smaller advantage overall; tennis    
players’ LE: 5-6 years longer if born < 1920, and 2-3 years overall; M LE was  
82 years for females and 76 years for males 
 
Mixed¹²    Gajewski & Poznańska       2113     Greater longevity overall in male (n = 1689; SMR = 0.50, CI 0.44–0.56) and female     ↑ 
     (2008)       (n = 424; SMR = 0.73, CI 0.48–1.05) Olympians (1924–2000)  
 
Mixed⁷      Kettunen et al.    2363   LE: ~5-6 years longer overall; endurance (79.1 years; CI 76.6–80.6), team (78.8            ↑ 
      (2014)      years; CI 78.1–79.8) and power (75.6 years; CI 74.0–76.5) sport athletes who 
  represented Finland in international competitions (active 1920–1965) had  
        higher LE than controls (72.9 years, CI 71.8–74.3), even after adjusting for socio- 
        economic status, birth cohort, and disease-specific mortality (HR = < 1); boxers had 
        increased risk of dementia mortality (HR = 4.20, CI 2.30–7.81) 
 
Mixed⁷     Kujala et al.                        2009     Greater longevity overall (SMR = 0.74, CI 0.69–0.79); all-cause mortality was              ↑ 
     (2001)       lower for endurance (SMR = 0.57, CI 0.47–0.68), mixed (SMR = 0.68, CI 0.61– 
0.76), and power (SMR = 0.90, CI 0.81–1.00) sport athletes who represented  
Finland in international competitions (active 1920–1965); increased risk of 
hypertension in power sport athletes (SMR = 2.63, CI 1.06–5.42); (SMRs  
calculated 1971–1995) 
 
Mixed⁶     Lindqvist et al.                    1199   MR was not increased overall in former power sport athletes, except a slight                 -- 
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     (2013)          increase at 45 years (CI 2.1–4.2); between 20-50 years, estimated HR = 1.44–1.46;  
   2.1–3.9 times increased MR from suicide between 30 and 50 years (overall, HR = 1.74,  
   CI 1.08–2.66; P = 0.025); however, there was a lower malignancy MR (HR = 0.71,  
   CI 0.50–0.98; P = 0.036); (active 1960–1979) 
 
Mixed¹²    Poznańska & Gajewski,      1505     Greater overall longevity (SMR = 0.42, CI 0.35–0.49), particularly between 1992–       ↑ 
                 (2001)                                               1998 (Olympians 1981–1998) 
 
Mixed      *Samaras et al.                       --        Modest correlation coefficients indicated that weight is only one risk factor that           -- 
     (2002)          affected the longevities of baseball players (n = 1278; r = −0.22, p < 0.025),  
   football players (n = 199; r = −0.33, p < 0.005), and Finnish elite athletes  
   (r = −0.51, non-significant) 
 
Mixed⁷     Sarna et al.                          2613     LE for endurance (5.7; M = 75.6, CI 73.6–77.5), team (4.0; M = 73.9, CI 72.7–75.1),   ↑ 
     (1993, 1997)         and in power (1.6; M = 71.5, CI 70.4–72.2) sport athletes was greater than the  
   referents (69.9); decreased CVD in endurance (OR = 0.49, CI 0.26–0.93) and team  
   (OR = 0.61, CI 0.41–0.92) sport athletes (active 1920–1965) 
 
Mixed      Zwiers et al.                        9889      High intensity sport athletes had lower longevity compared to low intensity                  -- 
     (2012)          sport athletes (high risk of bodily collision, HR = 1.11, CI 1.06–1.15, and high  
   levels of physical contact, HR = 1.16, CI 1.11–1.22 (Olympians 1896–1936; sex 
   breakdown unknown) 
 
Notes: AD, Alzheimer disease; ALS, amyotrophic lateral sclerosis; BMI, body mass index; CI, confidence interval; CVD, 
cardiovascular disease; GP, general population; HOF, Hall of Fame; HR, hazard rate/ratio of death; LE, life expectancy; M, mean; 
MLB, Major League Baseball; MR, mortality rate; NBA, National Basketball Association; NFL, National Football League; OR, odds 
ratio for mortality; PL, powerlifting; R², explained variation/total variation (coefficient of determination); RCS, relative conditional 
survival; RSR, relative survival ratio; SD, standard deviation; SMR, standardized mortality ratio; SPMR, standardized proportionate 
mortality ratio; SW, sumo wrestling; T & F, track and field  
Samples: ¹USA; ²France; ³Italy; ⁴Belgium; ⁵Norway; ⁶Sweden; ⁷Finland; ⁸New Zealand; ⁹Netherlands; ¹⁰Germany; ¹¹Japan; ¹²Poland; 
¹³United Kingdom; Studies with no subscript analyzed multiple countries, or other sports were used as controls. Full citations provided 
in reference list; all LE and MR data were compared to age-matched controls from the GP and all studies were on male participants, 
unless stated otherwise; descriptions reflect only the key findings;*reviews met inclusion criteria 
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Table 1.2: Online elite athlete mortality articles (n = 3) 
 
Sport/Country   Authors                        N                    Key Finding                                            LE vs. GP 
 
NFL¹     Baron & Rinsky                   6848      NFL players had a 46% decreased MR (SMR = 0.54); linemen had a 52% greater          ↑ 
   (NIOSH)       risk of death from heart disease than the GP, and three times the risk compared to  
  (1994)          football players; players had a decreased risk of death from violence (79%) and 
   accidents (39%); (players since 1959; death through 1991) 
 
NFL¹     Hargrove                              3850      The heaviest NFL players were more than twice as likely to die before their 50
th
           -- 
              (Scripps Howard News Service)     birthday than their teammates; players are generally not dying sooner than average, 
  (2006)        but offensive and defensive linemen had a 52% greater risk of dying from heart 
   disease than the GP; out of the 130 players who died before age 50, 1/69 players 
   born since 1955 are dead, 22% of which died of heart diseases (77% qualified as 
   obese) and 19% from homicides or suicides; when compared to 2403 MLB players  
   who have died in the last century, NFL players are more than twice as likely to die  
   before age 50 (born since 1905) 
 
Mixed¹  Barnwell                               4582      12.8% of football players had died (N = 3088) compared to 15.9% of baseball              -- 
              (Grantland)                             players (N = 1494) as of 2007 (active from 1959–1988) 
   (2012) 
               
Notes: GP, general population; MLB, Major League Baseball; MR, mortality rate; NFL, National Football League; SMR, standardized 
mortality ratio  
¹USA 
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CHAPTER THREE: THE PRECOCITY-LONGEVITY HYPOTHESIS 
 
 As discussed by Lemez and Baker (2015), research attention has been given to 
identifying which characteristics may be precursors to early mortality, such as handedness, 
anthropometrics and race. One characteristic that has received considerably more attention 
outside of sport is precocity’s role on mortality. The precocity-longevity hypothesis proposed by 
McCann (2001) asserts that factors related to early career achievement, such as early debut in 
professional sport, may cultivate early death. Until our two studies (pg.’s 74 and 80), only Abel 
and Kruger (2007) had examined this hypothesis in athletes. Although researchers began 
dissecting the relationship of early career achievement and mortality nearly a century ago (e.g., 
Sorokin, 1925), the subsequent development and investigation of this phenomenon has remained 
limited. The following section will examine the small body of research that has focused on the 
association of age at high career achievement and mortality from a historical perspective, and is 
organized chronologically, since precocity-longevity research has been sparse and the historical 
changes of samples and methodologies are important for explaining the evolution of the topic 
and its propagation today.  
Body – Part 1 
The first investigation linking precocity with longevity was initiated by sociologist 
Pitirim Sorokin (1925). Sorokin studied the lifespans of hereditary monarchs who belonged to 
seven groups: Roman Empire (Holy and Eastern), English kings, French kings, Austria, Prussia, 
Turkish sultans, and Russian czars. Scientists at that time believed that the environment 
surrounding monarchs produced physical, mental and moral degeneration, ultimately manifesting 
in shorter lifespans (e.g., Jacoby, 1904). Sorokin (1925) examined the correlation between mean 
accession age and mean length of life for the seven groups of monarchs and found that ages at 
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which monarchs inherited the throne was related to their longevity. Generally, it was found that 
monarchs who became rulers earlier tended to live shorter lives. Explanations for this lifespan 
discrepancy mainly surrounded the detrimental environment; high stress resulting from 
responsibility, strenuous workload, and other unfavourable conditions appeared to undermine 
and shorten lifespans (Sorokin, 1925).                         
 The influence of precocious achievement on lifespan was not revisited again until Harvey 
Lehman’s 1953 book Age and Achievement. Lehman (1953) examined the relationship between 
mean age at time of achievement and longevity in scientists from 10 different fields. A tendency 
towards greater longevity was found in scientists who made an exceptional contribution to their 
respective field at older mean ages, relative to scientists whose contributions occurred at younger 
ages. Thus, the trends shown by Lehman and his colleagues extended the notion that career 
precociousness may not be beneficial to lifespan, although the understanding of this relationship 
was still largely incomplete.  
Scientific discovery was also used to define precocity 33 years later in Zhao and Jiang’s 
(1986) examination of longevity of scientists. They reported that the lifespans of scientists were 
closely related to their peak age of achievement, which was approximately half the peak value of 
their lifespan (e.g., 37 years and 74 years, respectively). Further, Zhao and Jian (1986) noted an 
interesting trend where the distribution curves of achievements and lifespan were symmetrical, 
and suggested that declining ability in scientific research may be related to deteriorating health 
such as senility. While there are outliers to this relationship, where famous precocious scientists 
such as Albert Einstein, Galileo, Edmond Halley and Sir Isaac Newton exceeded their projected 
life expectancies, Zhao and Jiang (1986) reported that precocious scientists between the 16
th
 
century and 1960 lived shorter on average relative to ‘ordinary’ scientists. However, when 
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compared to the general population, the precocious group nevertheless had greater longevities 
(e.g., the average lifespan for the general population in 1871 was 36 years versus 59 years for 
precocious scientists). Therefore, these results were interpreted as support to further dispel the 
common (and outdated by this time) impression that mental labor was too much a tax on one’s 
brain that ultimately reduced lifespan, and supported the precocity-longevity link where 
precocious scientists died relatively younger compared to ‘ordinary’ scientists.  
   In a separate form of career achievement and productivity, Simonton (1991) explored 
the determinants of creativity and early eminence on the lifespans of 120 famous classical music 
composers (this deceased sample accounted for 89% of all music heard in the classical 
repertoire, thus making it highly representative of the entire domain). Although the focus of 
Simonton’s (1991) study was on the relationship between age and productivity, he nonetheless 
reported a significant correlation between creative precociousness and shorter lifespan. However, 
he interpreted the precocity-longevity relationship differently; Simonton suggested that 
precocious output simply permits a composer to die young and still earn recognition after death, 
thereby artificially inflating the precocity-longevity correlation (McCann, 2001). For example, 
famous composer Franz Schubert died at 31 years, but if he produced his masterpieces at a later 
age, his fame would have likely weakened (Simonton, 1991). In other words, the younger a 
composer is at the commencement of formal training the overall accomplishments are likely 
going to be higher, but the allure of producing a successful composition in early life may 
override later life achievements. As such, Simonton (1991) concluded that individuals with 
higher early creative potential may be predetermined to produce a successful/popular 
composition at a younger age, which may ultimately influence the rhetoric surrounding their 
death.    
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While Simonton’s (1991) theory highlighted the nuances of understanding the 
relationship between career achievement and death, McCann (2001) was the first to break the 
mold of restricted samples and name this phenomenon the precocity-longevity hypothesis. 
McCann (2001) studied 23 samples of eminent persons (N = 1,026) through five studies.  In his 
first study, McCann (2001) examined the longevities of US presidents and vice presidents, 
French presidents, Canadian, British, New Zealand and Australian prime ministers, British 
monarchs, popes, US Supreme Court justices, and Nova Scotia premiers (he excluded those who 
died by assassination). Robust support for the hypothesis was found, but perhaps more 
interesting was his finding of the average differences in lifespan for those above and below the 
median age at first becoming a leader. The largest difference was found in British monarchs 
where the average age to get appointed a monarch in Britain was 30.4 years, and an appointment 
after that age indicated greater longevity by 18.4 years relative to those who got appointed 
during their twenties. The ‘smallest’ difference was identified in US presidents, who exhibited a 
7.2 year longevity advantage if elected into office at a relatively later age.    
McCann’s (2001) second study extended the findings of his first study and tested whether 
the hypothesis was generalizable to high-level creative accomplishment. He examined 
exceptional creativity in the form of Nobel Prize winners and Oscar winners in the best actor and 
actress and best supporting actor and actress categories. The advantage in examining these two 
samples was that i) the Nobel Prize is the pinnacle of career peak achievement in several fields, 
making it one of the best measures of precocity, and ii) Oscars are awarded to males and females 
equivalently, making it possible to test the precocity-longevity hypothesis in women for what 
appeared to be the first time (McCann, 2001). Nevertheless, similar to previous findings, there 
was overall support for precocity negatively influencing lifespan; only in the field of Physics for 
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Nobel Prize was there an absence of statistical significance (although the correlations and mean 
differences were in the hypothesized direction). The largest reported difference in longevity for 
those above and below the median age at first being awarded a Nobel Prize was a 13.5 year 
lifespan advantage for recipients in the Peace field (above the mean age of 64.8 years).  Although 
overall support for actors and actresses was weaker relative to Nobel Prize recipients, males who 
won best supporting actor above the mean age of 54.8 years lived an additional 9.2 years. 
Therefore, McCann (2001) demonstrated that career precociousness affecting lifespan was not 
exclusive to high-level leadership positions, but to other influential and creative domains as well.    
The third study of McCann’s (2001) investigation into the precocity-longevity hypothesis 
examined a single momentous event; the signing of the US Declaration of Independence in 1776 
(N = 56). Unlike the previously studied samples, it was impressive past accomplishments that 
largely determined the sample, with the event itself being considered a unique occurrence. 
McCann (2001) assumed that by participating in this historic event, younger participants must 
have previously demonstrated superior early achievement. The mean age at signing was 44.8 
years (SD = 10.4) and the length of life was 66.4 years (SD = 14.7). McCann (2001) found a 
significant lifespan advantage of 7.7 years for signers who were above the median signing age, 
suggesting that precocity has a significant effect on longevity even when measuring precocity as 
a single event that was marked by past achievements.  
The fourth study of McCann’s (2001) investigation also examined the precocity-
longevity hypothesis from an atypical perspective, where he operationalized precocity as age at 
lesser/multiple career peaks. He examined the relationship between age at receiving an American 
PhD in Psychology and the lifespans of eminent American psychologists (N = 86).  Similar to 
previous findings, support was found for the precocity-longevity hypothesis; the mean age of 
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attaining a PhD was 27.5 years (SD = 3.1), which was significantly correlated with the mean 
death age of 71.8 years (SD = 11.5). Students who attained a PhD above the median age lived an 
average of 6.9 years longer, suggesting that the hypothesis is applicable to lesser career peaks as 
well (McCann, 2001). Alternatively, a person’s career trajectory is typically variable, where 
multiple career peaks may exist and be termed as ‘precocious’ achievement. McCann’s (2001) 
finding that ages at career peaks that are later surpassed still influences lifespan highlights that 
caution is needed in how we operationalize ‘precocity’ and begin to explore explanations for its 
effects in more depth. To date, all work in this area has been descriptive and the underlying risk 
factors remain speculative as most studies have been performed with the main purpose of 
establishing a link between precocity and longevity. Two proposed explanations of the precocity-
longevity hypothesis are i) statistical biases and artifacts and ii) epidemiological explanations.   
Expounding the Precocity-Longevity Hypothesis 
Statistical Biases and Artifacts 
The first proposed explanation suggests methodological limitations may explain, or at 
least artificially inflate, the link between precocity and longevity. An artifact is defined in the 
context of a scientific investigation as something that is observed that is not naturally present, but 
occurs as a result of the procedure (“Google Dictionary,” 2016). Thus, our understanding of the 
precocity-longevity hypothesis is confounded by the statistical strategy used to measure the 
effect.   
Life expectancy bias 
The life expectancy bias arises from older entrants into a sample, or those who reached a 
career peak after the median age of the cohort, being predisposed to having greater longevity 
than those who entered the sample at a younger age. Similar to a threshold hypothesis, a person 
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can only enter a sample by crossing a threshold (in this context, reaching an achievement peak); 
however, the ages at which it is crossed vary from person to person (McCann, 2001). For 
example, persons who achieved eminence in a given domain at the age of 25 years will have 10 
more years in which they could die compared with those who achieved eminence at 35 years. As 
Abel and Kruger (2007) describe within the context of sport, “whereas every player potentially 
has the same life expectancy at a given age, those who achieve success at a relatively late age 
have already lived longer than those who achieve similar success at an earlier age” (p. 934). 
Indeed, if life expectancy automatically increases with age if we assume a homogeneous life 
expectancy at birth, our measurement of the precocity-longevity link may simply reflect this 
sample inclusion artifact (McCann, 2001).          
Selection bias 
The basis for the selection bias artifact, initiated by Simonton (1988), is that early peak 
achievement allows a person to die prematurely and still be retained in an eminent sample. In 
turn, persons who enter a sample at an early age and die at any early age artificially inflate the 
precocity-longevity hypothesis. Alternatively, a person who enters an eminent sample at a later 
age has no chance of dying at an earlier age. This raises the issue of using an exclusively 
deceased sample to calculate precocity and longevity. When a sample does not include high 
achievers who are still alive it may result in a skewed average age that supports the precocity-
longevity hypothesis. For example, if earlier achievers who die prematurely are included in the 
same cohort as later achievers, there is a much greater likelihood of finding a significant 
correlation between the two variables (Abel & Kruger, 2007; McCann, 2001). Interestingly, 
while studies have attempted to control for the aforementioned artifacts (discussed in the next 
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section), all of the literature on this phenomenon to date has used samples with only deceased 
persons.      
The Healthy Worker Effect 
In epidemiology, the last proposed statistical artifact is known as the Healthy Worker 
Effect (HWE; McMichael, 1976). Although many factors other than the occupational 
environment influence longevity, McMichael (1976) was the first to suggest that when 
comparing the working population with the non-working population, the active workers are 
presumably healthy enough to have been and remain employable in a typical occupational 
setting, whereas the same theoretical conclusion cannot be made for the non-workers. Abel and 
Kruger (2006a) stated that this effect operates on two levels: i) a “healthy hire effect” where an 
initial selection bias occurs because ill and/or disabled persons are not typically hired, and ii) a 
“healthy survivor effect” where subsequent selection bias occurs and results in healthier persons 
remaining employed. In any case, a lifespan bias exists in favour of the working group.   
In sport, Abel and Kruger (2006b) suggested that the HWE is a result of three related 
factors: i) an initial selectivity associated with qualifying for employment, such as becoming a 
high performance athlete (e.g., Beaglehole & Steward, 1983); ii) the positive effects of regular 
physical activity on health (e.g., Morris et al., 1980), and; ii) a subsequent selectivity whereby 
workers/players who remain healthy and fit continue within their respective professions, which 
consequently results in a healthier occupational cohort (whereas the injury prone/unhealthy 
athletes become part of the general population; e.g., McNamee, 2003). Within the context of 
sport, the HWE is measured by career length (or ‘span of service’ in a more general context). 
Abel and Kruger (2005) examined the longevities of Major League Baseball (MLB) players and 
found that they lived an average of four years longer than age-matched controls from the general 
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population. More specifically, a HWE was attributed to a likely initial selection process of 
becoming a professional athlete, and subsequent maintenance of good health throughout their 
careers to retain a roster spot each year (e.g., muscular strengthening, conditioning, diet, 
physicals, etc.; Abel & Kruger, 2005). In revisiting the HWE on a larger sample size of MLB 
players, Abel and Kruger (2006a) found players to live 4.8 years longer compared to the general 
population, and more interestingly, robust support was found for the HWE. Career length both 
significantly and incrementally increased the lifespans of players from playing a single season 
(+4.1 years) to playing 11 or more seasons (+7.4 years; Abel & Kruger, 2006a). Similarly, strong 
support was found for the HWE in their follow-up study on professional football players (Abel & 
Kruger, 2006b). On average, professional football players lived 6.1 years longer than age-
matched controls from the general population, and longevity was again found to increase 
incrementally with the number of seasons played (+5.5 years for one season to 6.7 years for four 
or more seasons; Abel & Kruger, 2006b). In sum, research on the HWE in sport thus far 
corroborates findings from other occupations; the longer the span of service, the greater their 
lifespans appear to be.     
Epidemiological Explanations 
As the precocity-longevity hypothesis remains relatively under-studied as evidenced by 
the lack of scientific replication and long durations between studies, explanatory frameworks for 
its effect remain speculative. Nevertheless, two epidemiological explanations have been at the 
forefront of discussion (and have existed from the hypothesis’ inception, albeit as an undertone 
in the earlier studies): stress and personality type.       
Stress 
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McCann (2001) suggested that the most obvious explanatory risk factor is the role of 
stress on lifespan. The strains, challenges, and obligations that accompany precocious 
achievement have the potential to catalyze physical and mental declines (McCann, 2001). A 
large body of evidence suggests that when we experience psychological or social stress, we may 
activate physiological responses where stress-related disease emerges predominantly from 
repetitive activation of our physiological systems that respond to acute physical emergencies, yet 
our coping mechanisms generally fail to switch it off (Sapolsky, 2004). In turn, stress has been 
found to have an influence on individuals’ behaviours, such as both objective (e.g., life events) 
and subjective (e.g., distress) levels of stress that negatively affect physical activity and exercise 
participation (Stults-Kolehmainen & Sinha, 2014). Plenty of research has shown that stressful 
experiences may predispose us to disease, and ultimately premature death (e.g., Taylor, 1999); 
however, the role of stress on longevity is less known.   
In sport, four general sources of social, psychological and physiological stress have been 
highlighted: i) frequent changes in arousal and anxiety related to performance demands (Hoar, 
2007); ii) fear of physical injury and the subsequent recovery process (Wiese-Bjornstal, 2004); 
iii) normative and non-normative transitions out of sport and the robustness of their athletic 
identity (Taylor & Ogilvie, 2001), where athletes with stronger athletic identities appear more 
willing to engage in health compromising behaviours such as disordered eating (e.g., Sundgot-
Borgen & Torstveit, 2010), and; iv) coping with pressure stemming from early fame/exposure 
(Schaller, 1997). This last example of athlete stress best relates to the precocity-longevity 
hypothesis; stressors that complement high performance competition at an early age may 
promote premature ill health, or in McCann’s (2001) view, “the stresses that accompany a rapid 
drive to achievement peaks may eventually contribute to a shorter life” (p. 1430). The pressure 
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of precocious achievement, particularly in sports such as gymnastics where gymnasts’ ‘primes’ 
occur at relatively much younger ages, has also been suggested as a predictor of self-destructive 
behaviour, where early fame’s association with aversive self-consciousness may ultimately result 
in premature death (Schaller, 1997).          
Personality type 
The more stable and ingrained form of individual character is personality type, and the 
Type A-B personality dimension (Friedman & Rosenman, 1959; Friedman, 1969; Friedman & 
Rosenman, 1974) is the other proposed epidemiological explanation of the precocity-longevity 
hypothesis (although it can be argued that this is very similar to the stress hypothesis, as 
ultimately Type A personalities are generally predisposed to more stress). Type A personalities 
tend to be competitive, self-critical, ambitious, goal-oriented, impatient and aggressive; 
alternatively, Type B personalities are relaxed and non-competitive (McLeod, 2011). The 
seminal study by cardiologists Freidman and Rosenman (1959) found that Type A personalities 
had a higher risk of heart disease and high blood pressure relative to Type B personalities 
(although the external validity of this study has been questioned, due to its exclusively middle-
aged male sample and a lack of control variables such as diet). Since this proposed correlation, 
research has provided substantial evidence that Type A personality (e.g., greater autonomic 
arousal and heightened competitive drive required to be an elite athlete), alongside stress, can 
cause premature disease and death (e.g., Taylor, 1999). As such, research appears to support 
these two epidemiological frameworks to explain the precocity-longevity effect, although much 
more work is necessary to appropriately address these purported explanations and their specific 
relationship to premature death.    
Body – Part 2 
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The second part of this historical investigation of the development of the precocity-
longevity hypothesis discusses studies that have attempted to control for the aforementioned 
confounding statistical artifacts. To conclude McCann’s (2001) multi-study exploration into this 
phenomenon, his fifth and last study controlled for the life expectancy and selection artifacts 
using a subsample strategy on 22 samples of eminent persons where an initial significant 
precocity-longevity correlation was found. This strategy created an alternate ‘recruitment’ age in 
which all persons were assumed to have an equal life expectancy. As the recruitment age cut-off 
was arbitrary, it was crucial that the sample did not include any person who died before the age 
at which any other person reached their achievement peak (i.e., precocity). For example, those 
who died prematurely (e.g., 25 years) before others made a precocious contribution (e.g., 28 
years) would be excluded from the subsample (which places importance in cautiously selecting 
the cut-off age to retain as many cases as possible). Nevertheless, McCann (2001) found support 
for the precocity-longevity hypothesis in 21 of the 22 restricted samples after controlling for the 
statistical artifacts, suggesting through his comprehensive five-study investigation that enough 
reasonable evidence exists that precocity may adversely affect lifespan across a variety of 
domains. Further, his follow-up study on state governors, which also controlled for statistical 
artifacts (i.e., restrictive subsample strategy), also found support for the precocity-longevity 
hypothesis; relatively younger ages at election resulted in premature death for governors 
(McCann, 2003).  
The last study on the precocity-longevity hypothesis, prior to our two investigations, was 
a first exploration into its effects in sport. Abel and Kruger (2007) examined 3,760 deceased 
MLB players who debuted between 1900 and 1935. Precocity was defined as age at debut in 
MLB, which was a considerably narrower definition of precocity relative to other domains where 
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the variability in age of achievement was much greater (e.g., elected ages of state governors; 
McCann, 2003). Conversely, narrower measures of precocity may be inherent to high 
performance sport; athletic skills needed for peak performance in many sports such as speed, 
flexibility, and endurance are most prominent during a specific time period (e.g., Schulz & 
Curnow, 1988 suggested between 19 and 27 years of age). As such, defining precocity as age of 
entry into elite sport will typically restrict the age range of achievement, which can i) 
consequently play a role in diminishing the potential of finding a significant lifespan difference 
between precocious and non-precocious individuals, or ii) constitute impressive support for the 
hypothesis if a lifespan difference is found.  
Similar to previous methodologies, Abel and Kruger (2007) used a restrictive subsample 
strategy to control for the life expectancy and selection bias artifacts, using 28 years as the cut-
off age. They found that every year a player debuted before the average age of 23.6 years (SD = 
2.3 years), their lifespan was decreased by nearly a quarter of a year (0.24 years). A secondary 
analysis comparing the debut ages of Hall of Fame inductees (the pinnacle of sporting 
achievement in MLB) to non-inductees born in the same year also revealed support for the 
precocity-longevity hypothesis. Thus, similar to McCann’s (2001) fourth study examining 
multiple achievement peaks (i.e., PhD attainment and later life achievement), Abel and Kruger 
(2007) indicated that precocious achievement of MLB players (i.e., younger age at debut and 
Hall of Fame induction) significantly reduced their lifespan.     
Conclusion 
To date, the precocity-longevity hypothesis remains limited in its generalizability. The 
consistent trend towards early achievement cultivating premature death is alarming, and there is 
incomplete understanding of the mechanisms and risk factors explaining this link. A majority of 
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the previous research has focused on eminence in politics or academics; limited attention has 
been given to athlete mortality. Given the relatively more physically strenuous occupation of 
being an elite athlete, more research is needed on this cohort of the population to test whether 
precocious achievement in athletics supersedes the numerous other socially-constructed factors 
that promote greater longevity (e.g., physical activity, socio-economic status, etc.).  
Importantly, two issues have been highlighted that apply directly to how we structured 
our investigations: i) previous methodologies were fallible; a sample that excludes high achievers 
who are still alive may result in a skewed average age that falsely supports the precocity-
longevity hypothesis, and ii) defining precocity as ‘age of entry’ into elite sport lacks the 
necessary variability for a typical analysis of age at precocious achievement. Below, Study 1 
(pg. 74) examined the precocity-longevity hypothesis in living and deceased Canadian-born NHL 
players through Kaplan-Meier and Cox regression survival analyses, using a subsample strategy 
of including those who debuted only between 1917 and 1986 to limit the influence of players 
who were still living (i.e., censored cases), and excluded players who died within five years of 
debut and players whose date of death was unknown. A more rigorous methodological approach 
was undertaken in Study 2 (pg. 80) which analyzed i) only deceased and ii) deceased and living 
NBA/ABA players, defining precocity in three different ways: a) age upon entering professional 
sport, b) age at first All-Star game, and c) age at first All-League selection.  
While the priority of our two studies was to establish whether the precocity-longevity 
hypothesis is generalizable to professional sport (and in two sports with different sport-related 
injury profiles), more empirical evidence is needed to support the proposed explanations of the 
precocity-longevity hypothesis. Two methods to empirically test the aforementioned 
epidemiology explanations within sport are proposed:  
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i) The inference method: Stress levels (e.g., emotional readiness, pressure, arousal, etc.) 
and personality types are measured in current and recently retired elite athletes within the same 
sport. The scores would then be contextualized by age of achievement (e.g., debut age) and 
inferences would be made to the deceased cohort being analyzed. This method estimates the 
different stressors deceased precocious and non-precocious athletes may have faced that 
contributed to their death, although these inferences would likely be confounded by decade of 
play considering the evolving environment of professional sport. 
ii) The longitudinal method: Stress levels and personality types of current and former 
elite athletes are also measured; however, this same group of participants will be analyzed 
longitudinally. While this method may be limited by its impracticality considering the event 
being measured is death, with a large pool of respondents, mixed-methods analyses on 
subsamples of recently deceased athletes would provide more accurate explanations of the risk 
factors that underpin precocity and longevity.   
As explanations for why early achievement may negatively impact lifespan remain 
theoretical, methods such as these may be necessary to investigate whether different sources of 
stress are experienced and internalized by precocious and non-precocious individuals. From a 
broader perspective, the fundamental theory behind the precocity-longevity hypothesis can be 
questioned. Simonton (1988) noted that achievement is very much an attribution made by others. 
Further, perceptions of precociousness may be individualistic (e.g., receiving a bonus; how does 
it relate to “ordinary” persons?). Thus, current knowledge imposes a constraint on the range of 
possible explanations, making it exceedingly important to be cautious when disseminating and 
generalizing this phenomenon to the general public. 
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The precocity-longevity hypothesis re-examined: Does career start age in Canadian National 
Hockey League players influence length of lifespan? 
 
Dear Editor-in-chief, 
Available data on elite athletes suggests they have longer lifespans than the general 
population (Teramoto and Bungum, 2010); however, this relationship is likely more nuanced 
than previously considered. For example, the precocity-longevity hypothesis proposed by 
McCann (2001) asserts that factors related to early career achievement (e.g., debut age) may 
cultivate early death. Stress and personality type (e.g., McCann, 2001) have been the 
predominant explanations because of their purported association with disease states. To date, 
only Abel and Kruger (2007) have examined this hypothesis in sport, concluding that every year 
a Major League Baseball player debuted before the mean age of 23.6 years was associated with a 
decreased lifespan of 0.24 years. Little is known about the extent of this phenomenon among 
different athlete populations.      
This study explored the precocity-longevity hypothesis among Canadian-born National 
Hockey League (NHL) players. Based on the link between high career achievement and early 
mortality identified in previous research, we hypothesized that precocious NHL players would 
have shorter lifespans than those debuting at later ages. There have been 4,583 Canadian-born 
NHL players who debuted between 1917 and 2010 (Quant Hockey, 2014); however, we only 
analyzed those who debuted between 1917 and 1986 (n = 2, 971) to limit the influence of players 
who were still living (i.e., censored cases). Additionally, we restricted our sample to Canadian 
players to limit the influence of different developmental systems and socio-cultural factors that 
might affect longevity. Data were collected through the official website of the hockey hall of 
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fame (www.hhof.com), and a random sample (~10%) was cross-referenced within Total Hockey 
(Diamond et al., 1998) and www.hockey-reference.com which confirmed complete agreement.  
Kaplan-Meier and Cox regression survival analyses were used. Hazard ratios (HR) 
considered whether the predictor variable (debut age in the NHL) significantly influenced the 
event (age at death), while controlling for the potential confounders of position (i.e., Center, 
Wing, Defense, or Goalie) and years played. To limit the effect of statistical artifacts (see 
McCann, 2001), we excluded players who died within five years of debut and players whose date 
of death was unknown (~40 cases). All data were evaluated at the p ≤ .05 level of significance 
(95% confidence interval; CI), using SPSS 21 (IBM Corp., 2012).   
Overall, 910 out of 2,971 Canadian-born NHL players were deceased as of 1986 (30.62%). 
The mean age of entry into the NHL by decade were as follows: 25.18 (1917–1926), 22.59 
(1927–1936), 22.22 (1937–1946), 21.09 (1947–1956), 21.74 (1957–1966), 22.06 (1967–1976), 
and 20.84 years (1977–1986). Descriptively, 537 players who debuted above the median age, 
respective to their decade of play, were deceased (median life expectancy estimate: 81 years), 
compared to 373 players who debuted below the median age of entry (82 years). Kaplan-Meier 
analysis found no significant difference in survival distribution [x² (1) = 2.35, p = 0.12; see 
Figure 2.1]. In Cox regression models adjusted for player position and years played, no 
significant relationship between precocity and longevity was found (HR:  0.91, 95% CI: 0.79–
1.05).  
Our results do not support the precocity-longevity relationship in Canadian-born NHL 
players, raising the question of its generalizability to sport populations. In addition, our 
descriptive finding that early high achievers had a lifespan advantage, contradicts even the trend 
of previous precocity-longevity findings. This discrepancy may reflect methodological 
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differences; in particular, our sample contained both deceased and still-living athletes, while the 
samples of previous studies have only included deceased high achievers. A sample that excludes 
non-deceased high achievers may result in a greater age differential that artificially supports the 
precocity-longevity relationship. 
Our results may also reflect some of the complications that arise from the heterogeneity 
and unique demands of sport. For example, ice-hockey is likely more physically demanding than 
previously studied professions. In addition, sport typically has a narrower entry age range 
compared to other domains of eminence (e.g., McCann, 2001). As most skills needed for peak 
athletic performance are age-specific, finding a significant difference in players whose entry ages 
into professional sport are relatively narrow would indicate impressive support for the hypothesis 
(Abel and Kruger, 2007). Lifespans have tremendous variation and are influenced by many 
underlying etiological factors (e.g., genetics); therefore, it may be challenging to find widespread 
support for this phenomenon considering the age restrictions imposed by different domains of 
eminence.  
To more fully understand this phenomena, moderators such as sport-specific energy system 
demands (i.e., aerobic, anaerobic, mixed) may need to be considered. In addition, an important 
limitation of this study is that cause-of-death data were not considered. Since age-of-entry is 
relatively narrow in range, future research in sport may also benefit from examining precocity 
with respect to different accomplishments, such as age at first all-star selection. To date, analyses 
of the relationship between early high achievement and premature death are sparse, and largely 
limited to studies of a theoretical and descriptive nature. Given the limitations inherent to 
previous methodologies and the complexity of athlete populations, the precocity-longevity 
hypothesis should be interpreted cautiously. 
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Figure 2.1: Survival probability of Canadian NHL players 
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Study 2 Overview 
Objectives: To examine the precocity-longevity (P-L) effect in North American professional 
basketball players who debuted between 1946 and 1979, and to determine whether playing 
position and decade of play influenced the relationship between age of career achievements and 
lifespan. Methods: 1852 players were evaluated from a recognized sports archive (i.e., sports-
reference.com), which provided information on date of birth, death, and career debut, playing 
position, and indicators of achievement (i.e., All-Star team and/or All-League team selection). 
Athletes were categorized as above or below the median age of professional debut, and median 
age of selection to first All-Star team and/or All-League team. Analyses of deceased players (n = 
598) were comprised of bivariate correlations between age of achievement (age of debut, age of 
first All-Star game and age of first All-League team selection) and age of death, and t-tests to 
compared the average age of death of early and late achievers (p < .05). Survival analyses, using 
the entire sample (living and deceased players), compared the lifespans between those who 
debuted above and below the median age of achievement for each indicator of achievement. 
Results: Only the correlation between age of professional debut and age of death (r = 0.33, p < 
.001) and age of first all-star game and age of death (r = .29, p < .05) and the t-test comparing the 
average death age of early (66.4 y) and later (69.3 y) debut age groups (p =.01), reached 
statistical significance. Although, survival analyses demonstrated a trend for lower risk of death 
for early achievers, with one exception (i.e., age of debut) this trend was not statistically 
significant. Conclusions: Results did not support the P-L hypothesis, suggesting that contextual 
factors, such as the physical demands of a sport, and measurement methodologies, may influence 
support for the proposed hypothesis in sport. 
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Does early career achievement lead to earlier death? Assessment of the precocity-longevity 
effect in professional basketball players 
The precocity-longevity (P-L) hypothesis asserts that those who experience noteworthy 
high achievements earlier in life have a shorter lifespan than those who attain similar notable 
career milestones later in life. This hypothesis was first formally described by McCann (2001) in 
a study of high achievers in politics (presidents and prime ministers), law, entertainment, creative 
pursuits and academia, which showed evidence that the younger a person is when they achieve a 
notable peak in achievement (or a landmark contribution) the younger they tend to die. For 
example, Nobel Peace prize recipients who received the award above the median age of 64.8 
years lived 13.5 years longer than those who received the prize before this age [p < .01; 
(McCann, 2001)]. 
Two explanations have been at the forefront of discussion (and have existed from the 
hypothesis’ inception, albeit as an undertone in the earlier studies): stress and personality type. 
First, McCann (2001) suggested that the stress, challenges, and obligations that accompany 
precocious achievement have the potential to be a catalyst for poor health. McCann (2001) 
further highlighted that the ascension to career success may play an important role: “the stresses 
that accompany a rapid drive to achievement peaks may eventually contribute to a shorter life” 
(p. 1430). Research does support that stressful experiences predispose humans to disease, which 
can ultimately lead to premature death (e.g., Taylor, 1999), where repetitive stress may activate 
physiological responses that cause stress-related diseases to emerge (Sapolsky, 2004).  
Personality type, the more stable and ingrained form of individual character, is the other 
proposed epidemiological explanation of the P-L effect (McCann, 2001). Type A personalities 
tend to be competitive, self-critical, ambitious, goal-oriented, impatient, and aggressive; 
alternatively, Type B personalities are relaxed and non-competitive (McLeod, 2011).  The 
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seminal study by cardiologists Freidman and Rosenman (1959) found that Type A personalities 
have a higher risk of heart disease and high blood pressure relative to Type B personalities. 
However, contemporary research suggests a more complicated relationship between components 
of Type A personality (i.e., hostility and anger) and disease (e.g., Myrtek, 2001). Nevertheless, 
previous studies on the P-L relationship may have examined samples that likely fall in some 
components of the Type A personality category, such as professional baseball players (Abel and 
Kruger, 2007) and eminent persons such as presidents, prime ministers, and monarchs (McCann, 
2001), making personality type seemingly a valid explanatory theory.  
Although etiological studies of the P-L effect will be important, it has been suggested that 
a more immediate objective should be to determine the existence and generalizability of the 
phenomenon (McCann, 2004). To date, however, only a few studies have investigated the 
existence and generalizability of the P-L effect in the athletic disciplines. Abel and Kruger’s 
(2007) investigation of deceased Major League Baseball (MLB) players noted that when 
precocity was defined as age in which athletes debut professionally, there was a significant 
relationship with lifespan; for every year a player debuted before the average age of 23.6 years 
(SD = 2.3), their lifespan decreased by 0.24 years (2007).  Further, correlations between debut 
age and longevity were higher in Hall of Fame inductees relative to non-inductees (0.48 versus 
0.09, respectively), which further supported the proposition that precocious achievement may 
have negative effects on longevity. Alternatively, a recent analysis by Lemez and colleagues 
(Lemez, Wattie, Ardern, & Baker, 2014) on Canadian professional ice hockey players did not 
demonstrate a clear P-L effect. The authors speculated that the positive relationship between 
cardiovascular fitness and reduced all-cause mortality may explain the lack of an effect among 
ice hockey players compared to baseball and non-athletic eminent achievers. However, with only 
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two studies to-date on high achieving athlete populations there is a clear need to explore the P-L 
effect in other athlete samples.   
In addition to there being a limited number of studies on high performing athletic 
populations, there are also methodological challenges inherent to research on the P-L effect. 
First, there are some epidemiological and methodological influences that may affect the P-L 
effect: life expectancy and selection artifacts. The life expectancy artifact describes the potential 
that younger death age among high achievers may result from the fact that younger age is 
associated with shorter life expectancy (McCann, 2001). There is also the possibility that early 
death (and hence early achievement) simply permits a person to enter a study sample. This 
‘selection artifact’ (Simonton, 1994) means that the absence of still-living early achievers may 
skew effects in favour of a P-L effect. Both of these artifacts describe the inherent potential for 
bias when studying a sample of only deceased eminent achievers, and may increase the 
likelihood of Type I error (i.e., identifying a P-L effect when one does not exist).  
There may also be challenges to studying the P-L effect as a result of how ‘precocity of 
achievement’ is operationalized. Both Abel and Kruger (2007) and Lemez et al. (2014) defined 
precocious achievement in athlete samples as the age at which athletes entered professional 
sport. However, using age of professional sport debut as a measure of achievement may be 
impacted by the fact that the age range for professional sport debut is typically quite narrow 
(McCann, 2001). If this range is sufficiently narrow it would be difficult to find clear support for 
the P-L effect as the age difference between ‘early achiever’ and ‘late achiever’ would be quite 
small. Lemez and colleagues (2014) suggested that one way to circumvent these issues would be 
to use an alternate marker of accomplishment more independent of age and more indicative of 
exceptional achievement, such as age at first participation in an ”All-Star” game.  
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Taken together, it is clear that there is a need to study the generalizability of the P-L 
effect in different domains (e.g., sport vs. non-sport), and there is a need to start reconciling the 
methodological challenges inherent to studying this phenomenon. Based on the two studies of 
the P-L effect among eminent athletes, this study has two aims: 1. To explore the generalizability 
of the P-L effect among high achievers in a sample of athletes not previously studied (i.e., North 
American professional basketball players); and 2. To address some of the methodological 
challenges that are important to consider in this area of research. To that end, the current study 
aimed to explore the P-L effect using diverse approaches. First, we replicated previous 
methodologies for analyzing the effect using a sample of only deceased athletes in order to 
compare this sample to previous research. Second, the unique approach of analyzing an inclusive 
sample of deceased and living athletes allowed more ecologically valid analyses to be 
performed. Based on previous P-L research on athlete and non-athlete samples, we hypothesized 
that athletes who had younger ages of notable achievement would have shorter lifespans than 
those who had notable achievement at older ages.  
Methods 
Sample and variables  
This study did not involve any human participants or animals, and therefore adhered to 
recognized ethical standards and national/international laws (Harriss & Atkinson, 2013). Data 
were collected for all players who had played professional basketball from 1946 to 2012 (N = 
4015) from a recognized sports archive of aggregated publically available athlete records (i.e., 
sports-reference.com). During this period two professional leagues existed, the National 
Basketball Association (NBA) and the American Basketball Association (ABA).  A random 
sample of the data (10%) was also cross referenced with an official NBA encyclopaedia 
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(Shouler, Ryan, Smith, Koppett, & Bellotti, 2003) and showed complete consistency. We 
censored all players who debuted from 1980 to 2012 because the majority (98.4%) of that cohort 
was still living. This resulted in a final sample size of 1852. For each player, date of birth, career 
milestones (i.e., first year of professional debut, last year of play, date of first All-Star game, date 
of first All-League selection), playing position (i.e., Guard, Center or Forward), and date of death 
were collected. The All-Star game is an annual mid-season exhibition game where 12 players 
from each conference (i.e., Eastern and Western) who are playing at a notably high-level are 
selected by fans (starters) and coaches (reserves). Similarly, an All-League selection honours the 
best players following a season to two teams from 1946 to 1988 (N = 10), which are selected by a 
panel of sportswriters and broadcasters throughout Canada and the United States (e.g., 
NBA.com). From the above data, a number of additional variables were derived for the current 
study, including: i) length of playing career (in seasons played), ii) age at the start of playing 
career, iii) age at first All-Star game, iv) age at first All-League team selection, v) age at time of 
death (in years) and vi) age as of January 2013 (days) for living and former athletes. Although 
age-related variables were computed and analysed in ‘days’, results are presented in years for 
ease of understanding. Athletes were also coded as either deceased or living for the purpose of 
analyses.  
Precocity of achievement was defined in three different ways. First, we replicated Abel 
and Kruger’s (2007) definition of achievement as ‘age upon entering professional sport.’ In 
addition, in order to have a measure of achievement more independent of age, and more 
indicative of eminent achievement in this population, two other indicators of achievement were 
included: ‘age at first All-Star game’ and ‘age at first All-League selection’. For each indicator 
of achievement, variables were computed using a player’s first notable achievement. This was 
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necessary because the ABA only existed from 1967 to 1976, and therefore some players debuted 
in the ABA and transferred to the NBA (and vice versa). For example, if a player debuted or was 
nominated to an All-Star game in the ABA then later transferred to the NBA the achievement 
values were derived from their ABA. Consistent with previous research, we explored career 
precocity by coding athletes as debuting either below or above the median ‘age of achievement’ 
for each indicator of achievement. The median ages of achievement were calculated separately 
for each decade of debut, since these values fluctuate (this was particularly important for debut 
age, which has declined in more recent decades).   
Analyses – Part 1 (Deceased Sample) 
The purpose of our first set of analyses was to replicate the methods of previous studies 
in an unstudied population (i.e., professional basketball players) and with additional indicators of 
achievement.  Specifically, these analyses used a sub-sample of only deceased players who had 
debuted prior to 1980 (n = 598), similar to previous research on eminent athlete and non-athlete 
samples (Abel and Kruger, 2007; McCann, 2001). As such, all coding of the achievement 
measures in this portion of the analyses were based on the values (i.e., median ages of 
achievement) obtained from the deceased sub-sample of NBA players.  
 We described the study sample by calculating the median age of death, the sample 
composition according to playing position (Center, Forward, Guard), and the proportion of 
deceased athletes who had participated in an All-Star game, and who had been selected to an All-
League team. 
In accordance with previous research (see McCann, 2001), each of the three measures of 
achievement were correlated, and partially correlated (controlling for decade of debut), with age 
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at death (p < .05). Similarly, t-tests compared the mean ages of death for those who were above 
and below the median ages of achievement for each of the three measures of achievement.  
Two final analyses were included in Part 1. We also categorized athletes as above (later 
death) or below (early death) the median age of death (where each median death age was decade 
specific), and categorized athletes as either ‘eminent’ or ‘not eminent’ based on whether or not 
they had been selected as an All-Star or to an All-League team (respectively). Using these 
categorizations, two 2x2 chi-squares were run with a p < .05 significance criteria: All-Star 
Eminence (yes/no) x Death age (early/later); All-League Team Eminence (yes/no) x Death age 
(early/later). Similar to Abel and Kruger’s (2007) distinction between Hall of Fame and non-Hall 
of Fame athletes, these analyses sought to distinguish any potential differences in longevity 
associated with degree of eminence.  
Analyses – Part 2 (Alive or Deceased Sample) 
The second set of analyses for this study aimed to address the possibility that a P-L effect 
observed in a sample comprised of deceased eminent achievers may result from still-living 
eminent achievers not having entered the study sample (i.e., the selection artifact: Simonton, 
1994). Therefore, these analyses used a sample of deceased and still-living players who had 
debuted prior to 1980 (n = 1852) with the aim of testing whether or not those with earlier death 
age are in fact more precocious achievers than still living athletes. As with the first portion of 
analyses, achievement was defined as i) age of professional debut, ii) age at
 
first All-Star game, 
and (iii) age
 
at first All-League team  selection. However, when coding athletes as above or 
below the median age of achievement (for each indicator of achievement), the values of the 
entire sample (living and deceased) of athletes were used for these analyses (with median 
achievement values calculated separately for each decade of play and pertinent league).  
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We described the study sample by providing the proportions of each playing position 
(Center, Forward, Guard), and the proportion of the sample who had participated in an All-Star 
game, and who had been selected to an All-League team. We also describe the sample by listing 
the median age (in days) of achievement for the three indicators of achievement (stratified by 
decade) separately for deceased and still-living players.  
Three Kaplan-Meier (KM) analyses were used to visualize the univariate relationship 
between each career achievement (i.e., precocity) and longevity (p < .05). Cox proportional 
hazards regression was performed to assess the influence of career precocity on lifespan, after 
adjusting for playing position and decade of career debut. Hazard ratios (HR) and 95% 
confidence intervals (95% CI) were used to estimate the relationship between precocity and 
longevity, after adjusting for covariates.  
Results – Part 1 (Deceased Sample) 
The median age of death among the deceased players was 70.3 years (standard deviation 
± 14.4 years).  Overall, the majority of this sample was comprised of Guards (42.6%) and 
Forwards (42.4%), while Centers constituted only 15.1% of the sample. The majority of athletes 
participated exclusively in the NBA (88%), while smaller proportions played exclusively in the 
ABA (7.4%) or played in both leagues (4.7%). Of the 598 deceased athletes, 11.5% had 
participated in an All-Star game, and 6.3% had been selected to an All-League team.   
Table 2.1 presents the correlations between each of the achievement measures and age of 
death, as well as the results of the independent t-tests. Both age of professional debut and age of 
first all-star game demonstrated statistically significant positive correlations with age of death. 
The relationship between age of professional debut and age of death was a medium size 
correlation (r = 0.33), but decreased to a small correlation (r = 0.11) when decade of professional 
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debut was adjusted for.  The correlation between age of first all-star game and age of death was 
also medium-sized (r = .29), but this correlation was not statistically significant when decade of 
debut was adjusted for. Age at first All-League selection was not significantly correlated with 
age of death (regardless of whether decade of debut was adjusted for). T-tests were used to 
compare the average age of death between earlier and later achievers (see Table 2.2). Although 
there was a trend for early achievers to have a younger mean age of death for each of the 
indicators of achievement, the difference in death age was only statistically significant between 
those with earlier and later ages of professional debut (p = .01).   
Neither the chi-square test for All-Star Eminence (yes/no) x Death age (above vs. below 
median; χ2(1) = .13, p = .72), nor the chi-square test for All-League team Eminence (yes/no) x 
Death age (above vs. below median; χ2(1) = 1.07, p = .30) provided any evidence for the P-L 
hypothesis.  
Results – Part 2 (Alive or Deceased Sample) 
Of the 1852 players alive or deceased, the majority of the sample was comprised of 
Guards (42.4%) and Forwards (42.5%), while Centers constituted 15.1% of the sample. The 
majority of athletes participated exclusively in the NBA (73.4%), while smaller proportions 
played exclusively in the ABA (15.5%) or played in both leagues (11.1%). Overall, 14.7% had 
participated in an All-Star game, and 6.7% had been selected to an All-League team. Descriptive 
comparisons of median age of achievement between living and deceased players revealed that 
living athletes had younger median ages of achievement on all Age of Professional Debut 
comparisons, and 5 out of 11 comparisons for Age at first All-Star and All-League Team 
selection (see Table 2.3). 
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Age of Professional Debut. The median lifespan for early achievers was higher than it 
was for late-achievers (82.6 y v 81.0 y), although this trend was not statistically significant [χ2 (1, 
N = 1852) = 3.31, p = .07].  In a subsequent Cox regression, which adjusted for playing position 
and decade of playing debut (see Table 2.4), career precocity was associated with a lower risk of 
death (HR: 0.84, 95% CI: 0.71-0.98). No main effects were observed for decade of debut. 
However, compared to Guards, Forwards had a higher risk of death (HR: 1.21, 95% CI: 1.02-
1.45), but no difference in risk of death among Centers. No two-way interactions were observed.  
Age at first All-Star game. Although the median lifespan for early achievers was higher 
than it was for late achievers (84.1 y v 80.7 y) in the current sample, this trend was not 
statistically significant [χ2 (1, N = 271) = 0.05, p = .83].  In a subsequent Cox regression (see 
Table 2.4), which adjusted for playing position and decade of playing debut, career precocity 
was not independently associated with a lower risk of death. Moreover, no main effects were 
observed for decade of debut or playing position, and no interactions were observed. 
Age at first All-League Team selection. The median lifespan for early achievers was 
lower than it was for later achievers (82.4 y v 84.1 y), although this trend was not statistically 
significant [χ2 (1, N = 119) = 0.10, p = .75].  When decade of debut and playing position were 
adjusted for in a Cox regression (see Table 2.4), mortality risk did not differ between early and 
later achievers.  No main effects were observed for decade of debut or playing position, and no 
interactions were observed.  
Discussion 
 This study examined the relationship between precocity of achievement and longevity in 
elite professional basketball players. Previous work by McCann (2001) and Abel and Kruger 
(2007) observed that earlier achievement is associated with a shorter lifespan across different 
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domains, including sport. However, the current results present a more complicated picture of the 
P-L effect. Our interpretation is that the results from the first portion of analyses do not support 
the P-L hypothesis. First, the only statistically significant correlation and t-test were for the age 
of debut indicator of achievement. The weight of these results needs to be considered alongside 
the limitations associated with the age of professional debut indicator of achievement. This 
measure of achievement may be less than ideal because it is strongly dependent on age, and 
simply entering professional basketball may not truly describe eminence/highest achievement in 
professional basketball.  
Second, none of the Part 1 analyses on the age at first All-Star game and age at first All-
League selection reached statistical significance. The results of the chi-square tests for these two 
indicators of achievement also did not support the P-L hypothesis. In addition, there is the need 
to weigh the results of the first series of analyses against the results of Part 2.  
The second series of analyses aimed to expand on the methods used in the majority of P-
L research. It had previously been suggested that younger death age among high achievers 
results from lower life expectancies associated with younger age (Taylor, 1999), and that early 
death may simply permit a person to enter a study sample (i.e., the selection artifact: Simonton, 
1994). The inclusion of still living and deceased athletes and the subsequent results of the 
survival analyses (Part 2) suggest that the concerns related to the above artifacts are well-
founded in the current population of high achievers. Not only did the results of the survival 
analyses not support the P-L hypothesis, the trends for the three indicators of eminent 
achievement were opposite to those in Part 1 and suggest a lower risk of death for precocious 
achievers (although only the age of debut achievement indicator reached statistical significance). 
There is of course a notable limitation to using survival analyses in instances where the exposure 
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event (age of achievement) is itself a potential confounder of the outcome, which cannot be 
controlled for. In this case, it is not possible to control for the fact that precocious achievers are 
followed for a greater period of time than late achievers. The results of the current study should 
be weighed against such limitations (see Hanley & Foster, 2014). However, in light of the 
notable limitations to the methods presented in Part 1, we argue that survival analyses perhaps 
represents the lesser of two evils, and that for the time being a triangulation of multiple methods, 
which includes deceased-only and still-living athletes, may be prudent. It may be worth 
repeating, however, that one of the biases identified earlier is that precocious achievement and 
younger age is associated with greater risk of early mortality (McCann, 2001; Taylor, 1999). As 
such, if the limitations inherent to survival analyses biased our findings, they theoretically should 
have reflected biased support for the precocity-longevity hypothesis. However, the results of the 
survival analyses do not support the precocity longevity effect. We believe that these trends stem 
from the differences in age of achievement between living and deceased athletes.  
The discrepancy between the trends observed in Part 1 and Part 2 appear to be related to 
the different median age of achievements between still-living and deceased athletes (Table 2.3). 
Descriptive trends suggests that in many cases the median achievement age of deceased athletes 
does not accurately reflect the median achievement age for the overall population of athletes. In 
some cases it appears that the median age of achievement of the still-living athletes is actually 
younger than that of the deceased-only sub-sample, especially with regard to the ‘age of debut’ 
measure of achievement. These descriptive differences in median age of achievement suggest 
there is a precocity-longevity effect in the current sample, but unlike previous research precocity 
of achievement appears to be related to longer lifespan in this population.  The fact that the 
median age of achievement differs for deceased and still-living athletes in many cohorts (i.e., 
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decade of entry and league) of athletes suggests that this trend is systematic, not random, and that 
the Part 2 analyses are a more accurate reflection of achievement and mortality trends within this 
population. It also introduces the possibility of an additional bias; that the median age of 
achievement in previous studies of deceased-only samples may not accurately reflect the true 
median value for the entire population of eminent achievers. As Hanley and Foster (2014) 
suggested, “Theories such as the just-cited precocity-longevity hypothesis are seductive, and 
have a certain plausibility. But some of this may be a result of the framing” (p. 8). This seems to 
be the case for our data; as such, we conclude that the trends observed in Part 1 appear to be less 
representative of achievement trends than those observed in Part 2.   
There are many reasons that the P-L effect does not exist in the current sample of high 
achievers. As Lemez et al. (2014) noted, there are notable differences between previous research 
and the current investigation that might explain these discrepancies. First, given the importance 
of physical fitness for the reduction of all-cause mortality (Marijon et al., 2013), it is possible 
that the high levels of physical fitness required for elite performance in basketball players 
compared with the domains examined by McCann (2001) and the baseball players examined by 
Abel and Kruger (2007) buffered the effect of precocity on longevity. Moreover, beginning a 
professional career earlier and having the potential for longer exposure to financial rewards, 
health care, and fitness related health benefits may explain the finding that early achievers have 
longer lifespans in this sample. A related explanation is that players who eventually make it to 
play professional basketball, regardless of their age of debut, have a superior genotype for 
physical fitness than those in other domains, which negates any relationship between early 
achievement and length of lifespan. The ‘Healthy Worker Effect’ describes a form of selection 
bias wherein inclusion into a study sample reflects a health-advantage compared to those not 
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included (see Rothman, 2002).  As such, the Part 1 analyses of deceased-only athletes, which 
appear to support the trend for the P-L hypothesis, may reflect a sort of ‘inverse-healthy worker 
effect.’  
Although the results of the current study add to a relatively limited evidence base 
regarding predictors of early mortality in elite and professional sport, the current study did not 
provide any insights on cause-specific mortality. Future investigations that incorporate cause-
specific mortality, and any subsequent links to the proposed underlying risk factors of the P-L 
effect, such as stress and personality, may provide further insight into the long-term risks and 
benefits of participation in elite sport. The historical nature of this sample, and the possibility of 
generational differences in mortality trends and life expectancy, also reinforce the need to 
incorporate cause-specific mortality in future research. It will be important to consider these 
factors when exploring the generalizability of the current findings in other samples of eminent 
athletes.  
In summary, the results of the current study suggest it is unlikely that the P-L effect exists 
in NBA athletes. Importantly, the current study also raises a methodological consideration 
regarding the estimates of average precocity values, and whether or not the average age of 
precocious achievement among deceased eminent achievers is an accurate reflection of the entire 
eminent population. An average age of achievement among still-living eminent achievers that is 
significantly different than that of deceased eminent achievers could skew the results (as was 
likely the case for our data). Going forward it will be important to consider how the physical 
demands of a sport, the health and financial benefits associated participation in high performance 
sport, and measurement methodologies, may influence support for the precocity-longevity 
hypothesis in sport. Given the significant dedication toward talent identification and 
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development at early ages in many sports worldwide, the potential relationship between the 
milestones of athlete development (e.g., age of first participation in organized sport) and athlete 
health outcomes such as overuse injuries are important to consider. 
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Table 2.1: Bivariate and partial correlations between age of achievement measures and age of 
death 
 
Test 
Correlations 
Measure of Achievement 
(Age) 
Death Age 
(r)  
p value Death Age 
(r)† 
p value 
      
 Age Pro Debut (n = 598) 0.33 < .001 0.11 < .01 
 Age 1
st
 All-Star Game Nomination 
(n = 69) 
0.29 < .05 0.22 .07 
 Age 1
st
 All League Team 
Nomination (n = 38) 
0.10 .54 0.27 .10 
      
 
Table 2.2: T-test comparisons of the mean death age between earlier and later achievers  
 
Test Measure of Achievement Mean Death Age 
(years) 
t (df) p value 
T-Tests Above vs Below median 
Achievement age†† 
Earlier 
Achiever 
M(SD) 
Later 
Achiever 
M(SD) 
  
      
 Age of Pro Debut (n = 598) M = 66.4 
(±15.2) 
M = 69.3 
(±14.3) 
t (596) = 2.34 .02 
      
 Age 1
st
 All-Star Game Nomination         
(n = 69) 
M = 62.2 
(±16.7) 
M = 67.7    
(±9.6) 
t (67) = 1.65 .10 
      
  Age 1
st
 All League Team 
Nomination (n = 38) 
M = 63.1 
(±17.4) 
M = 69.1 
(±10.1) 
t (36) = 1.27 .21 
†Partial correlation controlling for decade of entry to professional basketball. ††Age of median achievement was 
calculated for each decade, and median splits were respective to athletes decade of entry to professional sport; M 
= mean; SD = standard deviation. All of the above analyses were repeated using a restricted inclusion criteria that 
ensured no athlete had died before all the individuals in the sample had accomplished their measure of career 
achievement.  
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Table 2.3: Presents the median age (in days) of achievement for age of NBA 
debut, age of first All-Star  game and age of first All-NBA selection, stratified by 
decade of professional debut, league (if applicable) and mortality status, and the 
difference (Δ) between the median values for alive and deceased athletes  
 
 Median Age of Achievement (days)  
Indicator of Achievement Alive          
(NBA | ABA) 
Deceased          
(NBA | ABA) 
Δ Alive - Deceased 
(NBA | ABA) 
Debut Age    1940s 8942 | n/a 9351 | n/a -409 | n/a 
1950s 8350 | n/a 8519 | n/a -169 | n/a 
1960s 8309 |8521 8561 | 8734 -252 | -213 
1970s 8265 | 8250 8348 | 8299 -83 | -49  
    
All-League         1940s 9893 | n/a 9168 | n/a 725 | n/a 
1950s 9671 | n/a 8883 | n/a 788 | n/a 
1960s 9107 | 9303 9923 | 9258 -816 | 45 
1970s 9002 | 8344 9538 | n/a -446 | n/a 
    
All-Star          1940s 9091 | n/a 9965 | n/a -874 | n/a 
1950s 8947 | n/a 8880 | n/a 67 | n/a 
1960s 9201 | 9277 9528 | 9077 -327 | 200 
1970s 8909 | 8604  9255 | 8444  -291 | 160 
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Table 2.4: Hazard ratios for age of achievement, decade of debut and playing position from Cox 
regressions for age of debut, age of first All-Star game, and age of first All-League team indicators 
of achievement  
 
  Hazard Risk 
Measure of Achievement Variables HRadjusted 95% CI 
Age of Debut Age of achievement       Early achievement 0.84 0.71-0.98 
 Late achievement - - 
    
 Decade of Debut                                 1940s 1.01 0.81-1.51 
 1950s 0.95 0.69-1.33 
 1960s 0.87 0.63-1.20 
 1970s - - 
    
 Playing Position                               Centers 1.20 0.94-1.52 
 Forwards 1.21 1.02-1.45 
 Guards - - 
    
Age at first All-Star game Age of achievement       Early achievement 0.82 0.54-1.44 
 Late achievement - - 
    
 Decade of Debut                                 1940s 0.96 0.36-2.55 
 1950s 1.14 0.45-2.85 
 1960s 0.81 0.34-1.91 
 1970s - - 
    
 Playing Position                               Centers 1.40 0.71-2.75 
 Forwards 1.64 0.95-2.83 
 Guards - - 
    
Age at first All-League team Age of achievement       Early achievement 0.80 0.40-1.61 
 Late achievement - - 
    
 Decade of Debut                                 1940s 0.68 0.21-2.19 
 1950s 0.57 0.18-1.87 
 1960s 0.55 0.17-1.74 
 1970s - - 
    
 Playing Position                               Centers 1.29 0.50-3.34 
 Forwards 1.38 0.66-2.88 
 Guards - - 
HR = Hazard ratio; CI = confidence interval; Bold font = statistically significant HR.  
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CHAPTER FOUR: EARLY DEATH IN ACTIVE PROFESSIONAL ATHLETES 
 
  
 
 
 
 
 
Early death in active professional athletes: Trends and causes 
 
 
 
Lemez, S., Wattie, N., & Baker, J. (2015). Early death in active professional athletes: Trends and 
causes. Scandinavian Journal of Medicine & Science in Sports, 26, 544–549. 
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Chapter Four Overview 
 
The objective of the study was to examine mortality trends and causes of death among 
professional athletes from the four major sports in North America who died during their playing 
careers. 205 deceased athletes who were registered as active when they died from the National 
Basketball Association (NBA), National Football League (NFL), National Hockey League 
(NHL), and Major League Baseball (MLB) were examined. Results were compared with the 
Canadian and U.S. general population. The leading causes of death in players reflected the 
leading causes of death in the Canadian and U.S. general population (i.e., car accidents). 
Descriptively, NFL and NBA players had a higher likelihood of dying in a car accident (OR 
1.75, 95% CI: 0.91–3.36) compared with NHL and MLB players. In addition, NFL and NBA 
players had a significantly higher likelihood of dying from a cardiac-related illness (OR 4.44, 
95% CI: 1.59–12.43). Mortality trends were disproportionate to team size. Overall, death in 
active athletes is low. Out of 53,400 athletes who have historically played in the four leagues, 
only 205 died while active (0.38%). Future examinations into the trends and causes of mortality 
in elite athlete populations will create a better understanding of health-related risks in elite sport. 
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Early death in active professional athletes: Trends and causes 
 
Public perceptions of the long-term value of being a professional athlete may be 
somewhat distorted by social media. For instance, deaths of widely known active athletes are 
known to the public, which may lead to public perceptions of early death in professional sport 
despite evidence suggesting otherwise. Teramoto and Bungum’s 2010 literature review 
suggested athletes exposed to more aerobic actions had greater lifespan than the general 
population. Further, athletes are not homogeneous; the relationship between mortality and 
professional sport is likely more nuanced than previously considered. There is corroborating 
evidence that suggests it may be a mistake to undervalue professional athlete lifespans. For 
example, a more contemporary literature review on the relationship between physical activity 
and lifespan suggests a conservative lifespan expectancy increase of 2–4 years for individuals 
who are physically active (Reimers, Knapp, & Reimers, 2012). In addition, specific to high-
performance sport, there is similar support for lifespan expectancy benefits at high-intensity 
levels of sport, such as in professional football players (Baron, Hein, Lehman, & Gersic, 2012), 
cyclists (Marijon et al., 2013), and soccer players (Taioli, 2007). 
It is important to consider the potential confounders of mortality, along with the potential 
outliers that may skew the overall findings of athlete longevity. For example, although Italian 
male professional soccer players were found to have an overall greater longevity compared with 
controls from the general population [standardized mortality ratio (SMR) 0.68, 95% confidence 
interval (CI): 0.52–0.86], they had an increased risk of death from car accidents (SMR 2.23, 95% 
CI: 1.46–3.27) and amyotrophic lateral sclerosis (SMR 18.18, 95% CI: 5.00–46.55; Taioli, 
2007). Active player mortality trends and causes of death provide interesting insight into the 
survival likelihood of an athlete at a specific time period in their life. Thus, the purpose of this 
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study was to examine mortality trends and causes of death among professional athletes who died 
during their playing careers. Given the limited empirical knowledge of causes of death in active 
athletes, it was hypothesized that the leading causes of death would be similar to those seen in 
age- and sex-matched controls from the general population. 
Methods 
 
Participants 
 
As of June 2014, deceased professional athletes from the four major sports in North 
America who were registered as active when they died made up the sample for this study (N = 
205): the National Basketball Association (NBA; n = 10), National Football League (NFL; n = 
60), National Hockey League (NHL; n = 48), and Major League Baseball (MLB; n = 87). To 
meet the entry conditions of our sample, all players had to have played at least one game in their 
sport and been part of an active roster on a professional team when they died. Alternatively, all 
professional athletes who played in alternative leagues for the entirety of their careers were 
excluded from the sample. For example, professional football players who died while active that 
played in the American Football League, Arena Football League, Canadian Football League, 
NFL Europe, or the X Football League (the “X” in XFL did not stand for anything) without 
having played a minimum of one game at the NFL level were excluded from the sample. In 
addition, athletes who had retired from sport were excluded, irrespective of still being considered 
physically capable of competing at an elite level and having the potential to re-enter professional 
sport as a player. Player data were analyzed from each sport’s respective inaugural season: NBA, 
1946; NFL, 1920; NHL, 1917; MLB, 1871. 
Grouping Criteria 
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There were 43 different causes of death in our sample. As such, causes of death were 
analyzed independently, with the exception of rare causes (n = 1), which were grouped as 
“other” (e.g., carbon monoxide poisoning, empyema, nephritis, etc.). In addition, some reported 
cause of death data may have been confounded by changing perspectives on mental health and 
suicide. For example, an athlete that overdosed on drugs without intent may have had his death 
classified as a suicide in an earlier time period; however, a more contemporary coroner/police 
report may classify it as an accidental drug overdose. Therefore, we kept different classified 
causes of death independent of each other during analysis (e.g., drug overdose and suicide). 
Data Collection 
Data were collected from www.wikipedia.org
1
 using the key word search of “active 
athlete death.” We verified these data by cross-referencing a number of online sources, such as 
www.nfl.com and www.football-reference.com for active death in NFL players, and official 
team press releases. In addition to our search of sport-specific websites, we further verified death 
date data through an archive search of the official sport encyclopedias/almanacs that were 
relevant to our sample, such as Total Basketball (e.g., Shouler, Ryan, Smith, Koppett, & Bellotti, 
2003), which confirmed complete agreement. All data were collected through secondary sources 
that were publicly accessible. 
General Population Comparison 
Mortality statistics of our sample were compared with age- and sex-matched controls 
from the general population. Canadian-born players make up most of the NHL, although the 
number of U.S.-born players in the league is growing (second highest nationality to participate 
                                                          
1
 Vital statistics may be an example where Wikipedia’s “open access” method provides 
accessible data that is similar or superior to traditional sources (Coate & Sun, 2013), having been 
proven accurate in (former) professional golfers (Coate & Schwenkenberg, 2012) and Olympians 
and tennis players (Coate & Sun, 2013). 
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all-time at 14.7%; 24.6% of the players in the 2013–2014 season were U.S.-born; Hockey 
Weekend Across America, 2012; Quant Hockey, 2014). In addition, a significant proportion of 
players who played in the NFL, NBA, and MLB were U.S.-born (e.g., 97.1% U.S.-born players 
made up the 2012 NFL season rosters; Kacsmar, 2013). Therefore, we compared the cause of 
death results from our sample to the leading causes of death in the Canadian and U.S. referents 
from the general population to limit the influence of different socio-cultural factors that might 
affect health and mortality rates. In order for survival comparisons to be made, general 
population mortality data were accessed through the latest mortality reports from Statistics 
Canada (2014a) and the Centers for Disease Control and Prevention (CDCP, 2014), which 
provided lifespan trend tables by age (15–44-year range analyzed, as the leading causes of death 
were organized into 15–24-, 25–34-, and 35–44-year-old age groups). 
Proportional Comparison 
For a proportional comparison of mortality rates between sports, we developed a 
numerator and denominator for our data using the overall proportions for the four leagues (i.e., 
number of active player deaths vs. number of total players). To collect the total number of 
players who played in each of the four leagues, we used the player indexes from www.sports-
reference.com, which provided an encyclopedia of all players who have historically participated 
in each of the four leagues, while excluding other personnel (e.g., managers, coaches, etc.; Sports 
Reference, 2014). These data were cross-referenced where accessible, which confirmed complete 
agreement (e.g., www.quanthockey.com, nfl.com, etc.). Each database was up-to-date as of June 
2014, and the proportions of deaths were reported per 1,000 athletes. 
Analyses 
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Descriptive and odds ratio (OR) analyses were performed using SPSS Version 21 (IBM 
Corp, 2012). The analyses were performed to assess the trends and causes of death in active 
professional athletes, after adjusting for type of sport, age, career length, decade of play, race, 
and Hall of Fame induction. All data were evaluated at the P ≤ 0.05 level of significance (95% 
CI). 
Results 
Descriptive 
Among the deceased players, the mean (M) death age was lower for NFL (26.05 years) 
and NBA (26.7 years) players than for the MLB and NHL players (28.6 years). The youngest age 
at death was 18 years and the oldest was 44 years (M = 27.7 years). Overall, the leading causes 
of death were from car accidents (n = 50; 24.4%), homicides (including casualties of war; n = 19; 
9.3%), plane crashes and cardiac diseases (n = 18; 8.8% each), and suicides (n = 14; 6.8%). 
Mortality rates began to increase from 1960 to 2014 (n = 138; 67.3%), when compared with the 
earlier decades (< 1960; likely, in large part because of the expansion of leagues resulting in a 
greater professional athlete pool). The sample was mainly comprised of deceased players of 
Caucasian (n = 125; 60.9%) and African-American (n = 55; 26.8%) descent. Given the 
variability of age at death [standard deviation (SD) = 4.46], career length did not appear to 
influence mortality trends in active professional athletes (M = 4.96 years; SD = 4.2). In addition, 
there were few inductees into the Halls of Fame of their respective sport (n = 14; 6.8%). See Fig. 
3.1 for an illustration of the leading causes of death data, by sport.  
As of June 2014, a total of 53,400 athletes have played in the NBA, NFL, NHL, and 
MLB. With a total of 205 athletes who died while active, the ratio of death was 3.83 per 1,000 
athletes (or 0.38%). Specifically, ratios of death for each sport were 2.37/1,000 (NBA; n = 
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4,217), 2.52/1,000 (NFL; n = 23,763), 6.75/1,000 (NHL; n = 7,103) and 4.74/1,000 (MLB; n = 
18,317). Relative to the NBA and NFL, the proportion of deceased players from the NHL and 
MLB was notably larger, although the percentages remained low (0.67% and 0.47%, 
respectively). Therefore, despite the NFL and MLB containing more athletes who died while 
active (147 players vs. 58 NBA and NHL players), mortality trends were not universally 
proportionate to team size. See Fig. 3.2 for the proportionate leading causes of death data by 
sport, per 1,000 athletes.  
When compared with the mortality databases from Statistics Canada and the CDCP, there 
was little difference between the leading causes of death in males in the 15–24-, 25–34-, and 35–
44-year-old age groups between the two databases from the general population, and our athlete 
sample. For example, the leading cause of death in all samples was unintentional injuries (i.e., 
car accidents, etc.). Although plane crashes presumably fell into this category for the national 
mortality databases, we kept road and aircraft accidents separate in our analyses as plane crashes 
remain a rare occurrence, and the frequency of death from this cause may be more pronounced 
through its ability to cause death to a greater number at one time. See Table 3.1 for the leading 
cause of death data, by country. 
OR Analyses 
 
Overall, NFL and NBA players had a higher likelihood of dying in a car accident (OR 
1.75) compared with NHL and MLB players, although the relationship just missed significance 
(95% CI: 0.91–3.36). In addition, NFL and NBA players had a significantly higher likelihood of 
dying from a cardiac-related illness (e.g., hypertrophic cardiomyopathy; OR 4.44, 95% CI: 1.59–
12.43) compared with NHL and MLB players. This should be cautiously interpreted, however, as 
proportional analysis indicated the NHL was the sport with the highest likelihood of having an 
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active athlete die from a car accident, if the number of participants between the four sports was 
considered (1.68/1,000). Therefore, the imbalance between sample sizes in the four sports will 
produce a higher frequency of deaths in sports with larger participant pools (NFL and MLB), 
suggesting the number of active player deaths is more likely due to team roster size, rather than 
participation in the sport itself. 
Discussion 
 
This study investigated the mortality trends and causes of death among professional 
athletes who died during their playing careers from the four major sports in North America. It 
was hypothesized that the leading causes of death would be similar to those seen in the age- and 
sex-matched controls from the general population. In our sample, the leading causes of death 
were from car accidents, homicides, plane crashes and cardiac diseases, and suicides. 
Importantly, there has been a low proportion of death in active athletes from the NBA, NFL, 
NHL, and MLB. Out of 53,400 athletes who have historically played in the four leagues, only 
205 died while active (0.38%). When compared with the age- and sex-matched controls, the 
leading causes of death in our athlete sample reflected the leading causes of death in the 
Canadian and U.S. male general population who were between 15 and 44 years old. The leading 
causes of death were also sensitive to the decade of play, where earlier participating athletes (< 
1960) were more prone to die from infectious diseases (e.g., tuberculosis in MLB players) vs. 
non-communicable diseases (e.g., heart disease) in the more contemporary players (> 1960).  
Although this study was able to determine risk and cause of death for active athletes, the 
inherent complexity of using historical data to answer questions with relevance in the present 
where socio-contextual factors may be different was a limitation of our study. For example, in a 
historical analysis, the impact of socio-contextual factors from specific eras may create a 
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problem in interpreting causal effects (e.g., causes of death). If the control group is from a 
suppressed socioeconomic developmental period, such as the Great Depression or during a 
period of international conflict (e.g., casualties of war being classified as a “homicide”), present-
day implications of the study will be limited. We can only draw causal inferences from 
quantitative analyses of historical data with great care (Simonton, 2003); therefore, a leading 
cause of death such as tuberculosis in active MLB players may not be as relevant today as non-
communicable conditions such as cardiovascular disease. 
Second, it is difficult to compare risk and cause of death of a historical sample to the 
present-day’s general population. That is, our data date back to 1871, MLB’s inaugural season, 
whereas the data provided by Statistics Canada and the CDCP are more contemporary reports. 
For example, we can determine the risk of death in Canadian males between the ages of 15 and 
44 years who died in 2009: 6,527 (deceased; Statistics Canada, 2014a) divided by 16,663,222 
(2009 Canadian male population; Statistics Canada, 2014b) results in just a 0.039% chance of 
death (or 0.39 per 1000). When compared with the active athlete death rate of 3.83 per 1,000, it 
appears that being an athlete is associated with an increased risk of death when compared with 
the Canadian male population; however, moderators such as the rate of death in active athletes 
likely fluctuating annually and the mixed cultural make-up of our sample makes socio-
demographic comparisons to the present-day statistics difficult.  
Last, caveats will inevitably arise in this research domain as mortality is an enormously 
complex outcome. For example, this study examined only active athletes who died if they played 
at least one game in one of the four sports and had been part of an active roster on a professional 
team when they died. Thus, this criterion excludes those athletes who have played in a farm 
system their entire careers, or those lacking the ability to move up to a higher level. This 
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selection bias of selecting arguably the best athletes limits this study’s ability to generalize risk 
and cause of death findings to all athletes who play or have played basketball, football, ice-
hockey, and baseball at a recreational or high-performance level. Further, the generalizability of 
our results to other countries and sports may be limited. Although culturally diverse participants 
are inherent to contemporary professional sport organizations, our historical sample 
predominantly contained Canadian and U.S. born athletes. Nevertheless, beginning to understand 
the role that sport (e.g., combat vs. non-contact) and socio-cultural (e.g., salary, popularity of 
sport, etc.) differences play in early death may create some transparency to the general 
unpredictability of death to relatively younger cohorts.  
The inclusion criteria for this study created some larger scale questions. For example, a 
Hall of Fame player, such as “Junior” Seau Jr., who committed suicide within 3 years of 
retirement was not included in this sample. Evidently, the entry conditions of this study in which 
early death was restricted to active career limits our discussion of potential consequences of elite 
sport participation in recently retired athletes. Nevertheless, given the findings we have 
highlighted above, it is important to begin identifying risk and cause of death among athletes so 
future studies can uncover the underlying mechanisms and characteristics that may predispose 
sport participants to specific causes of early death. 
Perspectives 
Our findings indicate that there has been a low proportion of death in active professional 
athletes from the NBA, NFL, NHL, and MLB. Further, the leading causes of death in our sample 
were similar to those in the Canadian and U.S. general population. In a broad sense, a 
comprehensive understanding of the implications of involvement in professional sport is 
necessary for the formation of evidence-based models of athlete development and care. 
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Acquiring a comprehensive understanding of athlete health outcomes will necessitate 
assessments of high performance athletes prior to, during, and after professional/elite 
participation in sport. Specifically, future examinations into the trends and causes of mortality in 
elite athlete populations will create a better understanding of potential health-related risks in elite 
sport. In summary, given our current lack of empirical understanding, future research should 
seek to provide new insight on which developmental pathways contribute to longer life 
expectancies. As such, this research can have important implications at the youth sport level for 
policymakers regarding how programs should be structured. For example, a larger focus on 
sampling sports rather than early specialization may reduce the incidence of overuse and acute 
injuries, which can minimize risk of osteoarthritis manifesting in later life that could inhibit 
lifelong maintenance of physical activity.   
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Figure 3.1: Leading causes of active player death, by sport (percentages represent the percentage 
of total causes of death in each sport) 
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Figure 3.2: Proportionate leading causes of active player death by sport, per 1,000 athletes (total 
historical players in each sport in brackets; 1871 to June 2014) 
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Table 3.1: Leading causes of death, by country (Centers for Disease Control and Prevention, 2014; Statistics Canada, 2014a) 
Age group (years)     Leading cause of death in males; percentage of total deaths in age group due to the cause indicated 
15–24                        Canada, 2009: Unintentional injuries (i.e., car accidents); 41.5%, intentional self-harm (suicide); 23.5%, assault    
                       (homicide); 9.1%, malignant neoplasms (cancer); 6.7%, diseases of the heart (cardiac); 2.9% 
              United States, 2010: Unintentional injuries (i.e., car accidents); 41.5%, homicide; 19%, suicide; 17.2%, cancer;     
            4.6%, cardiac; 3.2%  
25–34                       Canada, 2009: Unintentional injuries (i.e., car accidents); 34.2%, suicide; 23.6%, cancer; 7.7%, homicide; 5.6%,   
                       cardiac; 4.9% 
                                 United States, 2010: Unintentional injuries (i.e., car accidents); 37%, suicide; 15.9%, homicide; 12.2%, cardiac;    
                      7.6%, cancer; 6.1% 
35–44                       Canada, 2009: Unintentional injuries (i.e., car accidents); 18.6%, suicide; 18.4%, cancer; 17.1%, cardiac; 13.7%,  
                      chronic liver diseases and cirrhosis; 2.4%*  
                                 United States, 2010: Unintentional injuries (i.e., car accidents); 23.5%, cardiac; 17%, cancer; 11.8%, suicide;                     
                      11.6%, homicide; 4.3% 
*Chronic liver diseases and cirrhosis were the only dissimilar top 5 leading cause of death from these mortality reports. Homicide was 
the sixth leading cause of death in the 35–44 year-old group in Canada in 2009. 
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CHAPTER FIVE: HEIGHT AND LIFESPAN  
 
  
 
 
 
 
Do “Big Guys” really die younger? An examination of height and lifespan in former professional 
basketball players* 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*A consolidated version of this article is currently under review for publication in Scandinavian 
Journal of Medicine & Science in Sports 
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Chapter Five Overview 
Background: While factors such as genetics and socio-economic status may mediate the 
relationship between height and mortality, a sizeable amount of evidence suggests larger body 
size independently reduces longevity. The purpose of this study was to extend this research and 
critically examine the relationship between height and longevity in a population of athletes 
generally regarded as having superior height relative to the rest of the population; professional 
basketball players. 
Methods: We examined living and deceased players who played in the National Basketball 
Association (debut between 1946 – 2010) and/or the American Basketball Association (1967–
1976) using descriptive and Kaplan-Meier and Cox regression analyses. The cut-off date for 
death data collection was December 11, 2015.  
Results: Overall, 787 former players were identified as deceased with a mean height of 193.9 cm 
(± 8.83, Range: 167.6–228.6). Descriptive findings indicated that the tallest players (top 5%) died 
younger than the shortest players (bottom 5
%
) in all but one birth decade (1941–1950). Similarly, 
survival analyses showed a significant relationship between height and lifespan [² (1) = 13.04, p 
< .05], where taller players had a significantly higher risk of early mortality compared to shorter 
players (HR: 1.30, 95% CI: 1.13 – 1.50, p < .05). 
Conclusions: The uniqueness of examining the height-longevity hypothesis in a relatively 
homogeneous population of tall individuals should be considered when interpreting these results. 
More research is needed on this relationship in sport, where further evidence can inform and 
clarify our understanding of potential risks of early mortality to help generate more specific 
screening programs geared towards at-risk cohorts of the athlete population. 
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Do “Big Guys” Really Die Younger? An examination of height and lifespan in former 
professional basketball players 
“I tell my wife all the time, 'You don't see many 7-footers walking around at 
the age of 75,'" says Bird, who's 6-foot-9. "She hates it when I say that. I know 
there are a few of us who live a long time, but most of us big guys don't seem 
to last too long. I'm not lying awake at night thinking about it. If it goes, it 
goes.” 
   – Larry Bird, Hall of Fame basketball player (MacMullan, 2016) 
A recent article by ESPN senior writer Jackie MacMullan entitled “Larry Bird will die 
young. Just ask him” highlights a growing concern and “fatalistic view” of lifespan amongst 
former professional basketball players (MacMullan, 2016). Certainly, the death of a former 
teammate or competitor can often initiate one’s own contemplation of mortality, and recent 
young deaths of former “big guy” National Basketball Association (NBA) players (e.g., Anthony 
Mason, Darryl Dawkins and Moses Malone) may accentuate this perception.  
From a scientific standpoint, much of the work in this area has been dominated by one 
team of researchers (Samaras and his colleagues), which can have important implications in how 
an effect is perpetuated and disseminated. One of the main principles of the scientific process 
entails independent replication, and extensive work by a small number of researchers can be 
susceptible to a unidimensional viewpoint and places an increased emphasis on conducting 
rigorous and appropriate analyses. The premise that larger body size leads to reductions in 
lifespan has been substantiated ubiquitously through this research over the past 40 years (see 
www.humanbodysize.com for a complete list of Samaras et al.’s publications, in addition to 
having authored two books, The Truth About Your Height (Samaras, 1994) and Human Body Size 
and the Laws of Scaling (Samaras, 2007)). Samaras’ research suggests smaller body size is 
generally better for one’s health, and is supported by robust cross-cultural findings of average 
lifespan reduction with increasing height observed in groups such as deceased American male 
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veterans (Samaras & Storms, 1992), French males and females who died before the year 1861 
(Samaras, 1996; Samaras & Heigh, 1996) and males born in Sardinia, Italy between 1866 and 
1915 (Salaris, Poulain, & Samaras, 2012). This finding has been supported by several reviews, 
which also include similar longevity outcomes from animal data (e.g., Samaras, 2009b, 2012a, 
2014; Samaras & Elrick, 2002). Of particular interest, Samaras’ 2014 review showed evidence 
that smaller body size is related to greater longevity in eight different types of studies, where life 
expectancy differences have been found: i) within the same species (e.g., dogs; Bartke, 2012), ii) 
in caloric intake (i.e., caloric restrictions produce smaller body sizes and longer longevity; e.g., 
Fontana, 2009; Willcox et al., 2004), iii) in centenarians, who are generally smaller (adjusting for 
shrinkage; e.g., Martinez, Calzadilla, Fonseca, Castellano, & Sceo, 2009), iv) between ethnic 
groups (e.g., greater longevity in shorter groups such as the Asian population; e.g., Samaras, 
2009b), v) among developed countries (i.e., top populations for life expectancy were shorter 
(e.g., Macao) in relation to the tallest Western Europe populations (e.g., Sweden); Samaras, 
2009b), vi) between males and females (e.g., on average, men are approximately 9% taller than 
women, but have a 9% lower life expectancy; Samaras, 2009b), and in vii) survival and viii) 
lifespan studies that generally favour shorter individuals (e.g., a Spanish study of 1.3 million 
males reported a loss of 0.7 years per centimetre (cm) of increased height; Holzenberger, Martin-
Crespo, Vicent, & Ruiz-Torres, 1991). Thus, Samaras’ overarching conclusion suggests health 
practitioners should de-emphasize that a taller height is necessary for well-being and success in 
life (e.g., Samaras, 2012a), despite this being somewhat counterintuitive to society’s belief that 
increased height is a by-product of a healthy lifestyle (Samaras, 2009a). Nevertheless, the 
relationship between height and quality of life (particularly early to midlife) and eminence/higher 
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social status may be less clear and different than the height-mortality link, where quality of life is 
more socially constructed and mortality is more biologically linked to health.   
Biological Mechanisms 
 While the biological reason for the relationship between height and lifespan in humans is 
not yet fully understood (He et al., 2014), it is difficult to ignore the potential profound effect of 
genetics on lifespan. A study by He and colleagues (2014) on 8,006 American men of Japanese 
ancestry found height was positively associated with mortality, and perhaps of more interest, 
they were the first to conclusively link the “longevity gene” FOX03 to smaller body size and 
greater longevity in humans. In addition, Samaras (2014) provided a summary of studies 
illuminating proposed biological mechanisms that underpin superior longevity in smaller 
humans. Various biological and physiological parameters change with increases in body size 
(Samaras, 2014), such as greater cardiovascular load in bigger mammals, and some of most 
robust explanations for this apparent inherent detriment of greater height includes reduced cell 
replication potential in old age to maintain body tissues and organs (e.g., Samaras, 2012a) and 
higher incidence of DNA and free radical damage (e.g., Giovannelli, Saieva, Masala, Testa, 
Salvini, & Pitozzi, 2002). For example, an individual with a larger body size has trillions more 
cells compared to a smaller person (e.g., 6’7” versus a 5’9” individual), and as a consequence, 
cell replication required after cumulative exposure to stresses can ultimately lower the ability of 
healthy cells to replace the damaged ones later in life since regeneration is limited, leading to 
higher incidences of chronic diseases such as cancer and cardiovascular disease from greater 
exposure to carcinogens (e.g., Samaras, 2007, 2012b). In addition, organs such as the brain, liver 
and kidneys become disproportionate in size in taller individuals, which reduces their functional 
capacity relative to body mass (Samaras, 2007, 2012a).  
 
 
124 
 
While these biological and physiological changes, accompanied with the FOX03 
genotype, have been found to influence lifespan, it also important to recognize confounders of 
this relationship. Samaras (2012a) has suggested that height generally explains less than 10% of 
the proportion of variance regarding longevity, and has identified numerous confounders on this 
relationship (e.g., genetics, socioeconomic status (SES)). He and colleagues (2014) surmise that 
the lack of consensus on how height affects lifespan is likely due to the impact of these 
extraneous variables. For example, Gavrilov and Gavrilova (2012) did not find an association 
between height and survival to age 100 years, and reported that the average height of 
centenarians at ~50
th
 percentile (although they acknowledged the lack of effect may have been a 
result of a small sample size). In contrast, from a morbidity standpoint, a more recent study 
examining 144,701 postmenopausal women found a positive association of height with risk of all 
cancers (Kabat et al., 2013). Thus, conflicting findings in epidemiological studies on height and 
health reflect the inherent complexity of controlling for confounders and the difficulty gaining 
access to official death certificates produced by government officials, such as coroner/medical 
examiner reports, which may limit analyses to “all-cause” rather than cause-specific deaths.    
Although a sizeable amount of evidence suggests larger body size independently reduces 
longevity (e.g., Samaras & Elrick, 2002), attention has also been given to the potential influence 
of other factors that may mediate the relationship that has previously been observed between 
height and mortality, such as differences in genetics, SES, education, medical care, relative 
weight, hygienic practices, nutrition, and lifestyle choices such as engaging in regular exercise 
and avoiding smoking (e.g., He et al., 2014; Samaras, 2012a). In particular, medical practitioners 
are implementing cost-effective interventions to promote healthier lifestyles such as plant-based 
diets, which has been defined as “a regimen that encourages whole, plant-based foods and 
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discourages meats, dairy products, and eggs as well as all refined and processed foods” (Tuso, 
Ismail, Ha, & Bartolotto, 2013, p. 61). A recent report by the World Health Organization 
reviewing over 800 studies linked the carcinogenicity of excessive red and processed meat 
consumption to increased cancer risk (e.g., colorectal, pancreatic and prostate cancer; 
International Agency for Research on Cancer, 2015). Further, a review examining the 
effectiveness of plant-based diets found reduced risk of cardiovascular disease and mortality 
compared to individuals who consumed a non-plant-based diet (Dietary Guidelines Advisory 
Committee, 2010). From a caloric restriction standpoint, Okinawan Japanese are relatively 
shorter and consume significantly fewer calories than mainland Japan, and the residents of the 
island have historically had the longest life expectancy, highest prevalence of centenarians per 
capita, and the lowest mortality rates from chronic diseases such as cardiovascular disease, 
cancer, and diabetes in the developed world (e.g., Suzuki, Willcox, & Willcox, 2001; Willcox et 
al., 2004). The above confounders on height and mortality highlight the complex nature of this 
relationship, which is likely impacted by various known and unknown biological processes (He 
et al., 2014), prompting researchers to suggest the relationship may be more complicated than, 
for example, obesity’s role on longevity (Gavrilov & Gavrilova, 2012).  
Athletes 
Compared to the general population there has been much less investigation into the 
relationship of height and lifespan in athletes. Samaras (2009b) provided a summary of studies 
that have examined athletes, and a decrease in longevity per centimetre of height (years/cm) was 
reported in Finnish (–0.49) and Harvard (–0.70) athletes, and baseball (–0.35) and football (–
0.81) players. While each of these athlete samples had a negative correlation between height and 
longevity, it is important to recognize the aforementioned concern regarding having 
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predominantly one team of researchers conducting this work. Lawler, Lawler, Gibson and 
Murray (2012) examined mortality outcomes in professional basketball players, and Cox 
proportional hazards survival analyses did not reveal height to be a significant predictor of 
lifespan in their crude regression model (Hazard Ratio (HR) 1.01, 95% Confidence Interval (CI): 
0.96 – 1.05). Therefore, there is conflicting evidence on the relationship between height and 
lifespan in athletes. 
The purpose of this study was to extend this research and provide a more in-depth critical 
analysis on the time-dependent variable of height on a population of athletes generally regarded 
as having superior height relative to the rest of the population; professional basketball players. 
Considering the recent media speculation regarding the concern of NBA “big guys” dying 
younger, a more up-to-date study to Lawler and colleagues’ (2012) examination into the 
mortality outcomes of National Basketball Association (NBA) and American Basketball 
Association (ABA) players was conducted, since they included players as of the 2004-2005 NBA 
season and calculated deaths as of December 31, 2011. This study exclusively measured height 
and its role on lifespan, despite the expression of an individual’s longevity profile being affected 
by several variables. However, if height influences longevity independently, deceased 
professional basketball players represent a promising group to further investigate this 
phenomenon given the relative homogeneity of exceptional height and more affluence 
(particularly in the more recent decades), where the higher SES/social status may result in less 
confounding by factors such as ethnicity. We hypothesized that when adjusting for birth decade, 
exceptionally taller players will have died at relatively younger ages. 
Methods 
Population  
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 The population of this study was comprised of living and deceased players who played in 
the NBA (debut between 1946 – 2010) and/or the ABA (1967 – 1976). A large proportion of 
players who debuted in the 2009-10 season were still active at the time of this study. The cut-off 
date for death data collection was December 11, 2015. Data were collected from publicly 
available sources. 
Data Collection 
 To compile our data, basketball-reference.com was the primary source used for retrieving 
players’ lifespan and anthropometric information. Wikipedia.org was accessed as a 
supplemented source in the case of incomplete date of birth and/or death data (<10 cases). 
Twenty percent of the lifespan and anthropometric data were cross-referenced in the official 
NBA encyclopedia (Koppett, Shouler, Ryan, Smith, & Bellotti, 2003), which confirmed 
complete agreement between data sources.  
Variables 
 Athletes were coded as living or deceased. Height was converted into centimetres (cm) 
and the median height for each birth decade was calculated to categorize players into “below 
median height” or “above median height.” 
Statistical Analyses 
 Data were analyzed using i) descriptive and ii) Kaplan-Meier and Cox regression survival 
analyses. Since average height was liable to change over the time-course of the athletic 
population studied, it was analyzed by percentiles for separate birth decades of players. In 
addition, lifespan results were compared to males from the United States (US) general population 
using life expectancy data from the latest vital statistics report from the Centers for Disease 
Control (CDC; “Deaths: Final data for 2013,” 2016)  and from Noymer and Garenne’s (2000) 
study on mortality differences in the US. For the survival analyses, a t-test median split of height 
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per birth decade was performed to also account for the changing anthropometric birth cohort 
effects. Analyses were performed using SPSS version 23, and statistical significance was defined 
as p < 0.05, at the 95% CI.  
Results 
Descriptives 
 Overall, 787 former NBA/ABA players were identified as deceased as of December 11, 
2015. The mean height of the deceased NBA/ABA player population was 193.9 cm (± 8.83, 
Range: 167.6 – 228.6). Table 4.1 shows the mean ages of death per birth decade, displayed by 
percentile height (bottom 5
%
, bottom 10
%
, 50
th
 percentile, top 10
%
 and top 5
%
). The 5
th
 percentile 
included the shortest players whereas the 95
th
 percentile included the tallest players. A linear 
increase in mean height was observed for players born in the earliest decades (M = 188.6 cm) to 
the most recent decades (M = 205.7 cm), which supports the commonly held view that the 
evolution of basketball players (and other athletes) is predicated on them becoming bigger, faster 
and stronger.  
Since the inaugural season of the NBA was not until 1946, a high majority of deceased 
players in this population were subjected to dying prematurely; therefore, the influence of height 
on lifespan was interpreted by lifespan differences within the same decade of birth, rather than 
between decades. Descriptively, the tallest players (top 5
%
) died younger than the shortest 
players (bottom 5
%
) in all but one birth decade (1941 – 1950). In total, there was a negative 
linear relationship between height and lifespan; the shortest players lived the longest (75.1 years) 
and the tallest players lived the shortest (56.6 years). Interestingly, it appears that the robustness 
of this effect diminished in players born in more recent decades. More specifically, for players 
born in 1940 or earlier, the mean ages of death for the tallest players were below the mean ages 
of death for all players born within the same respective decade; however, this effect reversed for 
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those born in 1941 or later (i.e., the tallest players lived slightly longer on average than the mean 
age of death for each birth decade). The large overall discrepancy in lifespan between shorter and 
taller players is likely a result of the larger sample sizes of deceased players born in 1940 or 
earlier (n = 579) that found shorter players to live longer compared to more recently (≥ 1941; n = 
208).  
Given that our study included deceased former players as of December 11, 2015, only a 
small proportion had the opportunity to live a full life (i.e., to ‘old age’). Therefore, we compared 
the mean ages of death for players born in 1920 or earlier and between 1921 – 1930 to the life 
expectancies at birth and in 2013 (most recent data) for males from the US general population. 
The life expectancies at birth in the male US general population were 46.3 years in 1900, 48.4 
years in 1910, 53.6 years in 1920 and 58.1 years in 1930 (Noymer & Garenne, 2000). Evidently, 
the mean ages of death of the NBA/ABA player population far exceeded these estimates; players 
born in 1920 or earlier died at 76.7 years on average, and 75.2 years on average for those born 
between 1921 and 1930. Further, the tallest players (95
th
 percentile) had similar ages of death to 
their respective birth decade mean. Interestingly, when compared to the 2013 referent life 
expectancy of 76.4 years (“Deaths: Final data for 2013,” 2016), players’ mean ages of death 
were very similar, with the largest discrepancies found in players born in 1920 or earlier who 
were in the bottom 5
th
 percentile in height (lived 80.6 years on average) and those born between 
1921 and 1930 that were in the top 5
th
 percentile in height (lived 72.4 years on average).  
Survival Analyses 
Overall, data from 3,901 living and deceased players who played between 1946 and 2010 
were included in this analysis. Figures 4.1 and 4.2 illustrate survival curves which were grouped 
by above and below median height per birth decade. Kaplan-Meier survival analysis found a 
significant relationship between height and lifespan in former NBA/ABA players [² (1) = 13.04, 
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p < .05]. In addition, Cox regression analysis found taller players to have a significantly higher 
risk of early mortality compared to shorter players (HR: 1.30, 95% CI: 1.13 – 1.50, p < .05). 
Discussion 
 The purpose of our study was to examine the influence of height on the lifespans of 
professional basketball players, and we hypothesized that the relatively taller players would die 
at younger ages. Our hypothesis was supported through our key descriptive finding which 
indicated that there was an overall negative linear relationship between height and longevity 
where the tallest players died earliest on average. Interestingly, there was small lifespan 
favourability for the tallest players born in 1941 or later (in relation to the mean ages of death per 
birth decade); however, we postulate that this counterintuitive trend was likely a result from 
small sample sizes that may be skewing our findings. More specifically, 45.6% (n = 359) of the 
deceased players were born between 1921 and 1930, whereas only 6.7% (n = 53) were born 
between 1951 and 1960 and 4.7% (n = 37) after 1960. In addition to our descriptive analyses, 
Kaplan-Meier and Cox regression analyses also supported our hypothesis, where taller players 
had significantly higher risk of early mortality compared to shorter players. 
Our descriptive analyses allowed us to explore the nuances of lifespan for the 
exceptionally tall cohorts (i.e., 95
th
 and 90
th
 percentiles). Therefore, in the present sample, the 
tallest players appear to die relatively younger than the shortest players, although findings for 
players born in the earlier decades may have more meaningful significance since they had the 
opportunity to live a full life. The lifespan differences in the later born players were likely 
confounded by more unnatural causes of death rather than the suggested negative biological 
dispositions of increased height. This hypothesis is supported by Lemez, Wattie, and Baker 
(2015), who reported that the leading cause of death in active NBA players was car accidents, 
although only 10 cases of premature death were noted in this athlete group.  
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More importantly, a high majority of participants in professional basketball are likely 
taller than the average height of males in the general population, including players even in the 
bottom 10
th
 percentile of height. Therefore, although taller players appear to die younger relative 
to shorter players, we found the mean ages of death in the 95
th
 percentile in height of players 
born in 1930 or earlier to be similar to the life expectancies at birth in 2013 for males from the 
US general population (and still far superior to what their life expectancies estimated at the time 
of birth were, although time of birth estimates include those who die very young). Lawler and 
colleagues (2012) suggested that the reasons for particular mortality outcomes for basketball 
players are likely to be multifactorial, such as the income, life experience, and socio-economic 
status incurred from being a professional athlete which allow for greater life quality such as 
better medical care. These reasons, accompanied with exceptional height being such a rarity in 
the general population, complicate our understanding of health in individuals with heights in the 
highest percentiles. In fact, in David Epstein’s The Sports Gene, he states,  
“An American man who is seven feet tall is such a rarity that the CDC does not 
even list a height percentile at that stature. But the NBA measurements 
combined with the curve formed by the CDC’s data suggest that of American 
men ages twenty to forty who stand seven feet tall, a startling 17 percent of 
them are in the NBA right now. Find six honest seven-footers, and one will be 
in the NBA.”  
                                                                                  – (Epstein, 2013, p. 131 – 132)  
We calculated only 2% of the entire deceased player population to be seven feet (16/787; 
213.36 cm), with a majority being born between 1961 and 1970 (9/16). Therefore, as 
professional athletes continue to become taller, more data will become available for future 
research to explore the rates and causes of death in the exceptionally tall athletes, which will 
provide us with more complete knowledge to delineate the reasons behind the potential risks 
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involved with increased height, or whether being a professional athlete is enough to offset the 
apparent health detriments from larger body size.  
Limitations 
First, a potential limitation of the height variable was that a median split of height by 
birth decade was used to measure mortality outcomes, which may have been too crude of a 
measurement of height. However, using a more specific measure (e.g., .33 × .33 × .33) would 
have created small sample sizes, particularly in the deceased samples from more recent decades. 
This was further complicated by the players’ overall exceptional height; nearly all data was 
above the 90
th
 percentile for general US population height, making any-cut off point arbitrary. 
Second, since living players were included in the survival analysis, 79.8% of the NBA/ABA 
player population was censored, which may have limited some of the meaningfulness of the 
survival analyses results, although these findings were supported descriptively. Last, while the 
focus of this study was to critically examine the relationship between height and lifespan, many 
other socially constructed or biological variables could have influenced mortality outcomes. 
Conversely, if height is considered a unique predictor of death, then controlling for variables 
such as decade of birth may not be as important. 
Conclusion 
This study found that taller NBA/ABA players died earlier than shorter NBA/ABA 
players; however, the uniqueness of examining the height-longevity hypothesis in a relatively 
homogeneous population of tall individuals should be considered when interpreting these results. 
As many players have superior height compared to the age- and sex-matched average height of 
the US general population, there appears to be a curvilinear relationship between height and 
longevity where the magnitude of early risk of mortality decreases past a certain threshold (i.e., 
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for players in the 95
th
 percentile of height born in 1941 or later). However, smaller sample sizes 
in the younger players may have been driving this effect, and it is unknown whether this 
relationship is more monotonic in athletes. Further, Lemez and Baker’s (2015) review suggested 
that elite athletes live longer, despite most of them likely being taller than individuals from the 
general population. Thus, more research is needed on this relationship in sport, where further 
evidence can inform and clarify our understanding of potential risks of early mortality to help 
generate more specific screening programs geared towards at-risk cohorts of the athlete 
population (e.g., implementing more frequent cardiovascular screenings for the relatively taller 
players). From a general population perspective, it is unclear whether there is a threshold for the 
apparent longevity benefits from having smaller body size (i.e., do the same benefits apply to 
persons who are in the 5
th
 percentiles of height and weight?). Therefore, continued research on 
the height-longevity hypothesis is needed in both athlete and non-athlete samples to demystify 
the nuances of this relationship, such as including cause of death data and examining the 
mortality outcomes of the smallest individuals.   
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Figure 4.1: Kaplan-Meier survival probability, by above and below median height per birth 
decade [² (1) = 13.04, p < .05] 
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Figure 4.2: Cox regression hazard model, by above and below median height per birth decade  
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Table 4.1: Mean (M) ages of death per birth decade, by percentile height 
                    Height percentiles, calculated for each birth decade separately                % censored        
Birth Decade       M (M height in cm)               5
th
                      10
th
           50
th
                    90
th
            95
th
           (n of deaths) 
≤ 1920*           76.71 ± 12.41 (188.65)    80.66 ± 10.88 77.12 ± 12.25    76.82 ± 12.80    74.41 ± 12.02    75.96 ± 16.25       1.8 (109)     
1921 – 1930    75.29 ± 11.92 (191.49)    76.57 ± 12.64    76.78 ± 11.69     75.71 ± 10.86    73.49 ± 11.37    72.46 ± 11.05    18.6 (359) 
1931 – 1940    66.19 ± 13.78 (196.88)      66.01 ± 8.46    66.42 ± 15.30     66.48 ± 13.24    65.73 ± 13.34    62.00 ± 14.28    59.3 (111)     
1941 – 1950    56.69 ± 12.47 (197.21)    54.81 ± 14.84    56.34 ± 13.57     57.49 ± 12.43    54.67 ± 14.56    56.79 ± 14.37    82.3 (118) 
1951 – 1960      51.24 ± 9.60 (198.93)      56.71 ± 3.81      56.70 ± 5.19     48.92 ± 10.60      54.17 ± 5.51      52.36 ± 5.72      91.6 (53) 
≥ 1961*             39.61 ± 9.16 (205.67)    41.43 ± 11.87      36.98 ± 9.19        39.17± 9.05      39.28 ± 9.21      39.70 ± 8.97      97.9 (37) 
Total                68.11 ± 16.03 (193.88)    75.11 ± 13.07    74.58 ± 13.21     72.32 ± 13.97    59.01 ± 16.50    56.66 ± 16.48    79.8 (787) 
*The earliest birthdate was in 1902, and the most recent was latest was in 1982
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CHAPTER SIX: CAUSES OF DEATH 
 
 
 
Vital statistics and early death predictors of North American professional basketball players: A 
historical examination* 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*A consolidated version of this article will be submitted for publication to Journal of Science 
and Medicine in Sport 
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Chapter Six Overview 
Background: Health information disseminated through social media can be susceptible to 
creating misrepresentations and reductive generalizations, particularly in how we perceive 
visible issues such as a premature death of an elite athlete. While empirical evidence suggests 
elite athletes have superior lifespan outcomes relative to the general population, less is known 
regarding their causes of death. As such, the overarching purpose of this study was to critically 
examine the mortality outcomes of the entire deceased National Basketball Association (NBA) 
and American Basketball Association (ABA) population.  
Methods: Death data were collected from publicly available sources until December 11, 2015, 
and causes of death were categorized using the International Classification of Diseases, Tenth 
Revision (ICD). Four separate measures of mortality were utilized: i) cause-specific crude death 
rates (CDR), ii) estimates of death rates per athlete-year (AY), iii) years of potential life lost 
(YPLL), and iv) binary and multinomial regression analyses with the inclusion of players’ 
biological and occupational variables that were collected.  
Results: Our search identified 514 causes of death out of a total of 787 deceased NBA/ABA 
players (M = 68.1 y ± 16.0) from 16 different ICD groups, 432 of which were from natural 
causes and 82 from unnatural or premature causes. Findings showed i) similar leading causes of 
death and CDRs to the sex- and race-matched controls from the US population, ii) higher death 
rate differences per AY within time-dependent variables such as birth decade, iii) a high 
premature death rate (59.4%) if life expectancy was set at 75 years, but much lower if life 
expectancy at birth for each player was considered (28.7%), and iv) a higher likelihood of dying 
below the median age of death for black and taller players, although regression analyses results 
were highly confounded by birth decade.  
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Conclusion: More knowledge of mortality outcomes from participating in high performance 
sport would advance sport medicine, provide broad public health applications, and disarm 
potentially harmful stereotypes of health in elite athletes. In accordance with the growth in social 
media usage, researchers and practitoners alike should negotiate best avenues to improve health 
and the transparency between different mediums of information concerning health in athletes in 
order to reconcile otherwise limited empirical evidence. 
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Vital statistics and early death predictors of North American professional basketball players: A 
historical examination 
In recent years, our awareness of when an athlete retires from sport has grown, 
particularly with more notable athletes. The propagation of readily available information through 
various media formats and outlets (e.g., social media) has made an elite athlete’s transition into 
retirement a compelling storyline. Incidentally, they are often only in the young adulthood period 
of human life (~20 – 40 years), which generally leaves them with considerable years of life left 
post-retirement. While relatively few are able to sustain their level of admiration and popularity 
(e.g., being visible through working in media and coaching), barring a rare event, most are 
typically brought to mind again once they die, either through local or national media coverage.  
Similar to the differences in status while they were active athletes, the high-profile former 
athletes receive more coverage in death relative to the lesser known athletes. While this reporting 
is common throughout sports, it can create misrepresentations and empower biases in how we 
perceive the lifespans of certain groups of athletes, and in some cases the causes that contribute 
to their deaths. For example, it was widely reported when three relatively young and well-known 
former African-American National Basketball Association (NBA) players died from heart 
disease in 2015 (Anthony Mason, 48 years of age; Darryl Dawkins, 58 years of age; Moses 
Malone, 60 years of age). As such, the aggregation of similar causes of death in an alike 
demographic group in a short period of time can perpetuate reductive generalizations of death 
pertaining to certain subgroups of athletes.  
Lemez and Baker’s (2015) systematic review of mortality and longevity in elite athletes 
highlighted that almost all empirical evidence to date points to greater longevity for high 
performance athletes compared to age- and sex-matched controls from the general population. 
Researchers have investigated several risk factors that may impact longevity in athletes, such as 
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the type of sport participated in, which energy system was activated to meet the demands of that 
sport (i.e., aerobic, anaerobic, or mixed), playing position, race, weight, and handedness. While 
some risk factors appear to have more influence on lifespan than others, such as Body Mass 
Index (BMI), race, and player position (e.g., in National Football League (NFL) players; Baron, 
Hein, Lehman, & Gersic, 2012), it is difficult to itemize the importance of these characteristics 
on lifespan without knowing the cause of death. Unfortunately, cause of death in former athletes 
is reported far less often than data such as date of death.   
Sudden Cardiac Death in Athletes 
A majority of studies that have investigated causes of death in sport have established 
sudden cardiac death (SCD) as one of the leading causes of non-violent death in young athletes 
(see for example; Harmon et al., 2015; Harmon, Drezner, Wilson, & Sharma, 2014). Harmon and 
colleagues (2015) reviewed all National Collegiate Athletic Association (NCAA) deaths between 
2003 and 2013 (N = 514) and reported that the most common medical cause of death was SCD 
(15%), with the highest rate of disease occurring in male NCAA basketball players (n = 19; 
Harmon et al., 2015). In addition to basketball players, males and African-American athletes 
were also found to be at a higher risk of SCD (Harmon et al., 2015), which was supported in the 
cumulative finding of Harmon and colleagues’ (2014) 13-study review that investigated the rate 
of SCD in athletes.  
 While it appears that SCD accounts for a significant portion of cardiac-related deaths, 
certain caveats must be considered when describing its prevalence in competitive athletes. A 
review of SCD performed by Chandra, Bastiaenen, Papadakis, and Sharma (2013) described the 
challenges and diagnostic dilemmas inherent to evaluating athletes for underlying medical 
conditions. For example, several factors have been implicated as confounders of the 
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manifestation of SCD in young athletes, such as sex, race, and type of sport; however, 
identifying higher SCD risk in certain subgroups of athletes without considering the 
disproportionate participation rates may be misleading. Chandra and colleagues (2013) 
highlighted participation inequalities and the changing demographic of participants at the elite 
level in sport, where female involvement is generally lower compared to males, and black male 
involvement has dramatically increased in sports such as basketball and football over the past 
three decades (Chandra, Papadakis, & Sharma, 2012). They further suggested that potential 
biases such as the lack of sample size equivalency across sports (e.g., higher participation rates in 
basketball and football in the United States (US); Maron, Shirani, Poliac, Mathenge, Roberts, & 
Mueller, 1996), may confound the findings of higher SCD and perceived risk in these sports.  
 Cardiovascular diseases often advance health risks, and an athlete dying from a heart-
related disease has become a highly visible tragedy (Maron, Haas, Murphy, Ahluwalia, & 
Rutten-Ramos, 2014). However, Maron and colleagues (2014) reported a participation of 
4,052,369 student-athletes from 30 different intercollegiate sports between 2002 and 2011, which 
resulted in a low risk of SCD relative to the general population in their sample of athletes 
(1.2/100,000). As well, Chandra and colleagues (2013) described the etiology of SCD in athletes 
younger than 35 years of age and suggested that the common causes can be divided into three 
broad categories of cardiac abnormalities: (i) structural (e.g., SCD in young athletes is most 
commonly caused by an underlying genetic disorder, such hypertrophic cardiomyopathy; 
Semsarian, Sweeting, & Ackerman, 2015), (ii) electrical (e.g., Wolff Parkinson White 
syndrome), and (iii) acquired (e.g., infection such as myocarditis). Recently, Engel, Schwartz, 
and Homma (2016) examined cardiac structure (i.e., cardiac remodelling) in 526 active NBA 
players, the first large-scale study to provide comparative data for athletes with greater 
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anthropometry, and indicated that the characterizations of their hearts (e.g., left ventricular cavity 
sizes), although larger, were generally proportional to body size. Their findings highlighted the 
importance of standardized testing to account for abnormal physical dimensions of athletes, and 
argued that full medical context can prevent unnecessary exclusions of athletes from competition 
and improve clinical acumen (Engel et al., 2016). Altogether, while recent literature has 
emphasized the heterogeneity of cardiovascular disease and the clinical importance and 
complexity in accurately portraying risk of SCD in athletes, it has been argued that physical 
activity can nevertheless precipitate sudden death (Maron et al., 1996). 
Other Known Leading Causes of Death in Athletes 
 Overall, epidemiological studies involving athlete mortality have found the leading 
causes of death to be similar to those identified in the general population in the developed 
countries. For example, Lemez, Wattie, and Baker (2015) examined incidence and causes of 
death of active professional athletes from the NBA, National Football League (NFL), National 
Hockey League (NHL), and Major League Baseball (MLB) and reported accidents (33.1%), 
homicides (9.3%), cardiovascular diseases (8.8%), and suicides (6.8%) as the leading causes of 
death in 205 athletes who were registered as active competitors. Similarly, Harmon and 
colleagues’ (2015) review of 514 NCAA student-athlete deaths reported that accidents were the 
most common cause of death (50%) followed by medical causes (29%), homicides (8%), and 
suicides (8%). These are analogous to the leading causes of death in males between 15 and 44 
years of age from the general population in the US and Canada (Centers for Disease Control and 
Prevention, 2014; Statistics Canada, 2014). Moreover, researchers have examined single causes 
of death and associated risk factors in athletes. For example, Rao and colleagues’ investigations 
of NCAA athletes found a higher rate of suicide in males relative to females and in football 
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players relative to several other NCAA sports (Rao, Asif, Drezner, Toresdahl, & Harmon, 
2015a), as well as a higher incidence of homicide-related deaths in males, black athletes, and 
football players (Rao, Poon, Drezner, Zigman, Asif, & Harmon, 2015b). Importantly, the 
cumulative conclusion of Rao and colleagues’ findings highlighted that NCAA athletes had 
significantly lower relative risk of dying of homicide and suicide compared to the general and 
collegiate population of similar age (2015a; 2015b).  
Decades of epidemiologic studies highlight many robust determinants of health and well-
being, such as causal relationships between physical activity and reductions in certain chronic 
diseases. For example, in athletes, evidence has shown that former elite competitors have less 
incidence of cancer compared to the general population, which can be attributed to lifestyle 
factors such as abstaining from smoking (e.g., Robsahm et al., 2010; Sormunen et al., 2014). 
More recently, researchers have begun to focus more on the interplay between health and 
biological, behavioral, psychological, and social factors (Institute of Medicine (US) Committee 
on Health and Behavior, 2001). Consequently, as we begin to view health from a more 
multidimensional perspective, it may become more difficult for an individual to reconcile and 
comprehend how these various health factors interact with one another and impact their lifespan.  
 From a broader perspective, as the connection between physical activity and health 
continues to evolve, it is important for researchers to continue to investigate sport participants, 
which represent a considerable proportion of the post-industrial and developed population. 
Larson and Verma’s (1999) cross-cultural examination of how children and adolescents spend 
time has been widely regarded as a seminal and timely consideration of the relationship between 
participation in sport and other leisure-time activities. They found that among post-industrial 
populations (particularly in North America and Europe), sport was one of the most common 
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leisure-time activities youth participated and spent time in (Larson & Verma, 1999). While work 
comparing participation rates of voluntary activities in youth has been relatively rare (e.g., sport 
was also identified as the most frequent voluntary activity by Kirshnit, Ham, & Richards, 1989), 
more contemporary reports still show a general pattern of high participation in sport among 
youth (i.e., >50%; e.g., Australian Sports Commission Annual Report, 2015; Canadian Heritage, 
2013; The United Kingdom Sports Council Annual Report, 2015).  
 Two predominant goals suggested to improve population health have been to increase the 
overall population health and to reduce purported disparities, such as racial differences in 
lifespan (Kindig, 2012). However, is the divide in lifespans between certain subgroups of the 
population (e.g., high disparity in life expectancy at birth between the highest educated white and 
the lowest educated black Americans; Olshansky et al., 2012) generalizable to high performance 
athletes, or do common traits within their lifestyles that are valuable to lifespan (e.g., favourable 
genetic profiles and superior diet and physical activity) neutralize the disparities? Lemez and 
Baker (2015) highlighted several risk factors and characteristics that researchers have identified 
as potential precursors of early mortality in athletes; however, although there are a growing 
number of studies examining mortality in elite athletes, our knowledge on their causes of death 
remains incomplete. Thus, this study examined incidence and causes of death in professional 
basketball players, a sport where the historical composition of athletes allowed us to evaluate 
some of the previously suggested robust predictors of longevity in elite athletes. 
The NBA (1946-current) and the American Basketball Association (ABA; 1967-1976) 
contain a historical population of athletes whereby a large quantity may be deceased. Equally 
pertinent to this study, the popularity of this athletic cohort accompanied with a rich history of 
high participation rates and earlier inaugural seasons relative to other sports and sporting leagues 
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(e.g., the Women’s National Basketball Association’s inaugural season was in 1997) creates a 
greater opportunity to account for a higher proportion of authenticated deaths in the overall 
population. The current empirical understanding of mortality in professional basketball players is 
limited by relatively few studies, which have identified favourable lifespans (Fafian Jr., 1997), 
no relationship between handedness and lifespan (Lawler & Lawler, 2011a), and a racial 
disparity through which white players lived on average 1.5 years longer than the black players, 
although both races lived significantly longer relative to the general population (Lawler, Lawler, 
Gibson, & Murray, 2012). As such, the overarching purpose of our study was to obtain a more 
comprehensive understanding of the relationship between high performance sport and mortality 
through examining causes of death and early and later death predictors in former NBA and ABA 
players. More specifically, we aimed to initiate a more critical consideration of the interplay 
between previously identified risk factors and mortality outcomes by gathering data on the entire 
deceased NBA/ABA population.  
Methods 
Population and Variables 
 The population of this study was comprised of all players who played in the NBA and/or 
ABA from the inception (1946) until the 2009-10 season, and were deceased as of December 11, 
2015. The variables collected were related to their biological (i.e., age, birth decade, race, 
playing BMI, and handedness) and occupational (i.e., career length, playing position, and Hall of 
Fame (HOF) induction) characteristics. Birth decades were categorized as ≤ 1920, 1921-1930, 
1931-1940, 1941-1950, 1951-1960, and ≥ 1961. Race was categorized as “black” (deceased 
biracial players of Caucasian and African-American descent were categorized in this group for 
the purposes of this study; n= <5) or “white” (a single deceased player who was born outside of 
North America (i.e., Europe) was categorized in this group). BMI was calculated based on the 
   
 
151 
 
players’ height in inches and weight in pounds, and categorized as either “Normal” (18.5-24.9) 
or “Overweight” (25-29.9). One player who was considered “Underweight” (<18.5) and one 
player who was considered “Obese” (>30) were categorized as “Normal” and “Overweight,” 
respectively. Playing positions were categorized as “Guard,” “Guard/Forward,” “Forward,” 
“Forward/Center” and “Center.” As the study did not involve living human participants and data 
were collected from publicly available sources, ethics review was not required.     
Data Collection 
Dates of death 
 As with previous work in this area (Lawler & Lawler, 2011a, 2011b; Lawler et al., 2012), 
four main online sources were queried to compile our data; two primary online basketball 
sources, basketball-reference.com and apbr.org (Association of Professional Basketball 
Research), a general Google search of the player’s name followed by “NBA” or “basketball” 
(typically redirected to wikipedia.org), and/or the Social Security Death Index (SSDI). The SSDI 
is a freely available database of death records that was accessed through www.ancestry.com to 
search for deceased players. The collation of data included on the two basketball websites was 
performed through a collective effort of researchers, employees and volunteers, and the 
information helped to define the study population and ascertain the dates of birth and death, race, 
height, weight, handedness, playing position, and the duration of the professional basketball 
career of each participant. In addition, to examine high achievers, HOF data were gathered from 
the official Naismith Memorial Basketball HOF website (hoophall.com/hall-of-famers-index), 
and were fully cross-referenced in basketball-reference.com. Only those individuals who were 
inducted as players (i.e., not inducted as a coach or contributor) were categorized as HOF 
inductees. Credibility of the retrieved data was assessed by comparing information from the four 
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web-based sources for agreement. If disparities were apparent, the official encyclopedia of the 
NBA Total Basketball was referenced where applicable (Koppett, Shouler, Ryan, Smith, & 
Bellotti, 2003). As well, the reported death date on wikipedia.org was used in preference to 
basketball-reference.com for seven cases (a majority were <10 day difference), and we used “15” 
as the day of death for nine cases who were missing complete date of death information. All 
players born <1945 (70+ years of age) were cross-referenced in a minimum of two sources to 
ensure accurate reporting of lifespan.   
Causes of death 
 Causes of death were collected through publically available web-based sources. In all 
cases, multiple data sources were searched to verify cause of death information of our sample. 
Cause of death records were gathered from the following websites: Google.com (player name, 
followed by a combination of “NBA,” “basketball,” “death” and “cause of death,” or “former 
NBA death” through Google News), wikipedia.org, apbr.org, nytimes.com, legacy.com (e.g., 
obituaries; http://www.legacy.com/memorial-sites/nba/; http://www.legacy.com/memorial-
sites/nba/profile-search.aspx?beginswith=All), basketball-reference.com, nba.com, 
gobulldogs.truman.edu, old.post-gazette.com, articles.latimes.com, sabr.org, highbeam.com, 
collegehoopedia.com, calbears.com, vindy.com, grfx.cstv.com, exnba.com/tag/dead-nba-
players/, sportingnews.com (e.g., http://www.sportingnews.com/photos/4631498-notable-sports-
deaths-of-2015/), http://hoopshype.com/2015/12/27/the-members-of-the-nba-family-gone-in-
2015/, espn.go.com (Associated Press), bostonglobe.com, and other local newspapers (e.g., 
http://www.baltimoresun.com/news/obituaries/bs-md-ob-walter-budko-20130604-story.html).       
Classifications of Causes of Death 
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  We used the International Classification of Diseases, Tenth Revision (ICD) to categorize 
the different causes of death in our sample, through the online application provided by the World 
Health Organization, Version: 2016 (World Health Organization, 2016). In addition, listed 
causes such as “died at home after a long illness” were generally considered to be affected by 
chronic, natural and/or age-related conditions or diseases that may have been initiated by 
metabolic syndrome risk factors such as elevated blood pressure and cholesterol levels. 
Therefore, we subsequently categorized these types of causes as “natural/old age,” as it was 
highly unlikely that an unnatural cause of death would be reported in that manner. The two 
overarching classifications of death periodically used in general discussion were “natural” and 
“unnatural” causes, which encompassed the corresponding cause-specific deaths (natural/old age 
was considered a cause-specific death that was under the broad classification of “natural causes,” 
much like other diseases such as cardiac- and cancer-related deaths; i.e., they were not used 
interchangeably).  
Comparisons to the General Population 
The National Vital Statistics Reports released by the Centers for Disease Control (CDC) 
and Prevention in February 2016 were used to compare mortality statistics of our sample to the 
sex- and race-matched controls from the general US population. The reports included data on the 
rates of death (“Deaths: Final data for 2013,” 2016) and the leading causes (Heron, 2016) for the 
US general population in 2013. Cause of death data were compared by ICD classification and all 
data were disseminated using a common epidemiological reporting method of expressing death 
rates per 100,000 individuals per year, by dividing the number of reported causes of death by the 
total population (3,901), and multiplying the result by 100,000. This method is also known as the 
crude death rate (CDR), which measures the number of deaths in a population, relative to the 
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size of the population over a given period of time, and can provide insights into the health status 
of a population over time (World Health Organization, 2014). CDRs were also calculated 
separately for white and black players, and both races combined.  
Comparisons to Living NBA and ABA Players 
 Estimates of death rates were reported in athlete-years (AY) by calculating ages of the 
entire deceased and living NBA/ABA player population who played between 1946 and 2010 (N 
= 3,901) as of December 11, 2015 (i.e., until the cut-off date for death data collection). Data for 
living players were collected using the same aforementioned sources.  
Calculating Premature Death: Years of Potential Life Lost (YPLL) 
 It has been suggested that alternative measures to reflect mortality trends of younger age 
groups may be of added value, particularly to traditional mortality analyses such as CDRs which 
can provide incomplete understanding of temporal changes in mortality as there is often an 
inherent susceptibility to emphasize the underlying disease processes of the elderly (Centers for 
Disease Control, 1986). Thus, YPLL was included as an added measure of young death to 
estimate how many potential years were lost if a player died prematurely. YPLL were calculated 
by subtracting the age at death from two separate upper reference ages: from i) a set age of 75 
years (YPLL75), which is a common predetermined upper reference age used when calculating 
YPLL in the developed world (e.g., University of Wisconsin Population Health Institute, 2015; 
Vila, Booske, & Remington, 2006), and from ii) the life expectancy at birth for each player 
(YPLLLE). Life expectancies by birth year for the male general US population was accessed 
through Noymer and Garenne’s (2000) study on mortality differences in the United States and 
were cross-referenced in the latest CDC report (“Deaths: Final data for 2013,” 2016), although 
single year life expectancies were not provided until 1975 in the report (i.e., grouped by decade 
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prior to 1975). Birth year life expectancies were used to calculate YPLL at the time of death as 
opposed to life expectancies in year that they died to remove the birth cohort effect caused by 
changing lifespan factors, such as shifting causes of death and social conditions. Players who 
lived longer than their respective upper reference age were not included in this sub-analysis (i.e., 
did not die prematurely).  
Statistical Analyses 
 Mortality outcomes were analyzed using i) descriptive and ii) binary and multinomial 
logistic regression analyses, with the aforementioned biological and occupational variables 
serving as covariates (i.e., predictors). A t-test median split of age of death dichotomized the 
outcome variable into “below” or “above” categories. Analyses were performed using SPSS 
version 23, and statistical significance was defined as p < 0.05, at the 95% Confidence Interval 
(CI). Data were predominantly analyzed descriptively as the entire NBA/ABA player population 
was accessible; thus, inferential statistics were not needed to predict likelihood estimates. 
However, regression analyses were utilized to illustrate statistical limitations and potential 
artifacts of using historical data for likelihood estimates with relevance in the present. 
Summary of Measures of Mortality 
 Vila and colleagues (2006) concede that there is no one best measure that captures all 
aspects of mortality, and that various methods exist to quantify death rates, including CDRs, 
cause-specific mortality, age-specific mortality, age-adjusted mortality, YPLL, and life 
expectancy. Conceptually, all of these methods were either directly or indirectly incorporated in 
the analyses, although some were limited by the relatively small nature of the population studied 
(i.e., differentiating causes of death by age group would have drastically lowered the death rate 
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frequencies, further limiting generalizations to the general population). Below, we summarize the 
main measures of mortality used for this population. 
i) Cause-specific CDRs: compares death rates of the NBA/ABA player population to the general 
population and by race, reported as per 100,000 individuals.  
ii) AY: accounts of living players as well to estimate death rates per AY for causes and early 
predictors of mortality. 
iii) YPLL: measures premature death by calculating YPLL using two upper reference ages 
(YPLLLE and YPLL75). This method differs from the CDR calculation by providing a more 
accurate portrayal of premature deaths by ranking the leading causes of early death rather than 
overall numbers of deaths.  
iv) Regression Analyses: provides odds ratios of dying at younger and older ages, based on 
predictors of early mortality.  
Results 
Descriptives 
As of December 11, 2015, 787 former NBA/ABA players were identified as deceased out 
of a total of 3,901 players who competed between 1946 and 2010 (20.1%). The mean (M) age of 
death was 68.1 years (y) with a standard deviation (±) of 16.0 (range (R) = 24.3 – 99.6 y). Of 
those 787 former players with a confirmed death date, our search identified 514 causes of death 
(65.3%) from 16 different ICD groups, 432 of which were from natural causes (i.e., not directly 
caused by external forces; M = 68.9 y ± 14.6) and 82 from unnatural or premature causes (e.g., 
accident, suicide and homicide; M = 50.8 y ± 19.5). Further, the top two leading causes of death 
were from diseases of the circulatory system (i.e., cardiac-related) and malignant neoplasms (i.e., 
cancer), both natural causes, and accounted for 54.6% (281/514) of all-known deaths in the 
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population. The youngest ages of death on average occurred from certain infectious and parasitic 
diseases (n = 2; M = 39.1 y ± 4.5) and intentional self-harm (n = 6; M = 43.0 y ± 15.5) and the 
oldest from diseases of the digestive (n = 4; M = 80.8 y ± 3.5) and genitourinary system (n = 5; 
M = 79.0 y ± 17.6). A high majority of the located causes of death were cross-verified in another 
data source (>80%). See Table 5.1 for a complete list of causes of death and CDRs by ICD 
classification and race, and Figures 5.1 to 5.3 for illustrations of the leading causes of known 
death of this population and age of death distributions.  
Of the biological variables collected, a majority of the deceased NBA/ABA player 
population were white (n = 591; 75.1%), right-handed (n = 758; 96.3%), classified as “Normal” 
on the BMI scale during their playing career (n = 621; 78.9%) and were born in 1940 or earlier 
(n = 579; 73.6%). Of the occupational variables collected, a majority were Guards (n = 216; 
27.4%), non-inductees into the HOF as a player (n = 751; 95.4%) and played on average for 3.61 
years (± 3.4; Median = 2 years; one player played a high of 21 years). Table 5.3 shows average 
ages of death for all of the predictors collected.  
Comparisons to the general population  
 All known causes of death in NBA/ABA players who competed between 1946 and 2010 
were compared to data from the 2013 US general population by i) CDRs and race, where cause-
specific CDRs were reported by the average annual instance per separate calendar year 
calculated between 2010 and 2015 (Table 5.1), and by ii) CDRs for each year between 2010 and 
2015 for the two leading causes of natural and unnatural death (Table 5.2). With regard to Table 
5.1, since our comparative data were from a single year (2013), standardized CDRs were 
provided by calculating athlete causes of death over the past six years and producing an average. 
Due to the historical nature of this examination, investigating CDRs across multiple decades and 
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providing a rate for each year in which a death occurred in our population would have lacked 
usefulness and been largely redundant. For example, although 61.7% of our population died 
within the last 15 years (486/787), the first reported death dates back to 1957 (theoretically, a 
death could have occurred anywhere from the inaugural professional basketball season in 1946 
until December 11, 2015 in which the athlete would have entered our deceased sample). Further, 
Table 5.2 reported the leading causes of death by individual year, and only one instance of the 
second leading cause of unnatural death occurred since 2010 (i.e., homicide in 2010). This 
illustrates how fluctuation of cause-specific deaths in a relatively short time period can easily 
alter CDRs, particularly in a relatively smaller population.   
Nevertheless, considering the differences in population size, our findings depict 
moderately similar CDRs across causes of death of NBA/ABA players compared to the sex- and 
race-matched controls from US general population (see Tables 5.2 and 5.3). For example, the 
average CDR of malignant neoplasm across the last six years for the NBA/ABA player sample 
was 187.9 relative to 197.6 for the general population. CDR for circulatory disease was nearly 
identical between players in 2015 (256.3) and controls in 2013 (257.4). Race-matched 
comparisons were also similar for causes such as accidents, where white players had a CDR of 
55.2 compared to 56.8 for the general population, whereas other causes such as diseases of the 
nervous system (e.g., Alzheimer’s disease) for white players (77.3) were less similar relative to 
the controls (19.7). Interestingly, CDR discrepancies were also evident in the absence of certain 
causes of death for the player sample since 2010, such as no reported deaths from endocrine, 
nutritional and metabolic disease (e.g., diabetes mellitus) for white players (25.7 for race-
matched controls), no intentional self-harm (i.e., suicide) for white players (23.4 for race-
matched controls), one external cause of morbidity and mortality (i.e., homicide) for black 
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players (7.5 vs. 33.1 for race-matched controls), and no incidences of digestive system or 
infectious and parasitic diseases for either race.  
Athlete-Year 
 There were a total of 219,561 AY, with the highest representation of players who were 
non-inductees into the HOF (211,921 AY), right-handers (208,678 AY) and players with normal 
BMIs (173,009 AY). Overall, incidences of natural deaths per AY were more common across all 
predictors of mortality compared to unnatural deaths. Understandably, the most common rates of 
death were for players born in 1920 or earlier from natural causes (occurring once every 174 
AY), particularly from cardiac diseases (1:450 AY), and the least from cancer in those players 
born in 1961 or later (1:12,136 AY). Other predictors of mortality that were less time-dependent 
(i.e., were more likely to stay constant over time) such as career length, handedness and playing 
position did not appear to have considerable differences in rates of death per AY (e.g., death 
from cancer for right-handers occurred at a rate of 1:1,592 AY compared to 1:1,554 AY for left-
handers). Table 5.3 provides the estimates of the rates of natural, unnatural, cardiac and cancer 
deaths in athletes across all variables collected.    
Years of Potential Life Lost 
 Table 5.4 shows cause-specific YPLL by both life expectancy and race. Out of the total 
of 787 deceased players, 59.4% (468/787; 7,951.75 YPLL using an upper reference age of 75 
years) and 28.7% (226/787; 3,608.09 YPLL using life expectancy at birth as the upper reference 
age) died prematurely. Interestingly, there was a 30.7% decrease in NBA/ABA players whose 
deaths were classified as premature when using the more specific measure of individual life 
expectancy at birth, a reduction of 4,343.66 YPLL. Notably, the ranking of the overall leading 
causes of premature death in the deceased player population was the same as the leading causes 
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of all death, with the exception of diseases of the nervous system, where only four out of the 16 
incidences were considered premature when using 75 years as the upper reference age for life 
expectancy. Premature deaths were primarily due to diseases of the circulatory system (YPLL75, 
1,813.15; YPLLLE, 840.62), malignant neoplasms (YPLL75, 1,358.56; YPLLLE, 566.54) and 
accidents (YPLL75, 1,097.09; YPLLLE, 761.21).  Predictably, a higher overall percentage of 
premature deaths were from unnatural (YPLL75, 84.1%, 69/82; YPLLLE, 67.0%, 55/82) than 
natural (YPLL75, 59.7%, 258/432; YPLLLE, 29.8%, 129/432) causes. The highest percentages of 
cause-specific premature deaths with more than 10 cases were from homicides (YPLL75, 100%, 
21/21; YPLLLE, 85.7%, 18/21) and accidents (YPLL75, 76.7%, 33/43; YPLLLE, 60.4%, 26/43).  
 As it pertains to race (calculated using YPLLLE), black players had more overall YPLL 
compared to white players (2,242, n = 136 vs. 1,365.68, n = 90, respectively), and a higher mean 
of YPLL per player (16.4 vs. 15.1, respectively). Notably, all five premature incidences of death 
from respiratory system diseases and three incidences of endocrine, nutritional and metabolic 
diseases occurred in black players, in addition to having a far greater mean of YPLL from 
homicide compared to white players (26.2 vs. 14.8, respectively). Below, the influence of racial 
disparities in the earlier decades of the NBA on mortality outcomes is discussed.  
Statistical Biases from Regression Analyses  
 As highlighted previously, we deemed descriptive statistics to be the most appropriate 
methodological approach to analyze our population data, considering there was little to infer. On 
the other hand, analyzing likelihood estimates may also be useful in this circumstance since the 
NBA player population continues to grow each year as new cohorts of players get drafted into 
the league. In addition, inferential statistics in this regard also help to highlight the potential for 
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misinterpretations of early mortality risk and causes of death for certain predictor variables due 
to the nature of the population analyzed.  
Lifespan predictors 
 Race. Table 5.5 reports unadjusted and adjusted odds ratios (OR) for all of the biological 
and occupational variables collected. Notably, a significantly (unadjusted) higher likelihood of 
dying below the median age of death (71.0 years) was found in black players (OR 10.32, 95% 
CI: 6.65 – 16.02); however, it is important to consider cohort effects resulting from racial 
disparities in the earlier decades of professional basketball in North America. In the NBA/ABA 
population, we found low participation of black players relative to white players born in 1930 or 
earlier (12 vs. 539) or between 1931 – 1940 (89 vs. 184), and in contrast, higher participation for 
black players relative to white players born between 1941 – 1950 (373 vs. 307), 1951 – 1960 
(451 vs. 180) and 1961 – 1990 (1,296 vs. 298). These disproportions create statistical artifacts 
when using race as a predictor of lifespan and cause of death. For a player to enter the population 
analyzed in this study they had to be deceased. Consequently, black players become artificially 
predisposed to having a relatively younger age of death and to die from unnatural causes; 73.5% 
of deceased black players were born in 1941 or later (n = 144), which allow them to live a 
maximum of 74 years when using December 11, 2015 as the cutoff. In contrast, the higher 
proportion of white players who were born earlier, and thus debuted in the league in earlier 
decades, had a higher likelihood to live a full life and die from a natural cause. As a result, the 
mean age of death for white players was 72.2 years (± 14.3) compared to 55.5 years (± 14.1) for 
black players. This statistical bias was supported in YPLL outcomes and also illustrates 
multicollinearity, which exists when there is a strong correlation between two or more predictors 
(Field, 2013); Pearson bivariate correlations revealed that race and birth decade were 
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significantly correlated with one another (r = .648, p < .05). When race was adjusted for birth 
decade, the previously inflated significant OR of 10.32 for black players dying below the median 
age of death became insignificant (OR 1.67, 95% CI: .915 – 3.05). 
 Height. Players who were 77 inches (i.e., 6’5”) or taller were also found to have a 
significantly higher likelihood of dying below the median age of death (OR 2.70, 95% CI: 2.02 – 
3.61). Similarly, birth decade should be taken into account; 77.2% of deceased players who were 
below the median height (≤ 76 inches) were born in 1930 or earlier (n = 325). Thus, when height 
was adjusted for birth decade (i.e., multicollinear predictors; r = .460, p < .05), height became an 
insignificant predictor of lifespan (OR 1.27, 95% CI: .88 – 1.84). Therefore, having been born in 
earlier decades and playing in the NBA at a time when the average height was relatively shorter 
allowed the deceased players in this study a greater opportunity to live a full life.  
Cause of death predictors 
 Similar caution should be given when interpreting cause of death predictors. Logistic 
regressions revealed that white players had a significantly higher incidence of death from 
natural/old age causes compared to black players (OR 2.46, 95% CI: 1.38 – 4.37), and black 
players had a significantly higher incidence of death from homicide compared to white players 
(OR 2.53, 95% CI: 1.05 – 6.10). Further, natural/old age was used as the referent group in a 
multinomial logistic regression which revealed that white players had a significantly lower 
likelihood of dying from cardiac disease (OR 0.36, 95% CI: .195 – .697), cancer (OR 0.45, 95% 
CI: .235 – .859), homicide (OR 0.19, 95% CI: .070 – .526), suicide (OR 0.10, 95% CI: .018 – 
.625) and respiratory, endocrine, genitourinary, digestive and mental diseases (OR 0.34, 95% CI: 
.141 – .817) than they are of natural/old age causes relative to black players. This further 
corroborates previous trends where decade of play influences lifespan outcomes; in this case, the 
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nature of the population analyzed biases the influence of cause of death predictors such as race 
by allowing those who were born earlier (i.e., predominantly white players) to have a greater 
likelihood of dying from natural/old age causes (e.g., metabolic syndrome risk factors) relative to 
black players.  
Discussion 
The purpose of this investigation was to expand the limited empirical understanding of 
mortality in professional basketball players by a) ascertaining cause of death knowledge in 
former NBA/ABA players, and b) examining how exposure to certain biological and 
occupational variables influences mortality. Our overarching findings indicated that i) 
NBA/ABA players have similar leading causes of death and CDRs to sex- and race-matched 
controls from the US general population, ii) differences in death rates per AY exist within time-
dependent variables (e.g., birth decade) but less in more stable variables (e.g., handedness), and 
overall incidences of unnatural deaths per AY were less common across all predictors of 
mortality relative to natural deaths, and iii) a majority of the deceased player population died 
prematurely if the life expectancy was set at 75 years for each player, but less than 30% were 
considered young deaths if life expectancy at birth for each player was individually calculated. In 
addition, this investigation highlighted the potential dangers of disseminating likelihood 
estimates for certain predictors of early mortality in a population where the demographics have 
considerably evolved since its inception.  
 Gillett, Ross and Switzer (2015) highlighted two predominant storylines surrounding 
sport and the malleability of chronological age that are perpetuated through conversations and 
different media outlets; i) warning of the dangers and destructive potential of competitive sport, 
and ii) the transformative capacity of sports that allows individuals to overcome personal and 
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social challenges and constraints. While this ‘power of sport’ narrative is diverse (Gillett et al., 
2015), the vast dissemination of information through social media can dominate how we 
perceive certain issues. Thus, chronological age (i.e., early mortality risk) may actually be 
perceived less ‘malleable’ and more rigid in elite athletes, augmented through media’s 
predisposition to report a premature death rather than a death in old age (particularly for the 
earlier unheralded players). This supports the comprehensive undertaking of mortality 
measurements used in this study, which allowed us to examine the nuances and portrayals of 
death in more depth concerning the deceased NBA/ABA player population.  
The absence of rigorous methodology when examining a historically evolving population 
such as NBA participants can promote common oversights of death risks and propagate negative 
stereotypes. For example, parameters of time-dependent predictors of mortality were highly 
impacted in both the AY and regression analyses. More specifically, white and relatively shorter 
players were artificially predisposed to living longer than black and taller players since they 
made up a majority of the participants in the earlier decades; the unique shift in North American 
professional basketball participant demographics (even though nearly all deceased players were 
US-born) resulted in black and taller players entering the NBA in later decades, giving them less 
opportunity to live a full life since our analyses only included deceased players. In turn, while 
there was a noticeable difference between races for a cause of death such as homicide, where 
there were more deaths in black players (n = 11) relative to white players (n = 10) despite the 
significantly higher proportion of white deceased players (591/787), an odds ratio of 2.53 
estimating high risk of homicide for black players may be misleading. 
The CDR comparison to the general population provided a more standardized method of 
informing us how deaths in high performance athletes may relate to a less active population. 
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While there was a considerable discrepancy between the population sizes in our comparison, 
alongside elite athletes having superior longevities (Lemez & Baker, 2015), little variability was 
found in the leading causes of death and CDRs between the players and the general population. 
Interestingly, it appears that there were no apparent protective effects of exercise for the athlete 
group in this mortality measure. Another interesting finding was that there appeared to be a 
relatively lower number of premature deaths (YPLL) when each player’s life expectancy at birth 
was considered (28.7%). This notion was supported through a 2014 CDC press release which 
stated that approximately 900,000 Americans die prematurely from the five leading causes of 
death alone each year (“CDC Newsroom,” 2014), and accounting for the 2,596,993 reported 
deaths in the US in 2013 (“Deaths: Final data for 2013,” 2016), that equates to at least 34.6% of 
the general US population deaths being classified as premature. However, it is also important to 
recognize that players born earlier in the 20
th
 century had lower life expectancies at birth, thus 
potentially reducing the number of premature death classifications which would otherwise be 
considered a young death today.  
Limitations 
 A key limitation of this study in reporting vital statistics of former NBA/ABA players 
was that it was a non-forensic-based investigation; therefore, we were limited to how the causes 
of death were reported publically. The World Health Organization (2014) emphasizes that when 
assigning causes of death that it is critical that deaths are classified by the underlying cause (i.e., 
the cause that initiated the events leading to the death) rather than the immediate cause of death. 
This approach is more helpful in generating information that is useful for public health purposes 
(World Health Organization, 2014). For example, professional wrestler “Rowdy” Roddy Piper’s 
death in 2015 at the age of 61 years was due to cardiac arrest; however, hypertension caused his 
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chronic blood pressure, which created blood clots resulting in a pulmonary embolism that 
triggered his heart attack. As it relates to the ICD classification adopted in this study, another 
example includes endocrine, nutritional and metabolic disease being a precursor to disease of the 
circulatory system. Unfortunately, cause of death can be complicated by a number of 
contributing known and unknown underlying factors that are generally not reported publically, 
such as genetics and inheritance of diseases, along with a number of behavioural/preventable risk 
factors such as smoking and unhealthy diet. In the NBA, for example, anecdotal evidence of 
rampant drug use amongst players in the 1970s and early 1980s may have detrimentally 
impacted the cardiac longevity of players of this era, which would be considered an unnatural 
contributor to a ‘natural cause’ of death. While this limitation particularly applies to our 
incomplete knowledge of the underlying causes that contributed to natural deaths such as heart 
disease and stroke, which may have been precipitated by other factors such as prior drug use, 
reporting of unnatural deaths could have also confounded our results (e.g., suicide vs. alcohol-
related death). In addition, our inclusion of natural/old age as a cause of death category is a broad 
classification that may include more precise illnesses and diseases that led to players’ deaths that 
went unreported. Therefore, our findings may underestimate the importance of diseases that 
contribute to the underlying causes of deaths (Centers for Disease Control, 1986).  
 A limitation of using CDRs of our athletic population to compare mortality trends to the 
general population was that they are physically dissimilar populations. Further, Vila and 
colleagues (2006) suggested that a problem with this mortality measure is that the age 
distributions between the two populations may be different, which can confound the results. 
Consequently, the CDRs for the US general population in 2013 were for all age groups, whereas 
the athlete population had to have reached a certain age in order to be included in this analysis 
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(i.e., age in which they debuted in the NBA or ABA). Another common concern of this measure 
is comparing across time periods since mortality outcomes can vary considerably; however, we 
adjusted for this by calculating annual CDRs between 2010 and 2015 and reporting the average.  
 Last, while CDRs treat each death equally, using YPLL as a measure of mortality has 
been criticized for valuing premature death more than death at later ages, and the chronic and 
other conditions that contribute to it (Dranger & Remington, 2004; Vila et al., 2006). In addition, 
the year-to-year changes in the total and cause-specific rates of YPLL can alter how we rank the 
leading causes of YPLL among population subgroups (Centers for Disease Control, 1986).  For 
example, we found black players to have 288.74 YPLLLE from homicide (Table 5.4); however, 
we also revealed that only one incident of homicide in the NBA/ABA player population has 
occurred in the last six years (Table 5.2). While rates of premature mortality have been found to 
differ among racial groups (Centers for Disease Control, 1986), these year-to-year changes can 
create cause for concern to intervene and target groups that are unnecessarily perceived to be at 
high risk.  
Data Retrieval Limitations 
In Link and Estes’ (2012) study on SCD, they drew attention to the tendency of athletes’ 
deaths to be nationally noted, relative to lesser media speculation given to non-athletes, which 
often skews the public’s perception of risk. Comparatively, we were unable to locate cause of 
death for 273 persons in our study (34.7%). While ultimately it is the family’s decision of 
whether to disclose a cause of death, arguably, athletes who were more identifiable generally 
have a cause that accompanies the news of their death. In further examining this phenomenon in 
our population, two indicators of high achievement and recognizability attained were HOF and 
career longevity; only three were inducted into the HOF (1.1% vs. 4.6% who were inducted in 
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the overall deceased population of 787 players) and a majority played only two seasons or less in 
the NBA or ABA (69.5% vs. 54.5% overall) of the 273 former players whose cause of death data 
were undisclosed. Interestingly, while these outcomes appear to support common anecdotal 
assumptions of disproportional media coverage in favour of the better recognized athletes after 
they die, it is important to note that birth cohort effects may also play a factor. More specifically, 
205 of the 273 (75.1%) former athletes who were missing a cause of death were born in 1930 or 
earlier, compared to 59.5% of former players in the overall deceased sample (468/787). In 
addition, only 15.3% (42/273; YPLLLE) of players with unknown causes of death died 
prematurely, which suggests that it is less likely that a cause of death is publically reported if the 
player died later in life. Thus, cause of death data retrieval limitations are likely a result of a 
combination of inaccessible accurate death data of players from earlier generations and 
disparities between achievement/recognizability and relative obscurity amongst the players (i.e., 
media subjectivity in reporting).   
Future Directions 
Although there appears to be obvious caveats and inherent biases to disseminating 
mortality outcomes in a historically evolving population such as the one studied, the mortality 
measures utilized also offer several strengths and complement one another. For example, by 
knowing the (immediate) reported cause of death, it may inadvertently illuminate the morbidity 
caused by the disease (Vila et al., 2006), thus providing researchers an avenue for secondary 
examinations into the underlying causes of death and potential risky behaviours that preceded it. 
As well, YPLL measures of mortality can be used for prevention of future premature deaths in 
athletes. More specifically, death at younger ages has been suggested to be more attributable to 
preventable causes, which is desirable from an economic and social standpoint (Dranger & 
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Remington, 2004). By determining the relative importance of premature causes of death in a 
subpopulation, effective interventions and resources can be targeted towards the high risk groups 
in an attempt to extend lifespans and modify negative lifestyle and behavioural factors.     
Conclusion 
 From a broader perspective, despite the relative eminence of professional athletes, 
comprehensive knowledge on their causes of death is limited.  While it is important to respect 
that families of the deceased may not want to publically release cause of death knowledge, a 
media/content repository that collates and publicizes the causes of death if they are released, 
regardless of the level of popularity of the athlete, could advance sport medicine, provide broad 
public health applications, and help to disarm potentially harmful stereotypes of health in elite 
sport. This study found that deceased NBA/ABA players had similar causes of death to the 
general population, along with lower premature death if life expectancy at birth was considered, 
yet questions still remain, such as to what extent these results are generalizable to other high 
performance athletes and whether superior athletic ability transcends general life expectancies. It 
will also be worthwhile for future research to examine physical activity and other health patterns 
of high performance athletes after they retire, and to compare their health outcomes to similarly 
active controls. Therefore, in accordance with the growth in social media usage, researchers and 
practitoners alike should negotiate best avenues to improve health and the transparency between 
different mediums of information concerning health in athletes in order to reconcile otherwise 
limited empirical evidence.  
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Figure 5.1: Causes of known death in former NBA and ABA players, by percentage (N = 514) 
 
 
*Other: Disease of the Genitourinary System (n = 5), Disease of the Digestive System (n = 4), Complication of Surgical and Medical Care 
(n = 4), Poisoning by Drugs, Medicaments and Biological Substances (n = 2), Certain Infectious and Parasitic Disease (n = 2)  
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Figure 5.2: Leading causes of known death in former NBA and ABA players, by age of death (in years) 
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Figure 5.3: Age distributions of death in former NBA and ABA players, by frequency 
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Table 5.1: Cause-specific CDRs, by race      
 
                             Race (n)    
                             ICD Classification                    n        Age (yrs)     W       B   All Races     W (n)*         B (n)*   All Races     W          B            
   Disease of the Circulatory Systemª  143     63.9 ± 14.4     91     52     145.2    154.7 (14)    150.0 (20)   257.4     275.3     230.8 
   Malignant Neoplasmᵇ    138     67.2 ± 13.7     94     44     187.9    309.4 (28)    120.0 (16)   197.6     213.0     165.6 
   Natural/Old Ageᶜ      92     77.1 ± 10.8     76     16  158.0    320.5 (29)        60.0 (8)    ³83.2       90.7       66.7 
   Disease of the Nervous System ͩ    16     73.8 ± 16.9     14       2    34.1        77.3 (7)          7.5 (1)   ⁴16.6       19.1          7.9 
   Cerebrovascular Disease  ͤ     13     70.8 ± 10.7     10       3    12.8        11.0 (1)        15.0 (2)     34.5       35.8        35.1 
   Disease of the Respiratory Systemᶠ    12     72.3 ± 19.9       7       5       34.1      66.3 (6)        15.0 (2)      45.2      51.6        24.2  
   Endocrine, Nutritional and Metabolic       7      67.5 ± 14.2       2       5         8.5            -- (0)        15.0 (2)     25.6       25.7        30.5 
   Diseaseᶢ 
 
   Disease of the Genitourinary Systemʰ       5     79.0 ± 17.6       4       1        12.8       22.1 (2)     7.5 (1)      0.1         0.1         0.1 
   Disease of the Digestive System ͥ              4      80.8 ± 3.5         4       0          --              -- (0)            -- (0)    ⁵15.2      16.9          9.3 
   Certain Infectious and Parasitic                 2      39.1 ± 4.5         1      1           --           -- (0)            -- (0)      2.0         2.1          2.0 
   Diseaseʲ 
 
   Accidentᵏ       43     51.6 ± 22.9     31     12       29.9        55.2 (5)        15.0 (2)     52.6       56.8        43.1 
   External Cause of Morbidity and             21     45.8 ± 13.5     10     11         4.2             -- (0)          7.5 (1)       8.2         4.4       33.1 
   Mortalityᶫ 
 
   Intentional Self-Harm ͫ                               6     43.0 ± 15.5       2       4         4.2             -- (0)          7.5 (1)     20.6       23.4         9.0 
   Mental and Behavioral Disorderⁿ              6     53.7 ± 12.6       4       2          8.5           -- (0)       15.0 (2)    ⁶13.7       15.0         9.1 
   Complication of Surgical and Medical      4     68.6 ± 16.1       4       0           --             -- (0)      -- (0)       0.9        0.9         0.9 
   Careᵒ 
 
   Poisoning by Drugs, Medicaments and     2     63.74 ± 2.2       0       2          8.5           -- (0)       15.0 (2)    ⁷18.2       20.2       13.5 
Male US General 
Population 2013: 
Deaths/100,000² 
NBA/ABA Players   
1946-2010: 
Deaths/100,000¹ 
Natural 
Causes 
Unnatural 
Causes 
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   Biological Substancesᵖ 
 
   Unknown                                               273      72.0 ± 13.4   237     36        --           --               --                 --           --           -- 
   TOTAL                                                 787       68.1 ± 16.0   591   196       649.4   1,016.7        450.2            839.1     899.1    739.3 
ªIschaemic heart disease (n = 139), diseases of the arteries, arterioles and capillaries (n = 3), pulmonary embolism (n = 1); ᵇUnspecified cancer (n = 
74), leukemia (n = 11), prostate (n = 11), brain (n = 9), lung (n = 9), liver (n = 4), colon (n = 3), bladder, bone, esophagus, multiple myeloma, 
pancreas (n = 2), bone marrow, colon and liver, kidney, melanoma, myelodysplastic syndrome, rectum, throat (n = 1); ᶜReported causes included: 
natural causes, died peacefully, died at home, died after a brief illness, died after a long illness, and died from various illnesses (e.g., metabolic 
syndrome);  ͩAlzheimer’s disease (n = 7), Parkinson’s disease (n = 4), epilepsy (n = 2), Amyotrophic Lateral Sclerosis (ALS), brain aneurysm, 
brain disease (n = 1); ͤStroke (N = 13); ᶠPneumonia (n = 7), cardiorespiratory failure (n = 2), influenza, lung disease, pulmonary fibrosis (n = 1); 
ᶢDiabetes mellitus (n = 6), amyloidosis (n = 1); ʰKidney failure (N = 5); ͥLiver disease, peritonitis, portal hypertension, ulcer (n = 1); ʲAcquired 
Immune Deficiency Syndrome (AIDS), complications from staphylococcal infection (n = 1); ᵏCar accident (n = 27), fall (n = 6), drowning (n = 4), 
plane crash (n = 2), All-Terrain Vehicle (ATV) accident, falling tree, injury, motorcycle crash (n =1); ᶫHomicide (N = 21); ͫ Suicide (N = 6); 
ⁿAlcohol abuse (N = 6); ᵒSurgery complication (n = 3), pacemaker infection (n = 1); ᵖDrug overdose (N = 2) 
Standard Deviation = ±; ¹Total population = 3,901 (white = 1,508; black = 2,221); Cause-specific CDRs for the NBA/ABA player population were 
reported by the average annual incidence between the years of 2010 and 2015; For consistently in general population comparisons, only white 
players of North American nationality were included in this statistic (i.e., does not include European, Australian, or New Zealand players); ²Data 
from the Centers for Disease Control and Prevention (CD) national vital statistics reports (“Deaths: Final data for 2013,” 2016; Heron, 
2016); *Total frequencies between 2010 and 2015; ³Data for “All other diseases”; ⁴Data for “Alzheimer’s disease”; ⁵Data for “Chronic 
liver disease”; ⁶Data for “Alcohol induced deaths”; ⁷Data for “Drug induced deaths” 
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Table 5.2: Cause-specific CDRs for leading causes of natural and unnatural death, by individual year (2010 – 2015) 
  
            2010         2011                   2012                  2013                  2014          2015³          
              ICD Classification     n   Athletes        n   Athletes        n   Athletes        n   Athletes        n   Athletes        n   Athletes                               
   Disease of the     6    153.8       7    179.4            6    153.8           2      51.2           3      76.9           10    256.3        257.4 
   Circulatory System    
   Malignant Neoplasm    5    128.1           9    230.7          11    281.9     9    230.7     3      76.9      7    179.4             197.6       
   Accident            --              2      51.2            3      76.9            1      25.6                 --                  1      25.6               52.6 
   External Cause of           1      25.6                   --                         --                       --               --                           --                      8.2           
   Morbidity and Mortality 
 
    
¹Total population = 3,901; ²Data from the Centers for Disease Control and Prevention (CD) national vital statistics reports (“Deaths: Final data 
for 2013,” 2016; Heron, 2016); ³Causes of death were collected until December 11, 2015    
     
 
 
 
 
 
 
 
 
Male US General 
Population 2013: 
Deaths/100,000² 
NBA/ABA Players 1946-2010: Deaths/100,000¹ 
Natural 
Causes 
Unnatural 
Causes 
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Table 5.3: Predictors of mortality (N = 787) and incidence of known death (N= 514) per Athlete-Year (N = 3,901ª) 
            Deceased Players         NAT      INC     UNN       INC     Cardiac    INC     Cancer     INC       
   Predictors        (n)       %          Age (yrs)    AYsª    Death    / AY     Death     / AY       Death     / AY      Death     / AY 
 
Overall        787   100.0     68.1 ± 16.0    219,561ª    432   1 in 508      82   1 in 2,677    143   1 in 1,535    138   1 in 1,591  
Race  
   White        591     75.1     72.2 ± 14.3    100,202ᵇ    303   1 in 330      51   1 in 1,964      91   1 in 1,101      94   1 in 1,065               
   Black        196     24.9     55.5 ± 14.1    112,542ᶜ    129   1 in 872      31   1 in 3,630      52   1 in 2,164      44   1 in 2,557     
Career Length ͩ   
   ≤ 1-y        315     40.0     70.9 ± 15.1      68,155     146   1 in 466      28   1 in 2,434      36   1 in 1,893      48   1 in 1,419 
   2-y        114     14.5     67.6 ± 16.2      25,369       52   1 in 487      13   1 in 1,951      18   1 in 1,409      16   1 in 1,585 
   3-y          74       9.4     68.6 ± 16.2  17,663       45   1 in 392        5   1 in 3,532      16   1 in 1,103        9   1 in 1,962 
   4+-y        284     36.1     65.0 ± 16.3      95,271     189   1 in 504      36   1 in 2,646      73   1 in 1,305      65   1 in 1,465 
Handedness 
   Right        758     96.3     68.3 ± 15.8    208,678     412   1 in 506      77   1 in 2,710    135   1 in 1,545    131   1 in 1,592 
   Left          29       3.7     61.2 ± 19.2  10,883       20   1 in 544        5   1 in 2,176        8   1 in 1,360        7   1 in 1,554 
BMI 
   Normal       621     78.9     68.2 ± 15.8    173,009     350   1 in 494      67   1 in 2,582    104   1 in 1,663    112   1 in 1,544 
   Overweight       166     21.1     67.6 ± 16.5  46,552       82   1 in 567      15   1 in 3,103      39   1 in 1,193      26   1 in 1,790 
Birth Decade 
   ≤ 1920       109     13.9     76.7 ± 12.4    8,557      49    1 in 174        7   1 in 1,222      19   1 in 450           9   1 in 950 
   1921-1930       359     45.6     75.2 ± 11.9  34,356    183    1 in 187      24   1 in 1,431      48   1 in 715         53   1 in 648 
   1931-1940       111     14.1     66.1 ± 13.7  20,226      69    1 in 293        9   1 in 2,247      21   1 in 963         32   1 in 632 
   1941-1950       118     15.0     56.6 ± 12.4  46,232      71    1 in 651      16   1 in 2,889      23   1 in 2,010      30   1 in 1,541 
   1951-1960         53       6.7     51.2 ± 9.6        37,370      35    1 in 1,067   14   1 in 2,669      17   1 in 2,198        8   1 in 4,671 
   ≥ 1961         37       4.7     39.6 ± 9.1        72,819      25    1 in 2,912   12   1 in 6,068      15   1 in 4,854        6   1 in 12,136  
Position 
   Guard       216     27.4     69.1 ± 15.1  77,592    117    1 in 663      23   1 in 3,373      31   1 in 2,502      42   1 in 1,847 
   Guard/Forward    145     18.4     70.5 ± 15.1       22,172      85    1 in 260        9   1 in 2,463      27   1 in 821         25   1 in 886 
   Forward       190     24.1     65.8 ± 16.9      69,531    100    1 in 695      24   1 in 2,897      38   1 in 1,829      27   1 in 2,575 
   Forward/Center   155     19.7      68.3 ± 16.3      24,105      79    1 in 305      20   1 in 1,205      26   1 in 927         27   1 in 892 
   Center         81     10.3     65.8 ± 16.4      26,159      51    1 in 512        6   1 in 4,359      21   1 in 1,245      17   1 in 1,538 
Height 
   ≤ 76 in       421     53.5     72.3 ± 13.9      88,203    221    1 in 399      34   1 in 2,594      70   1 in 1,260      65   1 in 1,356 
   ≥ 77 in       366     46.5     63.2 ± 16.8    131,358    211    1 in 622      48   1 in 2,736      73   1 in 1,799      73   1 in 1,799 
HOF 
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   Inductee         36       4.6     71.1 ± 16.2        7,640      31    1 in 246        2   1 in 3,820      13   1 in 587           8   1 in 955 
   Non-inductee       751     95.4     67.9 ± 16.0    211,921    401    1 in 528      80   1 in 2,649    130   1 in 1,630    130   1 in 1,630 
                                 
AY = Athlete-Year, INC / = Incidence per, NAT = Natural, UNN = Unnatural; ªIncludes both living and deceased players who played in the NBA 
or ABA between 1946 and 2010; Ages for living players were calculated as of December 11, 2015 (i.e., until the cut-off date for death data 
collection); ᵇNorth American nationality (i.e., does not include European, Australian, or New Zealand players); ᶜ27 players were identified to be of 
African nationality, and were included in this statistic;  ͩLiving players who were active past the 2009-2010 season were excluded (n = 398) for 
consistency (i.e., full career length only)  
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Table 5.4: Cause-specific YPLL, by life expectancy and race 
 
                                   YPLL Sum (Mean per player; Number of premature deaths)                  Race 
                Cause of premature death              YPLL75               YPLLLE    Rate Change*        WLE                           BLE 
   Disease of the Circulatory System       1,813.15 (17.1; 106)   840.62 (14.4; 58)   -972.53   262.82 (13.1; 20)   577.80 (15.2; 38) 
   Malignant Neoplasm    1,358.56 (14.4; 94)   566.54 (12.5; 45)   -792.02   230.79 (14.4; 16)   335.75 (11.5; 29) 
   Natural/Old Age         325.38 (9.8; 33)       82.56 (8.2; 10)   -242.82         22.39 (7.4; 3)         60.17 (8.5; 7) 
   Disease of the Nervous System          94.30 (23.5; 4)       62.16 (31.0; 2)     -32.14          35.81 (n = 1)          26.35 (n = 1) 
   Cerebrovascular Disease           90.67 (11.3; 8)         15.88 (5.2; 3)     -74.79            3.42 (n = 1)         12.46 (6.2; 2) 
   Disease of the Respiratory System       115.48 (23.0; 5)       70.88 (14.1; 5)       -44.6                   --                70.88 (14.1; 5)    
   Endocrine, Nutritional and Metabolic           69.80 (13.9; 5)      31.97 (10.6; 3)      -37.83                   --                31.97 (10.6; 3) 
   Disease 
 
   Disease of the Genitourinary System               27.29 (n = 1)   19.09 (n = 1)          -8.2                  --                    19.09 (n = 1) 
   Disease of the Digestive System                               --                                -- 
   Certain Infectious and Parasitic                    71.75 (35.8; 2)       55.35 (27.6; 2)       -16.4          24.64 (n = 1)          30.71 (n = 1) 
   Disease 
 
   Accident                             1,097.09 (33.2; 33)   761.21 (29.2; 26)   -335.88   403.53 (28.8; 14)   357.68 (29.8; 12) 
   External Cause of Morbidity and              611.16 (29.1; 21)   392.61 (21.8; 18)   -218.55     103.87 (14.8; 7)   288.74 (26.2; 11) 
   Mortality 
 
   Intentional Self-Harm                                 191.93 (31.9; 6)     129.01 (25.8; 5)     -62.92          13.37 (n = 1)     115.65 (28.9; 4) 
   Mental and Behavioral Disorder               127.47 (25.4; 5)       59.86 (14.9; 4)     -67.61       32.67 (16.3; 2)       27.19 (13.5; 2) 
   Complication of Surgical and Medical         34.96 (17.4; 2)          12.55 (n = 1)     -22.41          12.55 (n = 1)                   -- 
   Care 
 
   Poisoning by Drugs, Medicaments and        22.52 (11.2; 2)            3.64 (n = 1)     -18.88                   --                      3.64 (n = 1) 
   Biological Substances 
 
Natural 
Causes 
Unnatural 
Causes 
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   Unknown                                             1,900.24 (13.4; 141)   504.15 (12.0; 42)  -1,396.09  219.81 (9.5; 23)    284.34 (14.9; 19) 
   TOTAL                                                   7,951.75 (16.9; 468)   3,608.09 (15.9; 226)   -4,343.66   1,365.68 (15.1; 90)   2,242 (16.4; 136) 
*Calculated difference between YPLL75 and YPLLLE (at birth) 
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Table 5.5: Mortality odds ratios, by earlier (≤ 71.0 years) or later (≥ 71.01 years) age of death predictors (N = 787); Predicted 
probabilities reported in reference to below median age of death 
                     Adjusted for Career 
        Age of Death Predictors      Adjusted for    Adjusted for     Length, Handedness, BMI,  
 Predictors      Unadjusted   Race                Birth Decade                        Position and HOF 
       OR (95% CI)          OR (95% CI)           OR (95% CI)              OR (95% CI)           
Race        
   White (ref)           
   Black            10.32 (6.65–16.02)  --           1.67 (.915–3.05)         8.96 (5.67–14.16) 
Career Length        1.12 (1.07–1.17)    1.03 (.98–1.08)          1.00 (.95–1.06)    --   
Handedness 
   Right (ref)           
   Left          1.96 (.90–4.27)    1.94 (.83–4.50)          1.28 (.46–3.56)    -- 
BMI 
   Normal (ref)          
   Overweight               1.14 (.81–1.60)           1.15 (.79–1.68)          1.16 (.76–1.76)    -- 
Birth Decade* 
   ≤ 1920 (ref)          
   1921-1930         1.08 (.67–1.75)    1.07 (.66–1.72)                      --                         1.10 (.67–1.79)  
   1931-1940             2.78 (1.58–4.87)          2.29 (1.25–4.20)           --            2.75 (1.52–4.97) 
   1941-1950                   36.20 (15.76–83.18)    27.20 (11.21–66.00)           --                  35.97 (15.22–84.97) 
   1951-1960                    M age of death = 51.2 y             --                 -- 
   ≥ 1961                     M age of death = 39.6 y             --                 -- 
Position 
   Guard (ref)                     
   Guard/Forward              .83 (.54–1.27)             .88 (.55–1.41)           1.17 (.70–1.95)    -- 
   Forward               1.29 (.87–1.91)           1.28 (.83–1.97)           1.18 (.72–1.92)    -- 
   Forward/Center           1.13 (.74–1.71)           1.11 (.70–1.76)           1.26 (.76–2.10)    -- 
   Center                 1.62 (.96–2.72)           1.58 (.89–2.79)           1.33 (.69–2.56)    -- 
Height (median split) 
   ≤ 76 in (ref)                    
   ≥ 77 in                               2.70 (2.02–3.61)         2.02 (1.48–2.77)           1.27 (.88–1.84)           4.53 (2.84–7.20) 
HOF 
   Inductee (ref)                             
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   Non-inductee                              1.41 (.71–2.78)              1.80 (.82–3.94)           1.27 (.57–2.83)                -- 
Significant ORs bolded (p < .05, 95% CI); *When analyzed into broader categories, players born between 1931 and 1950 had a 
significantly higher likelihood of dying below the median age of death relative to those born in 1930 or earlier (OR 6.64, 95% CI: 4.66 
– 9.46) 
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CHAPTER SEVEN: MORTALITY IN PROFESSIONAL ATHLETES FROM THE NBA, 
NFL, NHL AND MLB 
 
 
 
 
Mortality in professional athletes from the NBA, NFL, NHL and MLB* 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*A consolidated version of this article will be submitted for publication to The BMJ 
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Chapter Seven Overview 
Background: Critical and comprehensive investigations into the mortality outcomes of elite 
athletes can assist in decoding risk factors of premature mortality along with providing fruitful 
avenues to explore issues of human health through engagement in sport. As such, the purpose of 
this study was to comprehensively examine the lifespans and mortality trends of athletes from 
the four major sports in North America: Major League Baseball (MLB), National Basketball 
Association (NBA), National Football League (NFL) and National Hockey League (NHL).  
Methods: Sports-reference.com and wikipedia.org were used as the primary sources of 
information for all data collected, in addition to sport-specific publically available sources. All 
data were rigorously cross-referenced, and were analyzed descriptively and through Kaplan-
Meier and Cox regression survival analyses. 
Results: Overall, 17,523 out of 50,515 (34.7%) athletes were deceased as of the respective data 
collection cut-off date for their sport, with MLB players having the highest risk of imminent 
mortality (² (3) = 541.38, p < .05). Professional basketball players generally had the highest 
relative proportion of death when standardizing data by debut year, although NHL and NFL 
players who debuted after 2005 had the highest proportion of death. In addition, a one year 
increase in career length significantly decreased the risk of death (HR .982, 95% CI: .978 – 
.985), even after adjusting for sport type (HR .977, 95% CI: .974 – .980). 
Conclusions: Meaningful significance should be considered given the historical and unique 
nature of the dataset analyzed, which can influence our interpretation and dissemination of the 
results. Nevertheless, investigating risk of death differences through different occupational and 
biological variables can help highlight aversive trends to lifespan that permeate throughout high 
performance athlete populations. 
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Mortality in Professional Athletes from the NBA, NFL, NHL and MLB 
 
 There has been substantial evidence suggesting a clear inverse dose-response relationship 
between physical activity and all-cause mortality, the ultimate health outcome (e.g., Gebel et al., 
2015). Aggregations of epidemiologic studies normally show a 30% risk reduction of all-cause 
mortality among active individuals relative to the least active individuals, although the shape of 
the dose-response curve appears curvilinear where the lifespan benefits from being active 
become smaller as the amount of physical activity increases (Physical Activity Guidelines 
Advisory Committee, 2008). Interestingly, Moore and colleagues (2012) highlighted that few 
studies have quantified the actual years gained from engaging in regular physical activity (e.g., 
Franco et al., 2005; Paffenbarger, Hyde, Wing, & Hsieh, 1986; Wen et al., 2011). Accordingly, 
Arem and colleagues (2015) and Moore and colleagues (2012) conducted large pooled cohort 
analyses on over 650,000 participants each and demonstrated consistent years of life gained from 
physical activity involvement, particularly for those participating at moderate to vigorous 
intensities. These lifespan benefits extend to elite athletes as well (Garatachea et al., 2014; 
Lemez & Baker, 2015); however, although some evidence suggests that they are more physically 
active in later life compared to the general population (e.g., Fogelholm, Kaprio, & Sarna, 1994), 
much less is known about elite athletes’ physical activity patterns post retirement and whether 
their superior activity levels during youth and young adulthood translate into middle and late 
adulthood. Importantly, critical and comprehensive investigations into the mortality outcomes of 
elite athletes can assist in decoding risk factors of premature mortality (i.e., dying earlier than life 
expectancy at birth) along with providing fruitful avenues to explore issues of human health 
through engagement in sport.   
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 There are four major professional team sports leagues in North America that are 
universally considered to be the most prominent in their sport (generally defined by revenue 
generated and professional competition level): Major League Baseball (MLB), the National 
Basketball Association (NBA), the National Football League (NFL), and the National Hockey 
League (NHL). Lemez and Baker’s (2015) systematic review of mortality and longevity in elite 
athletes identified 16 studies exclusively conducted on MLB players, four on NFL players, three 
on NBA players and none on NHL players at the time of their review. However, a majority of 
these studies used restrictive sampling strategies and inclusion criteria that did not capture all of 
the living and deceased players at the time of the study, while others had different foci, in 
addition to the same research teams conducting multiple studies. For example, Abel and Kruger 
performed six studies (2004, 2005a, 2005b, 2006, 2007a, 2007b) that exclusively examined 
lifespans of MLB players, in addition to one study on NFL players and one study on a mixed 
athletic sample. Two of their studies examined the relationship between the initials of players’ 
names and longevity (Abel & Kruger, 2007b; Abel & Kruger, 2010); however, Smith (2011a) 
criticized their 2007 study on the basis of a small sample, selective initials, and a weak statistical 
test. Moreover, Smith (2011b) reported that the Sean Lahman Baseball Archive, which was used 
as the primary data retrieval method for nearly all of Abel and Kruger’s studies, had incomplete 
death data for a number of cases (particularly for the lesser known players who played in the 
earlier decades of the league), and highlighted the difficulty in determining whether missing 
values in the database was a result of the player still being alive or whether the death date was 
unknown. This is obviously problematic if researchers falsely assume that missing death data for 
each athlete implies that they are still alive. In addition, four of the 16 studies on baseball players 
were responses to previously published literature and one study investigated 28 players who died 
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from a poisoning-related cause (i.e., Boren & Erickson, 1998). While there were no studies 
exclusively examining the lifespans of NHL players, two mixed-sample studies included ice-
hockey players, although the inclusion criteria were restricted to players being born between 
1875 and 1930 and were at least 25 years of age at the time of death (Abel & Kruger, 2010) and 
Hall of Fame (HOF) players born between 1860 and 1930 (Bianco et al., 2007). Although the 
birthdate restriction method may have intuitive appeal that enables authors to capture the ‘full’ 
lifespans of former players, it also excludes those that died prematurely.  
 Interestingly, Lemez and Baker (2015) located only one study that compared survival 
curves across the four major sports (among five other sports that were included in the study; 
Bianco et al., 2007); however, the sample sizes were largely limited due to their focus on HOF 
players born prior to 1931 (baseball, n = 154; basketball, n = 58; football, n = 81; ice-hockey, n = 
130). Nevertheless, Bianco and colleagues (2007) concluded that life expectancies appear to be 
unaffected by the type of sport discipline after reporting no significant differences between the 
median life expectancies, which ranged from 74.5 years (ice-hockey players) to 78.0 years 
(basketball players) in the four major sports. More recently, Lemez, Wattie, and Baker (2015) 
addressed the relative lack of research comparing mortality outcomes of athletes from the four 
major sports and were able to gather cause of death data on 205 players who were still active 
competitors when they died. Similarities were found between leading causes of death of their 
sample to the Canadian and United States (US) general population, and the rare event (0.38%) of 
a professional athlete dying while active (i.e., premature) was highlighted. As a majority of the 
studies examining MLB, the NBA, the NFL and the NHL players were published in 2007 or 
earlier and/or included restrictive inclusion criteria, the purpose of this study was to provide a 
more up-to-date and comprehensive comparison of lifespans and mortality trends of athletes 
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from the four major sports. Investigating these large populations of athletes can provide broader 
and deeper awareness of the health status of elite athletes from sports with different 
physiological demands and challenge commonplace assumptions regarding health risks of 
participating in high performance sport. Our hypotheses were twofold. First, due to the inaugural 
season of MLB being much earlier than the other three major sports, we hypothesized that i) 
MLB players would have a significantly higher imminent mortality risk given the overall earlier 
birthdates of players compared to players from the other three leagues. Second, due to a 
curvilinear dose-response relationship between physical activity and lifespan, along with socio-
medical and economic similarities from playing in high revenue leagues, it was hypothesized that 
ii) proportional death rates would be similar across the four sports, when standardizing the data 
by debut years.   
Methods 
Data Collection 
With the exception of the MLB dataset, sports-reference.com and wikipedia.org were 
used as the primary sources of information for all data collected. Sports-reference.com is a 
recognized sports archive of aggregated publically available athlete records, which includes 
statistics on professional baseball, basketball, football, and hockey players. Wikipedia.org has 
been argued to be a similar or superior method of data retrieval to traditional sources due to the 
accessibility from its open access structure (e.g., Coate & Sun, 2013). A random sample from 
each player population was also cross-referenced in their respective official sport encyclopedia, 
among other sources (including all centenarians and players who died at very young ages). If a 
discrepancy between variables was identified during cross-referencing, the statistic that was most 
commonly reported in a majority of the data retrieval sources was used. In addition, a general 
web search was performed for all players who were missing a death date and were 65 years or 
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older in order to locate potential death dates that were not captured through the primary sources 
of data retrieval. A player was removed from the dataset if a death date was not located and they 
were 100 years old or older. Since life expectancies in all countries in the world are less than 100 
years old, and becoming a centenarian remains a relatively rare achievement, we were confident 
that this cut-off age would remove a vast majority of players who were already deceased. As 
well, while some studies examining lifespan in the four major sports excluded players who 
played for a short period of time (e.g., Lawler, Lawler, Gibson, and Murray (2012) excluded 
NBA players who appeared in less than five games), the aim of this study was to capture all 
players who played in any of the four leagues at any point in time. We argue that debuting in any 
of these professional leagues alone indicates a relatively superior level of cardiovascular fitness 
and athletic ability for most cases compared to the general population. Career length was 
reported in years and was calculated by subtracting the players’ last year in the league from their 
debut year. As some players, particularly in the earlier eras, took years off between their debut 
year and year in which they retired (e.g., Charley O’Leary played from 1904 to 1913, but 
returned to bat in one game in 1934), actual years played were searched (and adjusted 
accordingly) in a minimum of 25% of the players for each sport through their biographical pages 
on sports-reference.com as a more precise measure of active involvement in the league. In 
particular, a secondary search for precise career lengths was performed for all NBA/American 
Basketball Association (ABA) players since these athletes were more likely to go play in other 
professional leagues (e.g., particularly in Europe for the modern-era players) and come back to 
the NBA relative to athletes from the other three sports, as well as for all players who had a 
career length of 25 years or greater after subtracting their last year from their debut year. All 
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height and weight variables were converted to centimetres (cm) and kilograms (kg), respectively. 
Ethics review was not required as all data were collected from publicly available sources. 
Samples and Variables 
MLB  
Data on living and deceased MLB players were retrieved from two primary online 
sources; baseball-reference.com and through the 2014 version of the Sean Lahman baseball 
database (www.baseball1.com). Despite Smith’s (2011b) reporting of incomplete data for some 
players, this otherwise well-respected database, compiled by recognized statisticians and a team 
of researchers, was used as the initial method of data collection as it provided a current and 
comprehensive list of all players who played professional baseball starting in the National 
Association of Professional Base Ball Players (1871 – 1875; the first professional baseball 
league) to the 2014 MLB season. Nevertheless, our method of removing players from the 
datasets who were 100 years or older without a death date, along with a general web search for 
all players who were missing a death date and were 65 years or older, was rigorously instituted 
for this athlete population.  
The variables collected were: player name, career length, handedness (for both batting 
and throwing), height, weight, birthdate and death date. The Master table from the Lahman 
database used to collect these data did not include player position; therefore, these data were 
collected through mlb.com’s player index (mlb.mlb.com/stats/sortable.jsp). Death data were 
collected until January 25, 2016. We used “15” as the day of birth and/or “6” as the month of 
birth (less frequently) for 279 cases that were missing complete birthdate information, and for six 
cases that involved incomplete death date information. Since there was a time gap between the 
2014 version of the Lahman database and our data collection cut-off date, recent deaths (i.e., 
January 1, 2014 – January 25, 2016) were added through the online Baseball Almanac, which 
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provides a historical breakdown by year of death (http://www.baseball-
almanac.com/players/baseball_deaths.php) and each death was cross-referenced with baseball-
reference.com. All but one of the deaths that occurred in 2014 identified through the online 
Baseball Almanac was already included in the Lahman database. Players who were active past 
the 2013 season (i.e., were part of a MLB roster in 2014 or beyond) were censored for the career 
length analysis to ensure that a full career was captured. All data were cross-referenced in both 
of the primary sources, along with a random sample of 10% in Total Baseball (Thorn et al., 
2004) and through thedeadballera.com.  
 Total size of sample examined 
 Overall, 18,588 players were identified and extracted through our search. We removed 
127 players whose birthdate was publicly inaccessible. We removed an additional 42 players 
who were 100 years or older and were missing a death date (M = 150.26 y ± 12.76). Therefore, a 
total of 18,419 players were included in the analyses. In addition, 187 cases that were missing 
“career debut” and “career end” data in the Lahman database and were unable to be located 
through our search were censored for the career length/debut analyses, but were considered for 
other analyses (i.e., they were part of the total 18,419 player sample).   
NBA/ABA 
 Data were collected on living and deceased NBA and ABA players who played from the 
1946–1947 inaugural season to the 2009–2010 season from two primary online sources; 
basketball-reference.com and wikipedia.org. The variables collected were: player name, player 
position, career length, induction into the HOF (collected from the official Naismith Memorial 
Basketball HOF website, hoophall.com/hall-of-famers-index), handedness, height, weight, 
birthdate and death date. Death data were collected until December 11, 2015. We used “15” as 
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the day of death for nine cases that were missing complete death date information. Players who 
were active past the 2009–2010 season were censored for the career length analysis. All data 
were cross-referenced in both of the primary sources, along with a random sample of 10% in 
Total Basketball (Koppett, Shouler, Ryan, Smith, & Bellotti, 2003), nba.com’s historic player 
index and apbr.org’s biographical database compiled by John Grasso.  
Total size of sample examined 
Birthdates for all players were publicly accessible and no players were at least 100 years 
old and missing a death date, as the oldest living player as of December 11, 2015 was 98 years of 
age. Therefore, a total of 3,901 players were included in the analyses.   
NFL 
 Data were collected on living and deceased NFL players who played from the 1920 
inaugural season (originally named the American Professional Football Association from 1920–
1921) to the 2012 season (ended on December 30, 2012) from two primary online sources; pro-
football-reference.com and wikipedia.org. The variables collected were: player name, player 
position, career length, height, weight, birthdate and death date. Death data were collected until 
September 10, 2015. We used “15” as the day of birth for 31 cases and “6” as the month of birth 
for 26 cases that were missing complete birthdate information, and “15” as the day of death for 
158 cases and “6” as the month of death for eight cases that involved incomplete death date 
information. Players who were active past the 2011 season were censored for the career length 
analysis. All data were cross-referenced in both of the primary sources, along with a random 
sample of 10% in Total Football (Carroll, Gershman, Neft, & Thorn, 1999) and nfl.com’s 
historic player index.  
Total size of sample examined 
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 Overall, 22,797 players were identified and extracted through our search. We removed 
113 players whose birthdate was publicly inaccessible. We removed an additional 69 players 
who were 100 years or older and were missing a death date (M = 113.65 y ± 6.34). Therefore, a 
total of 22,615 players were included in the analyses.     
NHL 
 Data were collected on living and deceased Canadian- and US-born NHL players who 
played from the 1917–1918 inaugural season to the 2010–2011 and 2012–2013 season, 
respectively, from four primary online sources; hockey-reference.com, quanthockey.com, 
wikipedia.org and sihrhockey.org. Variables were collected from hockey-reference.com and 
quanthockey.com and included player name, nationality, player position, career length and 
birthdate. Height and weight were only collected for US-born players during the time of data 
collection. Death data were collected until December 31, 2015 for both the Canadian- and US-
born players from hockey-reference.com, wikipedia.org and sihrhockey.org. We used “15” as the 
day of death for two cases that were missing complete death date information. During the time 
period in which data for the Canadian-born players were collected, we elected to use “1” as the 
day of birth for this sample of players, which likely minimally altered the age of death findings. 
Canadian-born players who were active past the 2009–2010 season and US-born players who 
were active past the 2011–2012 season in the NHL were censored for the career length analysis. 
All data were cross-referenced in each of the primary sources, along with a random sample of 
10% in Total Hockey (Duplacey, Diamond, Dinger, Kuperman, & Zweig, 1998) and hhof.com 
(official website of the hockey HOF).  
Total size of sample examined 
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Birthdates for all players were publicly accessible and no players were at least 100 years 
old and missing a death date. The oldest living Canadian-born player was 97 years of age, and 
the oldest living US-born player was 96 years of age as of December 31, 2015. Therefore, a total 
of 5,580 (4,601 Canadian-born and 979 US-born) players were included in the analyses.   
 Overall, 50,515 athletes from the four major sports in North American were examined in 
this study.  
Statistical Analyses 
 Data were analyzed descriptively and through Kaplan-Meier and Cox regression survival 
analyses. All data were analyzed using SPSS version 23, and statistical significance was defined 
as p < 0.05 at the 95% Confidence Interval (CI). Given the large sample sizes where p values 
indicated statistical significance, Hazard Ratios (HRs) were only marked as significant if CI 
excluded 1.00. Separate analyses for each sport were also performed because of the unique 
histories and constraints to each sport. For example, professional baseball started in 1871 while 
professional basketball started in 1946, and each sport has unique playing positions. Of the 
variables collected, career length was the only variable included as a covariate in the combined 
sport survival analysis, as it was collected for all players and did not appear to be highly 
confounded by type of sport. 
Results 
Combined Sport Analyses 
Descriptives. Overall, 17,523 out of 50,515 (34.7%) athletes were deceased as of the 
respective data collection cut-off date for their sport. More specifically, 9,358 of 18,419 (50.8%) 
MLB players were deceased as of January 25, 2016, 787 of 3,901 (20.2%) NBA/ABA players 
were deceased as of December 11, 2015, 6,129 of 22,615 (27.1%) NFL players were deceased as 
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of September 10, 2015, and 1,250 of 5,580 (22.4%) Canadian- and US-born NHL players were 
deceased as of December 31, 2015. Descriptive data on mortality outcomes by sport are shown 
in Table 6.1.  
Standardized Comparisons. Descriptive data standardized by debut years are shown in 
Table 6.2. Given the inaugural season differences between the leagues, this allowed proportional 
comparisons of athlete death rates across the four sports, standardized by the time period in 
which they debuted in their respective league. NBA/ABA players who debuted between the 
inaugural season and 1975 and between 1986 and 1995 had the highest proportion of death 
relative to the other three sports during the same time period. In contrast, MLB players who 
debuted between 1976 and 1985 and between 1996 and 2005 had the highest proportion of death 
relative to the other three sports during the same time period. Interestingly, NHL and NFL 
players who debuted after 2005 had a higher proportion of death relative to MLB players, while 
no deaths have been reported in NBA/ABA players. Overall, there was a moderate amount of 
variability in the death rates between the four sports in each of the debut year time periods 
analyzed. Much of this variability was created by NHL players having consistently lower 
proportions of death between the debut years of 1946 and 2005 relative to the other three sports. 
The largest death rate disparity was observed for athletes who debuted between 1946 and 1955, 
where 63.0% of the NHL sample was deceased at the time of data collection, which was a 
considerably lower proportion of deceased athletes compared to those who played in the 
NBA/ABA (82.2%), NFL (81.5%) or MLB (78.0%) during the same time period.   
Survival and Cox Regression Analyses. Kaplan-Meier survival analysis found the median 
survival times to be 75.0 years for MLB players, 81.4 years for NBA/ABA players, 78.7 years 
for NFL players, and 80.0 years for NHL players (77.5 years overall; ² (3) = 541.38, p < .05; 
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see Figure 6.1). Compared to MLB players, Cox regression analysis found a significantly lower 
risk of death for NBA/ABA (HR) 0.56, 95% CI: .53 – .61), NFL (HR 0.75, 95% CI: .73 – .78), 
and NHL (HR 0.66, 95% CI: .63 – .71) players (see Figure 6.2). After excluding those players 
who were still active (i.e., measuring only full career lengths), we found that a one year increase 
in career length significantly decreased the risk of death (HR .982, 95% CI: .978 – .985), even 
after adjusting for sport type (HR .977, 95% CI: .974 – .980). Interestingly, while this effect was 
small and appeared to be influenced by the large sample size, unadjusted Cox regression 
analyses found a similar pattern across each of the four sports (NBA/ABA athletes narrowly 
missed statistical significance). Survival and Cox regression data on mortality outcomes by sport 
are shown in Table 6.3.  
League-Level Analyses 
MLB 
 Descriptives. The median age of death was 70.4 years and the mean age of death was 
68.0 years (SD = 16.2) for the entire MLB sample. A total of 17 centenarians were identified 
with the oldest player living to 107.4 years, and the youngest death occurred at 19.6 years. Of the 
occupational variables collected, we found players to average 5.8 years (SD = 5.1) in career 
length, with a majority being right-handed batters (65.7%) compared to batting left-handed 
(27.6%) or ambidextrously (6.7%), and a majority were right-handed throwers (79.9%). We 
identified 42.9% pitchers, 9.6% catchers, and 47.5% who played other positions (i.e., first, 
second and third baseman, shortstop, and left, center and right fielder). Of the biological 
variables collected, players averaged 84.2 kg (SD = 9.5) in weight and 183.5 cm (SD = 6.6) in 
height, with the highest participation in those who were born between 1960 and 1979 (20.3%) 
and the least in those born between 1820 and 1839 (0.1%) and 1840 and 1859 (4.0%).  
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 Survival and Cox Regression Analyses. MLB players were found to have a significantly 
lower risk of death for every one year increase in career length (HR .977, 95% CI: .973 – .981), 
one kg increase in weight (HR .985, 95% CI: .982 – .988) and one cm increase in height (HR 
.975, 95% CI: .972 – .978). In addition, pitchers had a lower risk of death compared to players in 
other positions (HR .946, 95% CI: .906 – .988). After adjusting for birth decade, only career 
length remained as a significant predictor of early mortality risk. In contrast, no statistically 
significant differences in mortality risk were found between laterality preferences of players.  
NBA/ABA 
Descriptives. The median age of death was 71.0 years and the mean age of death was 
68.1 years (SD = 16.0) for the entire NBA/ABA sample. No centenarians were identified with 
the oldest player living to 99.6 years, and the youngest death occurred at 24.4 years. Of the 
occupational variables collected, we found players to average 4.9 years (SD = 4.4) in career 
length, with a high majority being right-handed (94.5%). We identified 35.1% guards, 10.0% 
guards/forwards, 31.4% forwards, 11.1% forwards/centers and 12.4% centers. In addition, 2.9% 
of the living and deceased player population were inducted into the basketball HOF. Of the 
biological variables collected, players averaged 93.9 kg (SD = 11.7) in weight and 197.8 cm (SD 
= 9.3) in height, with the highest participation in those who were born between 1960 and 1979 
(33.4%) and the least in those born between 1900 and 1919 (1.9%).  
Survival and Cox Regression Analyses. NBA/ABA players who played as both a guard 
and forward during their career had a significantly lower risk of death compared to players who 
just played as a guard (HR .738, 95% CI: .571 – .953), while players who played exclusively at 
the center position had a significantly higher risk of death compared to guards (HR 1.50, 95% 
CI: 1.14 – 1.97. Each of these positions remained significant predictors of risk of early mortality 
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after adjusting for birth decade. No statistically significant differences in early mortality risk 
were found between player career longevities, anthropometrics, laterality preferences or 
inductees and non-inductees into the HOF.  
NFL 
Descriptives. The median age of death was 71.8 years and the mean age of death was 
69.1 years (SD = 15.6) for the entire NFL sample. Five centenarians were identified with the 
oldest player living to 104.2 years, and the youngest death occurred at 21.9 years. Of the 
occupational variables collected, we found players to average 4.4 years (SD = 3.7) in career 
length, and a majority playing the offensive line position (18.6%) and the least playing as a 
punter (1.1%) or kicker (1.3%). Of the biological variables collected, players averaged 101.4 kg 
(SD = 17.3) in weight and 186.3 cm (SD = 6.4) in height, with the highest participation in those 
who were born between 1960 and 1979 (32.7%) and the least in those born between 1880 and 
1899 (4.2%; two players were born prior to 1880).  
Survival and Cox Regression Analyses. NFL players were found to have a significantly 
lower risk of death for every one year increase in career length (HR .971, 95% CI: .964 – .979) 
and one cm increase in height (HR .982, 95% CI: .978 – .986), although each of these effects 
became insignificant when adjusting for birth decade. In addition, player position appeared to 
have a moderate influence on early mortality risk. For example, relative to wide receivers, 
offensive linemen (HR 1.77, 95% CI: 1.61 – 1.95) and running backs (HR 1.62, 95% CI: 1.47 – 
1.79) had a significantly higher risk of death, whereas defensive backs (HR .713, 95% CI: .615 – 
.827) had a significantly lower risk of death. Each of these positions remained significant 
predictors of early mortality risk after adjusting for birth decade. Interestingly, weight was not 
found to be a significant precursor to premature mortality. 
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NHL 
Descriptives. The median age of death was 72.7 years and the mean age of death was 
69.7 years (SD = 15.6) for the entire NHL sample. One centenarian was identified, living to 
100.9 years, and the youngest death occurred at 20.4 years. Of the occupational variables 
collected, we found players to average 5.8 years (SD = 5.0) in career length, and a majority 
playing defense (28.1%), followed by center (21.7%), right wing (21.2%), left wing (19.2%) and 
goalie (9.8%). Of the biological variables collected with the US-born sample, players averaged 
88.7 kg (SD = 7.6) in weight and 184.1 cm (SD = 5.7) in height, with the highest participation in 
those who were born between 1960 and 1979 (36.1%) and the least in those born between 1880 
and 1899 (3.0%; one player was born prior to 1880).  
Survival and Cox Regression Analyses. NHL players were found to have a significantly 
lower risk of death for every one year increase in career length (HR .972, 95% CI: .961 – .984). 
When accounting for country of birth, Canadian-born players showed a similar pattern of lower 
risk of death for every one year increase in career length (HR .971, 95% CI: .959 – .983); 
however, this relationship was not statistically significant for the US-born players (HR .971, 95% 
CI: .900 – 1.05). Shorter US-born players were found to have a lower risk of death (HR .956, 
95% CI: .915 – .999), although this relationship became statistically insignificant after adjusting 
for birth decade, while no statistically significant differences in early mortality risk were found 
between player weight. In addition, combined and separate Cox regression analyses on 
Canadian- and US-born players did not reveal playing position to significantly influence the risk 
of death, although lower risk of death for US-born left wingers relative to goalies narrowly 
missed statistical significance (p = .07). Nevertheless, career length remained a significant 
predictor of mortality risk for the overall NHL player sample after adjusting for birth decade.  
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Discussion 
The purpose of this study was to provide a current and comprehensive examination of 
mortality outcomes of athletes from the four major sports in North America. We hypothesized 
that i) MLB players would have a significantly higher imminent mortality risk relative to the 
other three sports and that ii) proportional death rates would be similar across the four sports. 
Our first hypothesis was supported; the combined sport Kaplan-Meier survival analysis indicated 
that MLB players had a significantly higher imminent mortality risk relative to the other three 
major sports. In addition, the overarching influence of career length on mortality suggests that 
longer participation in professional sport lowers risk of death, regardless of physiological and 
other context-specific demands. When adjusting for birth decade, the key finding from the 
league-level analyses indicated that player position has a low to moderate influence on early 
mortality risk for NBA/ABA and NFL players, and no influence in MLB and NHL players. The 
other variables analyzed (i.e., anthropometric data, handedness and HOF induction) were not 
found to significantly impact mortality risks of the athletes.  
Our second hypothesis was partially supported; similarities between the proportional 
death rates of athletes who played during the same time periods were mostly seen between MLB, 
NBA/ABA and NFL players, although NBA/ABA generally had higher rates of death. 
Alternatively, former NHL players debuting between 1946 and 2005 consistently had the lowest 
proportionate rate of death. Further, the finding that NHL and NFL players who debuted after 
2005 had a relatively higher proportion of death supports the recent media attention garnered 
towards the issue of concussions and their relationship to suicide in these two sports. A visible 
tragedy such as young player committing suicide as a result of head injuries sustained from 
competition threatens to ignore the complete picture of mortality risk that preceded the event. 
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Interestingly, the overall mean ages of death, including the variability in ages of death, were very 
similar in athletes across the four sports examined. Therefore, while the ages of death are 
generally similar between the four sports, there appears to be proportionate death disparities 
between NHL players and athletes from the other three sports, where Canadian- and US-born 
NHL players die at a lower rate.  
Statistical vs. Meaningful Significance  
Importantly, caveats exist to the practical use of some of the key findings of this study. In 
contextualizing these findings, it is important to recognize how the characteristics of the 
historical and unique nature of the dataset analyzed can influence our interpretation and 
dissemination of the results. MLB players were found to have a higher risk of death relative to 
the other three sports; however, statistical significance was most likely driven by the MLB 
inaugural season (1871) occurring much earlier than the other three sports (≥ 1917), resulting in 
15.1% (n = 2,783) of the players being born in the 19
th
 century. Thus, while MLB had the 
relatively highest proportion of deceased players (50.8%), it also contained a large cohort of 
players whose life expectancies at birth were lower compared to athletes born after 1900, 
predisposing the Kaplan-Meier estimate to produce a statistically significant hazard risk. The 
intuitiveness of this finding arguably limits the meaningfulness of the result, which likely would 
have been more useful if each of the four major sports started on the same date. As such, the 
death rate comparisons standardized by debut year across the four sports may have more 
meaningful significance than mortality risk estimates.    
The characteristics of the dataset also indicate that the practical use of the statistically 
significant results from the Cox regression analyses was likely limited by the large sample sizes 
of athletes driving the effect. A majority of the unadjusted and adjusted variables measured had 
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small effect sizes, and the CI ranges were small and close to 1.00 (i.e., equivalence in the hazard 
rate). The largest effect sizes of early mortality risk were found in the player position variable. 
For example, centers in basketball were found to have the highest early mortality risk of any 
other player position examined after adjusting for birth decade. In addition, we found NFL 
defensive linemen to have the second-highest adjusted mortality risk, which supports Baron, 
Hein, Lehmen and Gersic’s (2012) finding of NFL defensive linemen having the highest 
mortality risk from cardiovascular disease. Since centers and linemen are usually the largest 
players on their respective field of play, the largest effect sizes of the variables analyzed suggest 
that relatively larger body size increases risk of early mortality. In contrast, anthropometric 
predictors (i.e., height and weight) did not have a robust impact on early mortality risk for 
athletes from any of the four sports when adjusted for birth decade, although the unadjusted 
trends for MLB, NFL and US-born NHL players suggested that lower height and weight was 
conducive to longevity. While the reasoning behind this counterintuitive finding is unclear, we 
speculate that given the positional demands, defensive linemen have a higher percentage of body 
fat relative to players in other positions where muscularity is more favourable to performance 
(e.g., running backs).  
Overall, this study suggests that i) MLB players have the highest imminent mortality risk, 
ii) NHL players generally die at the lowest proportional rate, and iii) longer career lengths and 
smaller body sizes generally reduce early mortality risk. While the overall magnitude of the 
effect sizes of the variables analyzed was small, the aforementioned trends provide interesting 
avenues for future research to explore in more depth. For example, previous work in this area has 
suggested that the energy systems required for participation in certain sports (i.e., 
aerobic/endurance, mixed, and anaerobic/power) may influence mortality outcomes; athletes 
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from sports with aerobic demands generally have superior longevities to athletes participating in 
anaerobic sports (Lemez & Baker, 2015; Teramoto & Bungum, 2010). However, this trend was 
only partially supported in this study through the proportional death rate analysis; NHL players 
died at the lowest proportional rate, but NBA/ABA players died at the highest proportional rate 
(both sports are more aerobically demanding than MLB and NFL). Unfortunately, it is outside 
the scope of this study to determine the causes behind the mortality trend disparities between 
these sports. 
Limitations 
 The main limitation of this type of analysis is the inability to account for the lifestyle 
factors of these athletes prior to their death. Due to the historical nature of our examination and 
the lack of publicly accessible information regarding their physical, mental, and social well-
being, our knowledge of their health outcomes is largely limited to how long they lived. In other 
words, exposure to a certain type of sport (cause) does not necessarily explain an athletes’ 
mortality outcome (effect). Our data are also unable to delineate the difference between lifespan 
and health span, where a number of athletes may have lived a long life but were unhealthy from 
a disease and/or disability standpoint. In addition, the inclusion of causes of death would likely 
help explain certain mortality trends seen in these athletes (e.g., deaths during World War II). 
Another limitation of this study is not having a reference control group from the general 
population; however, the main purpose of this study was to compare the mortality outcomes of 
athletes between the four major sports. A final limitation of this study relates to data collection; 
there were possible data entry errors and potential omissions of death dates due to the large 
quantity of data that were collected, despite adopting a rigorous cross-referencing approach. In 
addition, a function of longitudinal data collection resulted in having different ending points for 
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the death data between the four sports, which may have minimally biased some of the results 
(i.e., death data cut-offs were five months apart between the four sports, September 2015 to 
January 2016). 
Conclusion 
More broadly, the association between sport type and lifespan is buffered by several 
determinants of health; however, investigating risk of death differences through different 
occupational and biological variables can help highlight aversive trends to lifespan that permeate 
throughout high performance athlete populations. For example, identifying robust predictors of 
premature death and other worrisome mortality trends in groups of athletes may allow for 
practical feedback to health and sport practitoners that may initiate modifications to current 
healthcare models for active and retired athletes. In turn, continued empirical examinations into 
the health outcomes of high performance athletes can help dispel common assumptions regarding 
health risks from participating in sport.  
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Figure 6.1: Kaplan-Meier survival probability for living and deceased MLB, NBA, NFL and 
NHL players [² (3) = 541.38, p < .05] 
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Figure 6.2: Cox regression hazard model for living and deceased MLB, NBA, NFL and NHL 
players 
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Table 6.1: Descriptive mortality data of professional athletes from the four major sports in North America 
 
  Sport (Debut Years                       % Dead by      Median Death    Mean Death        
           Analyzed)           n        Cut-off Date*    Age in Years    Age in Years   Minimum   Maximum     
 
MLB (1871 – 2014)            18,419           50.8                   70.4              68.0 ± 16.2        19.6           107.4               
NBA/ABA (1946 – 2009)     3,901           20.2                   71.0              68.1 ± 16.0        24.4             99.6               
NFL (1920 – 2012)             22,615           27.1                   71.8              69.1 ± 15.6        21.9           104.2 
NHL – CA (1917 – 2010)     4,601           25.5                   72.7              69.7 ± 15.5        20.4             97.2 
NHL – US (1917 – 2012)        979              7.9                   73.4             70.1 ± 16.8        25.7           100.9 
Overall                                50,515            34.7                   71.1             68.5 ± 16.0        19.5           107.4 
*Uncensored cases 
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Table 6.2: Standardized mortality data of professional athletes from the four major sports in North America, by debut years 
 
                                    MLB                                      NHL                                      NFL                                   NBA/ABA 
                         M Death     % Dead               M Death    % Dead                M Death     % Dead                M Death     % Dead       
Debut Years       n         Age (y)    by Cut-off     n       Age (y)   by Cut-off     n       Age (y)    by Cut-off     n       Age (y)    by Cut-off     
1871 – 1900   2,058   61.3 ± 17.6   100.0                             --                                             --                                           -- 
1901 – 1916   2,333   68.3 ± 15.6   100.0                             --                                             --                                           -- 
1917 – 1919      268   69.1 ± 15.5   100.0          65   67.1 ± 15.0   100.0                             --                                           -- 
1920 – 1930   1,304   71.0 ± 14.8   100.0        321   70.3 ± 14.7   100.0       1,821   70.6 ± 14.5   100.0                          -- 
1931 – 1945   1,696   73.8 ± 14.3     98.4        457   74.0 ± 13.8     98.5       1,763   72.7 ± 14.8     98.6                          -- 
1946 – 1955   1,098   73.8 ± 12.8     78.0        335   73.5 ± 12.9     63.0       1,680   73.2 ± 12.8     81.5        578    75.6 ± 12.1     82.2 
1956 – 1965   1,125   66.5 ± 12.7     35.5        280   64.6 ± 14.1     28.2       1,771   64.8 ± 12.3     33.3       260     65.8 ± 13.6     41.5 
1966 – 1975   1,288   56.5 ± 12.8     14.0        736   56.8 ± 13.4     10.6       2,570   56.3 ± 11.4     12.6       782     56.0 ± 11.9     17.1 
1976 – 1985   1,384     51.4 ± 9.3       6.1     1,068     47.9 ± 7.7       2.2       2,937     44.9 ± 9.1       5.0       596     49.6 ± 10.0       6.0 
1986 – 1995   1,697     40.8 ± 8.0       1.9        962     36.3 ± 9.0       1.4       3,979     37.9 ± 7.7       2.4       674       40.4 ± 9.4       4.0 
1996 – 2005   1,995     33.3 ± 5.7       1.2        827     29.9 ± 3.8       0.8       3,546     31.6 ± 5.5       1.0       674       34.0 ± 5.9       1.0 
2006 – 2014* 1,986     24.6 ± 3.2       0.2        529     25.1 ± 5.3       0.4       2,548     26.6 ± 2.1       0.4       337              --               -- 
*Debut was calculated until 2009 for NBA/ABA players, 2010 for Canadian-born NHL players and 2012 for US-born NHL players and NFL 
players       
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Table 6.3: Cox proportional hazard ratios for sport-specific variables 
                      
    Age of Death Predictors  Adjusted for      
Variables  Unadjusted               Birth Decade                         
                HR (95% CI)             HR (95% CI)                 
MLB        
Career Length                 .977 (.973 – .981)         .986 (.983 – .990) 
Position 
   Other (ref) 
   Pitcher               .946 (.906 – .988)         1.02 (.984 – 1.07) 
   Catcher                        1.07 (1.00 – 1.15)          1.05 (.986 – 1.13) 
Weight                            .985 (.982 – .988)          1.01 (1.00 – 1.01) 
Height                             .975 (.972 – .978)          1.00 (1.00 – 1.01) 
Bats 
   Both (ref) 
   Right                            1.02 (.928 – 1.12)          1.02 (.927 – 1.12) 
   Left                              1.01 (.916 – 1.12)          1.02 (.927 – 1.13) 
Throws 
   Left (ref) 
   Right                            1.01 (.959 – 1.07)          .985 (.958 – 1.01) 
 
NBA 
Career Length                 .985 (.966 – 1.00)          .989 (.969 – 1.00) 
Position 
   Guard (ref) 
   Guard/Forward            .738 (.571 – .953)          .734 (.569 – .949) 
   Forward                       1.23 (.945 – 1.63)          1.22 (.927 – 1.60) 
   Forward/Center           .813 (.627 – 1.05)          .813 (.627 – 1.05) 
   Center                          1.50 (1.14 – 1.97)          1.48 (1.13 – 1.94) 
Weight                            1.01 (1.00 – 1.02)          1.01 (1.00 – 1.02) 
Height                             1.01 (1.00 – 1.02)          1.01 (1.00 – 1.02) 
Handedness 
   Left (ref) 
   Right                            .938 (.647 – 1.36)          .925 (.638 – 1.34) 
HOF 
   Non-inductee (ref) 
   Inductee                       .842 (.602 – 1.17)          .835 (.597 – 1.16) 
 
NFL 
Career Length                 .971 (.964 – .979)          .996 (.988 – 1.00) 
Position 
   Wide receiver (ref)          
   Defensive back            .713 (.615 – .827)          .794 (.684 – .921) 
   Defensive line             1.29 (1.13 – 1.48)           1.44 (1.26 – 1.65) 
   Kicker                          .611 (.394 – .947)          .725 (.467 – 1.12) 
   Linebacker                   .829 (.791 – .980)          1.01 (.854 – 1.19) 
   Multiple                       1.54 (1.39 – 1.70)          1.20 (1.08 – 1.33) 
   Offensive line              1.77 (1.61 – 1.95)          1.29 (1.17 – 1.42) 
   Punter                          .619 (.340 – 1.12)          .862 (.473 – 1.56) 
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   Quarterback                 .996 (.835 – 1.18)          .972 (.815 – 1.16) 
   Running back              1.62 (1.47 – 1.79)           1.19 (1.08 – 1.32) 
   Tight end                     .548 (.387 – .774)          .719 (.508 – 1.01) 
Weight                            .998 (.996 – 1.00)          1.01 (1.00 – 1.01) 
Height                             .982 (.978 – .986)          1.00 (1.00 – 1.01) 
 
NHL 
Career Length                 .973 (.961 – .984)          .983 (.971 – .995) 
Position 
   Goalie (ref) 
   Center                          .874 (.699 – 1.09)          .889 (.711 – 1.11) 
   Left wing                     .843 (.675 – .994)          .825 (.661 – 1.03) 
   Right wing                   .876 (.703 – 1.09)          .858 (.688 – 1.07) 
   Defense                        1.03 (.833 – 1.27)          1.01 (.820 – 1.26) 
Weight*                          .990 (.963 – 1.02)          1.00 (.976 – 1.03) 
Height*                           .956 (.915 – .999)          .989 (.943 – 1.04) 
 
Significant HRs bolded (p < .05, 95% CI exclude 1.00); *US-born players only 
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CHAPTER EIGHT: GENERAL DISCUSSION 
 The overarching purpose of this research was to provide an evidence-based portrayal of i) 
incidence, ii) predictors and iii) causes of death in athletes from Major League Baseball (MLB), 
the National Basketball Association (NBA)/American Basketball Association (ABA), the 
National Football League (NFL) and the National Hockey League (NHL). Mortality differences 
of athletes between and within sport(s) were explored throughout this dissertation beginning in 
Chapter Two, which systematically reviewed mortality and longevity literature in elite athletes 
from a broad range of sports, to Chapter Seven, which examined survival trends of players from 
the four major sports in North America. In addition, biological and occupational risk factors and 
characteristics of early mortality were also consistently investigated, and attention was given to 
statistical artifacts that may distort the risk of death from certain predictors, particularly in 
Chapters Three (precocity) and Six (birth decade artificially inflating risk of premature death for 
black and taller players). The seven studies in this dissertation provide a more complete 
understanding of whether participation in high performance sport is a healthy pursuit when 
viewed from a lifespan perspective.  
Key Findings 
Chapter Two 
 The initial investigation into the mortality and longevity of elite athletes identified 54 
peer-reviewed studies and three online articles, where an overwhelming majority reported 
favourable lifespans for athletes compared to their age- and sex-matched controls from the 
general population. This review substantiated previous research in this area that suggested 
aerobic (i.e., endurance athletes such as cyclists) and mixed-sport (e.g., soccer players) athletes 
have superior longevity outcomes relative to more anaerobic (i.e., power athletes such as 
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weightlifters) sport athletes. Further, player position, weight, education and race were identified 
as robust predictors of longevity, whereas other risk factors such as precocity appeared to be less 
examined in sport.  
Chapter Three 
 In exploring the generalizability of the precocity-longevity hypothesis in sport, the 
overarching finding of the studies on former Canadian-born NHL players and NBA/ABA players 
did not find precocity to be a significant predictor of lifespan in athletes, even after using three 
different indicators of achievement to define precocity. The results present a more complicated 
narrative of the precocity-longevity effect, suggesting that contextual factors, such as the unique 
physical demands of sport, and measurement methodologies, may influence support for the 
proposed hypothesis in sport.  
Chapter Four 
 A low incidence of death was found in athletes who were still active when they died, 
which is a cohort of the athlete population that is particularly susceptible to having their death 
widely disseminated by popular media. As well, the leading causes of death in players from the 
four major sports reflected the leading causes of death in the age- and sex-matched controls from 
the Canadian and United States (US) general population. 
Chapter Five 
 Addressing the recent heightened anecdotal belief that ‘bigger’ athletes die younger, 
taller former NBA/ABA players were found to die younger and have significantly higher risk of 
early mortality compared to shorter players, supporting recent claims in the media by former 
players.  
Chapter Six 
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 Investigations into the causes of death of former NBA/ABA players indicated that i) they 
have similar leading causes of death and Crude Death Rates to sex- and race-matched controls 
from the US general population, ii) differences in death rates per Athlete-Year (AY) exist within 
time-dependent variables (e.g., birth decade) but less in more stable variables (e.g., handedness), 
and overall incidences of unnatural deaths per AY were less common across all predictors of 
mortality studied relative to natural deaths, and iii) a majority of the deceased player population 
died prematurely if the life expectancy was set at 75 years for each player, but less than 30% 
were considered young deaths if life expectancy at birth for each player was individually 
calculated. In addition, birth decade was a robust confounder of race and height’s influence on 
lifespan, as black and taller players entered the NBA in later decades, giving them less 
opportunity to live a full life since our analyses only included deceased players. 
Chapter Seven 
 A comprehensive examination of mortality outcomes of athletes from the four major 
sports found former MLB players to have a significantly higher imminent mortality risk relative 
to the other three major sports, although this was anticipated given MLB’s early inaugural season 
resulting in more players whose life expectancies at birth were relatively lower. Further, 
NBA/ABA players generally had the highest relative proportion of death when standardizing 
data by debut year, although NHL and NFL players have recently (debut > 2005) had the highest 
proportion of death. Career length also appeared to play an overall factor on lifespan, where each 
one year increase in career length lowered the risk of death.  
Type I vs. Type II Error: Limitations of Previous Work 
This dissertation highlighted caveats to the type of statistical measures used in previous 
literature, along with potential ramifications of disseminating risks of death without considering 
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the unique characteristics of the population studied. In particular, Chapters Three and Five drew 
attention to the importance of independent scientific replication, using the precocity- and height-
longevity hypotheses as examples of areas of research that are dominated by one researcher or 
team of researchers. Consequently, if extensive work is being performed by a small number of 
researchers, a larger onus on performing rigorous and appropriate methodological procedures 
may be needed.  
From a hypothesis testing standpoint, a Type I error (i.e., a false positive), often thought 
to be the more problematic error outside of medical research, occurs when the null hypothesis is 
incorrectly rejected in favour of the alternative. In contrast, a Type II error (i.e., false negative) 
occurs when the null hypothesis is falsely accepted. As it relates to the studies conducted on 
precocity-longevity, both types of errors may be present. First, a Type I error in this context 
erroneously suggests that early career achievement reduces lifespan. As noted in the historical 
review of precocity-longevity literature, the life expectancy bias/artifact describes the potential 
that younger death age among high achievers may occur because having a younger age is 
associated with shorter life expectancy (McCann, 2001). There is also the possibility that early 
death (and hence early achievement) simply permits a person to enter a study sample. This 
‘selection artifact’ (Simonton, 1994) means that the absence of still-living early achievers can 
skew effects to artificially support a precocity-longevity effect. Both of these artifacts describe 
the inherent potential for bias when studying a sample of only deceased eminent achievers 
(which all previous research has done) which can exaggerate the effect of the relationship, thus  
increasing the likelihood of a Type I error (i.e., identifying a precocity-longevity effect when one 
may not exist). 
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A related issue with Type I error is confusing statistical significance with practical 
significance (addressed in Chapter Seven). While MLB players were found to have a higher risk 
of death relative to the other three sports, statistical significance was most likely driven by the 
MLB inaugural season (1871) occurring much earlier than the other three sports (≥ 1917), 
predisposing the Kaplan-Meier estimate to produce a statistically significant hazard risk. As a 
result, the meaningfulness of this result is diminished, as the finding would have likely been 
more useful if each of the four major sports started on the same date. In addition, large sample 
sizes likely caused statistically significant Cox regression results, as the variables measured had 
predominantly small effect sizes with confidence interval ranges close to 1.00. The extremes of 
this Type I error issue were demonstrated in Chapter Six, where birth decade largely confounded 
the unadjusted predictors of race and height which portrayed black and relatively taller players as 
having significantly higher risks of earlier death.  
A Type II error in the context of precocity-longevity suggests early career achievement 
does not reduce lifespan when in fact it does. In sport, both Abel and Kruger (2007) and Lemez, 
Wattie, Ardern, and Baker (2014; Study 1 in Chapter Three) defined precocious achievement in 
athlete samples as the age at which athletes entered professional sport. However, the manner in 
which ‘precocity’ was operationalized may have reduced the likelihood of finding a significant 
precocity-longevity effect considering the age range for professional sport debut is typically 
quite narrow. This makes Abel and Kruger’s (2007) finding all the more interesting; however, 
they excluded living players in their sample.  
In any case, this dissertation addressed the Type I and Type II error likelihoods through 
rigorous methodological approaches which allowed for more ecologically valid analyses to be 
performed. In Chapter Three, while the first study on Canadian-born NHL players used ‘debut 
 
 
226 
 
age’ as a measure of precocity, living players were included in the analysis, accounting for the 
aforementioned statistical artifacts. In the second study on NBA/ABA players, precocity was 
defined through three different indicators of achievement, in addition to using both ‘deceased 
only’ and ‘deceased and living’ subsample strategies. It should be noted, however, that 
examining subgroups (e.g., players who were all-stars) may inflate Type I error, as more 
heterogeneities are likely to be found in smaller samples. In Chapter Six, an entire section was 
devoted to highlighting statistical biases from regression analyses in populations such as 
NBA/ABA players. More specifically, cohort effects were accounted for through combinations 
of odds ratio analyses that adjusted for different predictor variables, which illustrated the robust 
impact of birth decade on statistical significance. This bias was further corroborated and 
discussed in the cause of death interpretation, where those who were born earlier (i.e., 
predominantly white players) had a greater likelihood of dying from natural/old age causes 
relative to black players. 
(More) Practical Implications 
 The key findings of this dissertation suggest that athletes from the four major sports in 
North America have favourable mortality outcomes, although numerous factors need to be taken 
into consideration. The value of focusing on professional athletes rather than recreational or 
amateur athletes is that more biological and occupational factors are documented and publicly 
accessible at the elite levels of sport compared to lower levels of competition, thus allowing this 
dissertation to control for a greater number of variables that help increase the explained variance 
of mortality. The findings of this dissertation may also have applications for semi-professional 
and collegiate athletes, where similar biological and behavioural characteristics of athletes at 
lower levels of sport may illuminate health risk factors earlier, helping to increase overall athlete 
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well-being and reduce health outcome disparities within the athlete population. In turn, a 
comprehensive understanding of the implications of involvement in professional sport is 
necessary for the formation of evidence-based models of athlete development and care.  
The systematic review examining mortality and longevity of elite athletes in Chapter Two 
detailed the differences and nuances of health outcomes between and within sport(s). 
Investigating these large populations of athletes can provide broader and deeper awareness of the 
health status of elite athletes from sports with different physiological demands and behavioural 
expectations and challenge common assumptions regarding health risks of participating in 
certain high performance sports and/or positions. For example, the energy system demands of the 
four primary sports examined in this dissertation differ, where NBA and NHL players are 
generally exposed to more aerobic training and performance demands compared to MLB and 
NFL players. Training and performance demands differ between positions as well, such as a 
wide receiver needing to have higher aerobic capacity relative to a kicker in the NFL. Positional 
demands are also correlated with certain biological mechanisms that are conducive to 
performance but can be less favourable to health, such as NFL linemen being generally bigger in 
size relative to the other positions, and centers in the NBA whose exceptional heights assist in 
getting rebounds. Further, different playing eras between these four sports contained different 
socially-constructed factors that may have impeded long-term health, such as the widely known 
‘steroid-era’ in MLB and anecdotal evidence of widespread drug use amongst NBA players in 
the 1970s and early 1980s.  
In particular, this research informs our broader understanding of general athlete health, 
which can necessitate assessments of programs sporting organizations currently have in place for 
active and retired athletes. For example, the NBA, in conjunction with the Players Association 
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and the Retired Players Association, has recently sponsored a cardiovascular screening program 
that allows retired NBA players to receive free baseline tests and familiarize themselves with 
local cardiology groups (Smith, 2016). This is also an example of media and research attention 
working in a positive capacity through raising awareness of premature death in athletes 
(technology can also play a critical role in health education through ‘digital epidemiology,’ a 
timely way to receive health and disease information through digital data sources such as 
electronic devices; Salathé et al., 2012). While attention given to the recent string of former NBA 
player deaths from a cardiovascular-related cause likely produced the initial impetus to 
implement screenings, a by-product of this program may be more valuable to long-term health, 
helping former athletes build proactive rather than reactive health behaviours (e.g., regular 
doctor visits).  
While this is a positive and proactive first step, more empirical evidence on elite athlete 
health risk factors is needed to bolster health insurance policies post-retirement. In particular, 
health issues that manifest several years after retirement need to be considered in future 
discussions on health insurance restructurings, particularly from contact- and combat-based 
sports. For example, the repercussions of repetitive head trauma have been at the forefront of 
recent media coverage of NFL players, with chronic traumatic encephalopathy (CTE), a 
neurodegenerative brain disease generally manifesting in later life, being identified as a primary 
by-product of long-term concussive and subconcussive injury (e.g., Huber, Alosco, Stein, & 
McKee, 2016). 
 From an alternative perspective, while investigating risk of death differences through 
different occupational and biological variables can help highlight aversive trends to lifespan that 
permeate throughout high performance athlete populations, different measures of lifespan can 
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provide interesting insight into the impact of death outside of the health domain. An example of 
this is the measure of years of potential life lost (YPLL) in Chapter Six, which is used to help 
quantify social and economic loss as a result of premature death (Gardner & Sanborn, 1990). For 
professional athletes, the determinants of health created from societal-level conditions such as 
opportunity, social connections and resources are generally superior relative to the general 
population; however, a high rate of premature death can impact economic productivity. 
Premature deaths of athletes from the four major sports in particular, which generate a 
substantial amount of revenue, can create societal burden and produce indirect economic costs 
from productivity losses. In contrast, premature death of an exceptional achiever can actually 
produce a short-term economic gain, such as a spike in album sales of a recently deceased artist. 
Nevertheless, the occasional economic boost from a high achiever’s premature death is often 
short lived, and public health policies should aim to effectively target risk factors of early 
mortality to reduce economic costs to society. In sport, while YPLL may not have as large an 
economic impact as a chronic condition such as cancer in the general population (since the 
general population contains a very low proportion of elite athletes), this measurement is a 
microcosm of well-being that can nevertheless stimulate action to improve health and health 
education by illuminating precursors to specific causes of death, which in turn can cut healthcare 
costs through more health conscious behavioural change (e.g., altering diet to lower risk of 
diabetes, and by association, heart disease). 
Future Directions 
As the connection between physical activity and health continues to evolve, it is 
important for researchers to continue to investigate sport participants, which represent a 
considerable proportion of the post-industrial and developed population. Although typical 
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measures of mortality provide information about death and lifespan, we have a limited 
understanding of the contribution of specific diseases, injuries and underlying conditions (e.g., 
diet) to death (Parrish, 2010). In particular, studying elite athletes longitudinally (i.e., prior to 
death) will elicit a more complete understanding of their health outcomes and the causes that 
contribute to their death. For example, metrics relating to i) mortality and life expectancy, such 
as condition-specific mortality rates (e.g., diseases, injuries, occupational mortality, smoking-
attributable mortality, etc.) and ii) self-perceived health states, such as reporting psychological 
distress, would provide more targeted and efficient outreach efforts to investigate the underlying 
causes of death as opposed to the immediate causes of death.  
Parrish (2010) suggested that the relative value placed on long life compared to well-
being during life varies. While measuring mortality and life expectancy has been the traditional 
approach to indicate the health status of a population, information regarding the quality of their 
physical, mental and social domains of life is limited (“Healthy People 2020,” 2010). Going 
forward, the quality of the years lived will be an important avenue for researchers to explore in 
more depth considering the slow but steady increases in life expectancies globally. For example, 
future work in this area could look to utilize the multidimensional concept of health-related 
quality of life (HRQoL) through Ferrans, Zerwic, Wilbur, and Larson’s (2005) model that 
encompasses various domains and characteristics to better explain HRQoL over time (as 
suggested in Bakas et al.’s 2012 systematic review). More specifically, The Short Form (36) 
Health Survey (Ware & Sherbourne, 1992) is an example of a questionnaire that could be 
administered to athlete samples to broadly capture their quality of life post-retirement from elite 
sport by assessing their physical and mental health. In turn, this can highlight important HRQoL 
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differences between former elite athletes and the general population to help determine whether 
participation in elite sport is indeed a healthy pursuit.  
In addition, more research attention should be given to the career transition process and 
post-career experience of elite athletes, and the coping challenges that accompany retiring from 
sport, such as adjusting their (athletic) self-identity to meet their new day-to-day needs. Initial 
transitional challenges are typically influenced by whether discontinuation was normative (i.e., 
predictable and anticipated) or non-normative (i.e., involuntary); thus, using a lifespan model 
such as Wylleman and Reints’ (2010) “whole career/whole person” conceptualization of career 
transitions of elite athletes could be valuable. Examining longitudinal health-related behaviour 
patterns in athletes after they retire can highlight the importance of adopting a holistic 
perspective when considering the entirety of a lifespan. In particular, a strong and exclusive 
athletic identity is associated with negative psychological outcomes such as inadequate coping, 
negative affect and disturbed mood (Stambulova, 2003). As physical health can moderate 
psychosocial health (and vice versa), future work examining former athletes’ adaption to their 
post-athletic career life may assist in identifying factors leading to longer lifespans, such as 
illuminating sociobehavioural patterns of former athletes who lived exceptionally long.   
Conclusion 
The aggregation of different health measures and outcomes creates better assessment of 
public health research, practice and policy. This dissertation demonstrates that numerous 
biological and socially-constructed factors operating throughout the lifespan can have complex 
interactions and important implications on lifespan. Gavrilov and Gavrilova (2015) emphasized 
that knowledge of robust predictors of mortality and longevity is critical for actuarial science and 
practice. Key findings of this dissertation have practical implications for sport federations and 
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governing bodies (i.e., policies and programs underpinning sport organizations), as well as 
healthcare practitioners and clinicians. Therefore, as life expectancies continue to increase 
(Oeppen & Vaupel, 2002), public dialogue on health disparities between sub-populations and 
risk factors for premature death will be important, and continued research on athletes will assist 
sport stakeholders in implementing strategies to circumvent early incidence, predictors and 
causes of death.  
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